The Ultrastructural and Abnormal Calcium Handling in Pulmonary Vein Sleeve Cells, Atrial and Ventricular Myocytes During Ageing by Masoud, Said
Open Research Online
The Open University’s repository of research publications
and other research outputs
The Ultrastructural and Abnormal Calcium Handling in
Pulmonary Vein Sleeve Cells, Atrial and Ventricular
Myocytes During Ageing
Thesis
How to cite:
Masoud, Said (2018). The Ultrastructural and Abnormal Calcium Handling in Pulmonary Vein Sleeve Cells,
Atrial and Ventricular Myocytes During Ageing. PhD thesis The Open University.
For guidance on citations see FAQs.
c© 2018 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
1 
 
The ultrastructural and abnormal calcium 
handling in pulmonary vein sleeve cells, 
atrial and ventricular myocytes during 
ageing 
 
 
A thesis submission to the Open University for the Degree 
of Doctor in Philosophy 
 
Said Masoud, BSc 
 
 
Supervisors: 
Dr. Katja Rietdorf 
Dr. Martin Bootman 
Prof. Fraser McDonald 
 
 
 
 
January 2018 
 
 
 
 
2 
 
DECLARATION 
 
I declare that the work presented in this thesis is the result of my own work and includes 
nothing which is the outcome of work performed by other researchers, or in 
collaboration. This work does not contain any material submitted for a degree, diploma or 
any other qualification at the Open University. Contributions made by other researchers 
are fully acknowledged in relevant parts of the thesis. 
 
 
 
Said Masoud 
January 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
ABSTRACT 
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with age being a 
significant risk factor. It is well established now that electric activities originating from 
pulmonary vein sleeve cells (PVCs) initiate AF. Factors that are involved in maintaining AF 
include structural remodelling and abnormal Ca2+ handling in PVCs and atrial myocytes. 
Whilst structural changes and alterations in the Ca2+ homeostasis have been described 
previously in atrial myocytes, similar studies are still lacking in PVCs. Thus, this thesis 
investigated structural remodelling and Ca2+ handling, particularly in PVCs from 3- and 
24month-old mice. 
Using immunohistochemical and electron microscopy (EM) studies, this thesis revealed 
that PVCs just like atrial and ventricular myocytes, express RyR2, Cx40, and Cx43. Whilst 
RyR2 and Cx43 expressions did not change with age, Cx40 expression was found to 
deteriorate during ageing. Additionally, EM studies showed significant alterations in 
mitochondria which increased in size and numbers during ageing. Unlike PVCs, 
mitochondria in atrial myocytes were enlarged but did not increase in numbers during 
ageing. Mitochondria in ventricular myocytes did not deteriorate with age. 
This study also showed that Ca2+ homeostasis in PVCs is disrupted during ageing. PVCs 
from aged mice had an increased frequency and duration of spontaneous Ca2+ waves, 
with reduced amplitude, less able to follow electrical pacing and had higher basal ROS 
levels compared to PVCs from young mice. 
Additional studies attempted to induce ageing chemically with hydroxyurea (HU) in 
neonatal rat ventricular myocytes (NRVMs). HU inhibited pacing ability, induced 
autophagy and increased inducible ROS. Although some changes in chemically ageing 
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model were similar to those in aged PVCs, further studies are needed to fully establish 
whether HU can induce ageing in NRVMs. 
In conclusion, this study showed that structural remodelling and Ca2+ homeostasis differs 
in PVCs during ageing which may facilitate the occurrence of arrhythmias. 
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IKR  – rapid rectifier potassium current 
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INCX – NCX current 
ITO – transient outward current 
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ASPA – Animals Scientific Procedure Act 
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AV node - atrioventricular node 
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Na+ - sodium 
NCLX – mitochondrial Na+/Ca2+ exchanger 
NCX - Na+/Ca2+ exchanger 
NHE – Na+-proton exchanger 
nM - nanomolar 
NRVMs – neonatal rat ventricular myocytes 
HF - heart failure 
Hz - Hertz 
LSM - Laser scanning microscope 
PB - Phosphate buffer 
PBS - Phosphate buffered saline 
22 
 
PFA – paraformaldehyde 
PKA – protein kinase A 
PLN - phospholamban 
PMCA - plasma membrane Ca2+-ATPase 
PV – pulmonary vein 
PVCs - pulmonary vein sleeve cells 
RaM – rapid mode of Ca2+ uptake 
ROIs – regions of interests 
RyRs - Ryanodine receptors 
RyR2 - Ryanodine receptor type 2 
ROS – reactive oxygen species 
RT - room temperature 
SA node - sinoatrial node 
SEM – scanning electron microscope 
SERCA - sarcoplasmic reticulum Ca2+-ATPase 
SERCA2a - sarcoplasmic reticulum Ca2+-ATPase type 2 
SLN – sarcolipin 
SOCE – store operated Ca2+ entry 
SR - sarcoplasmic reticulum 
TBS – Tris buffered saline 
TEM – Transmission electron microscope 
Tn1 - Troponin 1 
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VOCCs - voltage-operated calcium channels 
 
23 
 
Chapter 1. Introduction 
1.1. Setting the picture: AF, ageing and why they are important issues 
Atrial fibrillation (AF) is the most sustained common form of arrhythmias with age 
becoming a significant risk factor (Kopecky et al., 1987, Go et al., 2001). The prevalence of 
AF increases strongly with age. Almost all cases occur in people who are 65 years old and 
above (Hayashi et al., 2002, Nattel et al., 2008). With our ever increasing ageing 
population, the prevalence of AF is predicted to increase (Teh et al., 2012, Colilla et al., 
2013). This reinforces the need to study age-dependent cardiac diseases like AF which are 
predicted to escalate in the future (Teh et al., 2012, Colilla et al., 2013). It is well 
established now that ectopic electrical activity originating from pulmonary vein sleeve 
cells (PVCs) (Sueda et al., 2005; Haissaguerre et al., 1998) initiates AF. This thesis explores 
the effects of ageing mostly in PVCs and the influence of age-dependent changes on 
facilitating the occurrence of arrhythmias. 
1.2. The heart 
The heart is a muscular organ that works repetitively and continuously to pump blood to 
supply the lungs and the body with oxygen. Our understanding of the heart originated in 
1628 with William Harvey’s finding that the heart is a muscular organ that pumps blood 
to the body with each heartbeat. This, coupled with the advances in technology in 
imaging, biochemistry and biophysics of cardiac function have greatly enhanced our 
understanding of the physiology of the heart and diseases associated with it. The heart 
rate varies between species in relation to body size; the larger the body the slower the 
heart rate. The average human heart beats 72 times per minute at rest, whereas a 
mouse’s heart beats on average 450 - 500 times per minute (Janssen and Smits, 2002). 
The mammalian heart is made up of four chambers; the left and right atria and the left 
and right ventricles as shown in Figure 1.1 below. The heart consists of many cell types 
with different properties depending on their spatial and their structural variances (De 
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Souza et al., 2013). Apart from cardiac myocytes, the heart tissue contains non-myocyte 
cells including fibroblasts, endothelial cells, smooth muscle cells and conducting cells in 
the sino atrial (SA) node (Kwak 2013). The major types of cardiac myocytes are atrial 
myocytes and ventricular myocytes (De Souza et al., 2013), but a third myocyte type can 
be found in the pulmonary veins which are labelled below in Figure 1.1. These are called 
pulmonary vein sleeve cell (PVC). This thesis will mainly focus on studying PVCs, atrial and 
ventricular myocytes. 
 
Figure 1.1. The structure of the heart.  The basic structure of the heart showing the four 
chambers and pulmonary veins. From 
http://classconnection.s3.amazonaws.com/250/flashcards/2024250/jpg/human-heart-
diagram-unlabeled-i41349297592107.jpg. 
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1.3. Pulmonary vein sleeve cells (PVCs) 
In 1876, Brunton and Fayrer observed an independent pulsation of a rabbit pulmonary 
vein after all motion had ceased in the heart (Cheung 1981). It is well known now that a 
layer of striated muscle is present in the pulmonary veins of small rodents and other 
mammals (Masani 1986). These cells are frequently the initiator of AF and are what we 
call PVCs. There is a general agreement that myocardial muscle fibers extend from the 
left atrium into all of the pulmonary veins at a length of 2 – 4 cm, independent of species 
(Calkins, 2008). Most of the previous studies have shed lights that PVCs cover almost all 
of the pulmonary vein ostium, however, the length and thickness of myocardial sleeves 
inside the pulmonary veins varied widely (Ho et al., 2001, Mueller-Hoecker et al., 2008). 
The sleeves with PVCs are longer and thicker in the superior pulmonary veins compared 
to inferior pulmonary veins but with no difference in-between AF patients and healthy 
individuals (Ho et al., 2001). The length of sleeves extends as far as the hilus of the lungs 
in rodents (Figure 1.2) but less so in humans where the lungs are usually devoid of PVCs 
(Ho et al., 2001, Mueller-Hoecker et al., 2008).   
 
Figure 1.2. Abundant cardiac myocytes in the wall of pulmonary veins.  A). Cardiac 
myocytes, identified by the lacZ expression targeted via a Troponin C promotor, are not 
only found in the heart but are also abundant in the pulmonary veins and reach inside the 
lungs. B). Cells expressing lacZ within the pulmonary veins demonstrating the location of 
PVCs (Kracklauer et al., 2013). 
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The wall of pulmonary veins from rodent lungs includes a layer of endothelial cells, scant 
smooth muscle cells and a layer of striated cardiac muscle. The presence of PVCs inside 
the lungs of rodents enables us to study PVCs in lung slices (Rietdorf et al., 2014, Rietdorf 
et al., 2015). Light and electron microscopic (EM) studies have shown similarities between 
PVCs and atrial myocytes (Jones et al., 1994, Townsley 2012). The alpha-myosin heavy 
chain gene expression pattern of PVCs appears to be similar to that of atrial myocytes 
(Jones et al., 1994). Furthermore, both types of myocytes are connected by desmosomes 
and intercalated discs and, as a consequence, are in electrical continuity (Spach et al., 
1972, Tsai et al., 2000). Previous studies have shown that ectopic activity in the form of 
spontaneously developing depolarisations of the membrane potential and calcium (Ca2+) 
transients, leading to the occurrence of spontaneous action potentials (APs), can arise 
within the PVCs and travel back to the atria (Tsuneoka et al., 2012). To date, the role of 
PVCs in pulmonary vein physiology is not completely understood. Interestingly, (Paes de 
Almeida et al., 1975) suggested that contractions of the pulmonary veins caused by APs in 
PVCs in rodents might act like a “throttle valve” to prevent a backflow of blood into the 
lungs during systole, and therefore prevent a pulmonary oedema (Mueller-Hoecker et al., 
2008). 
Several groups have reported evidence of conducting cells in pulmonary veins in both 
animals and humans. (Levin et al., 2009) found melanocyte-like cells and (Perez-Lugones 
et al., 2003) found pacemaker cells, transitional cells and Purkinje cells in human 
pulmonary veins from patients with a history of AF. Interestingly, these cells were not 
seen in pulmonary veins from humans without the history of AF. Furthermore, 
morphological studies in rats found conducting cells in pulmonary veins (Masani 1986) 
and more recently cardiac myocytes and interstitial Cajal-like cells (ICLC) have been found 
in pulmonary veins from both humans and rodents (Gherghiceanu et al., 2008, Mueller-
27 
 
Hoecker et al., 2008). Although ICLC are involved in pace-making activity in the intestine, 
their role in the automaticity of the pulmonary vein is unclear as they have also been 
found in the normal atrium (Schotten et al., 2011). The presence of conducting cells in 
PVCs makes it more likely that PVCs show spontaneous activity and may act as a pro-
arrhythmic substrate. 
1.4. Cardiac cycle 
The cardiac cycle is the series of events that initiate the rhythmical beating of the heart. It 
constitutes of diastole and systole. During diastole, all four chambers are relaxed. During 
systole, an AP generated by the SA node leads to atrial and ventricular contraction. The 
SA node is the primary pacemaker centre of the heart and is located in the upper wall of 
the right atrium. The AP generated at the SA node travels to atrioventricular (AV) node 
and creates an electrical wave that sweeps over the atria and eventually causes the atria 
to contract and pump blood into the ventricles. Apart from the SA node, the 
atrioventricular (AV) node is the other major pacemaker and is located in the lower part 
of the right atrium. However, the AV node does not have a pacemaker role in normal 
heart. Nonetheless, on reaching the AV node, there is a brief pause in the conduction of 
the electrical signal (~0.1 s in humans) to allow the blood to be completely emptied from 
the atria into the ventricles before those start contracting. Additionally, the AV node acts 
as an insulator between the atria and ventricles. This property is very important in 
preventing the spreading of spontaneous electrical activities from the atria to the 
ventricles (Fearnley et al., 2011). The electrical signal is then propagated down the bundle 
of His, which splits to the right and left, thereby activating both, the right and the left 
ventricle. Signal propagation continues down the Purkinje fibers, allowing the ventricles 
to contract simultaneously from the apex and upwardly, thus pushing the blood from the 
heart to the lungs through the pulmonary artery or to the rest of the body through the 
28 
 
aorta. Backflow of blood into the atria is prevented by valves between the atria and the 
ventricles. 
1.5. Excitation-contraction coupling 
1.5.1. Coupling machinery 
Just like other muscles, the cardiac muscle consists of bundles of myofibrils that contain 
myofilaments as illustrated in Figure 1.3. Each cardiac muscle cell (cardiac myocyte) is 
made up of sarcomeres (the distance between one Z-line to another) that contain thick 
and thin filaments. The Z-line is a region where thin actin filaments attach. The average 
distance between Z-lines is 1.8 µm in length in small rodents (Soeller and Cannell 1999). 
The thick filaments are composed of myosin and thin filaments are composed of actin 
(Figure 1.3).  Shortening of the sarcomeres usually occurs when the actin filaments slide 
along the adjacent myosin filaments forming cross-bridges and bringing the Z-lines closer 
together, thus resulting in muscular contraction. 
 
 
Figure 1.3. The basic structure of myofibril. An image showing the basic structure of a 
myofibril and the major proteins within a sarcomere (Figure from boudless.com).  
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1.5.2. Importance of Ca2+ for cardiac contraction 
More than 130 years ago, The Journal of Physiology published the milestone discovery of 
Sidney Ringer (Sidney Ringer, 1883) that Ca2+ ions are an essential constituent in the 
extracellular fluids for normal cardiac contraction. Since then, the detailed steps linking 
changes in the intracellular Ca2+ concentration to the electrical depolarisation of cardiac 
myocytes and their contraction have been described / elucidated.  
As described in 1.4, the SA node is the heart’s main pacemaker. The APs generated at the 
SA node sweep across the heart cells, it opens voltage-operated Ca2+ channels (VOCCs) 
localised on the sarcolemma of cardiac myocytes. As the Ca2+ concentration outside the 
cell is ~1-2 mM, but it is only ~ 100 nm inside the cell, the opening of VOCCs leads to an 
influx of Ca2+ down its electrochemical gradient into the cell, more specifically into the 
dyadic cleft. The dyadic cleft is the ~10 – 12 nm wide space between the sarcolemma and 
Ryanodine receptors type 2 (RyR2) on the sarcoplasmic reticulum (SR) membrane 
(Ayettey and Navaratnam 1978). The opening of VOCCs causes an increase of Ca2+ within 
this micro-domain from ~ 100 nM to 10 µM. The elementary Ca2+ signal caused by the 
opening of VOCCs is known as a “Ca2+ sparklet” (Wongchaoren et al., 2007; Fearnley et 
al., 2011). This initial rise in cytosolic Ca2+ is not sufficient to elicit contraction, however, it 
allows the opening of RyR2s on the SR membrane, which to leads to an efflux of Ca2+ from 
the SR to the cytosol (Figure 1.4) in a process known as Ca2+-induced Ca2+release (CICR). 
The effect of CICR is to cause elementary Ca2+ release events in the dyadic cleft termed 
“Ca2+ sparks”. It is estimated that ~10 - 100 RyR2s underlie a single Ca2+ spark, although 
this number can vary between different cell types (Fearnley et al., 2011). The opening of 
RyRs increases the cytosolic Ca2+ concentration to over 100 µM in the dyadic cleft, which 
is high enough to elicit contraction of the cardiac myocyte. Diffusion of Ca2+ ions increases 
global Ca2+ concentration to ~ 500 nM - 1 µM (Fearnley et al., 2011). At this cytosolic Ca2+ 
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level, Ca2+ binds to Troponin C (TnC). When Ca2+ binds to TnC, TnC binds more strongly to 
Troponin I (TnI) and pulls TnI away from its actin binding site, thus allowing the myosin 
heads to interact with actin, forming cross-bridges and eliciting contraction (Bers 2008). 
Relaxation is initiated when the cytosolic Ca2+ concentration starts to fall again, owing to 
Ca2+ sequestration into the SR by the sarcoplasmic reticulum Ca2+ ATPase (SERCA) pump, 
by extrusion to the extracellular space by the Na+/Ca2+ exchanger (NCX) and to a lesser 
extent by the plasma membrane Ca2+ ATPase (PMCA), as illustrated in Figure 1.4. The 
SERCA sub-type that is mostly expressed in cardiac cells is SERCA2a (Periasamy et al., 
2008; Park and Oh, 2013). In ventricular myocytes, the activity of SERCA2a is under the 
control of a protein that binds to the SR membrane known as phospholamban (PLN) 
whereas, in PVCs and atrial myocytes, sarcolipin (SLN) controls the SERCA2a activity. In 
their dephosphorylated states, both PLN and SLN inhibit SERCA2a; however, they release 
their inhibition when being phosphorylated, allowing more rapid pumping of Ca2+ back 
into the SR by SERCA2a and thus faster relaxation (Mattiazzi et al., 2006, Bhupathy et al., 
2007, Smeazzettoet al., 2011). In hearts of larger mammals like rabbits, dogs and humans, 
~70 % of the decrease in the cytosolic Ca2+ concentration is accounted for by reuptake of 
Ca2+ into the SR, and only 30 % by elimination via NCX. In contrast, in mice and rats up to 
90 % of the Ca2+ is sequestered into the SR (Bassani et al., 1994, Pieske et al., 1999, Bers 
2008). 
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FF  
Figure 1.4. Scheme of events during excitation-contraction coupling in a cardiac 
myocytes. The AP opens VOCCs in the sarcolemma which allows an influx of Ca2+ down a 
concentration gradient (1) and activates RyR2s on the surface of the SR (2). This rise in the 
cytosolic Ca2+ generates a global Ca2+ transient and activates the contractile apparatus. 
Free cytosolic Ca2+ is then removed back into the SR by the SERCA2a pump (3) or out of 
the cell by PMCA, NCX and uptake into mitochondria (4).  
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1.5.3. Store operated Ca2+ entry 
 
A rise in Ca2+ in the cytosol can arise from an influx of Ca2+ from the extracellular medium 
as described above, or through Ca2+ release from intracellular stores such as the SR. The 
depletion of Ca2+ from SR activates an influx of Ca2+ across the plasma membrane to refill 
the SR in a process known as store operated Ca2+ entry (SOCE), see Figure 1.5 (Hogan et 
al., 2015). Despite the phenomenon of SOCE being a long established one, the molecular 
identities of the channel responsible for SOCE have only recently been identified. STIM1 
and STIM2 function as Ca2+ sensors in the SR and can interact with plasma membrane 
channels Orai1, Orai2 and Orai3 to form a CRAC channel that allows Ca2+ into the cytosol, 
Figure 1.5 (Vig et al., Feske et al., 2005, Feske et al., 2006).  
 
Figure 1.5. Mechanism of SOCE. An agonist activates a G-protein coupled receptor in the 
plasma membrane that leads to an increase in inositol 1, 4, 5-trisphosphate (IP3) 
production that causes Ca2+ to be released from the ER. The reduction of Ca2+ in ER lumen 
assembles STIM1 to redistribute near the plasma membrane activating Orai channels and 
allows Ca2+ entry through a CRAC channel (From Putney 2010). 
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 The main role of SOCE is to replenish SR Ca2+ and it helps maintaining the SR Ca2+ 
homeostasis. SOCE is best studied in non-excitable cells, where it is the key source of Ca2+ 
entry pathways (Mathews et al., 1989; Hogan and Rao 2015). Recent studies have 
suggested that SOCE may also play a role in Ca2+ homeostasis in excitable cells 
(Touchberry et al., 2011, Liu et al., 2015); however, the role of SOCE in the heart is still 
unclear (Bootman and Rietdorf, 2017). Within the cardiovascular system, SOCE plays an 
important role in vascular contraction, for example, Ca2+ influx induced by intracellular 
stores depletion activated pulmonary artery and arterial smooth muscle contraction 
(Snetkov et al., 2003, Bergdahl et al., 2005). Additionally, SOCE is involved in maintaining 
the pace maker current in SA node cells (Liu et al., 2015).  
Having seen recently that SOCE also play a role in SA node cells which resemble PVCs in 
generating spontaneous APs (Liu et al., 2015), and increased contractions and Ca2+ levels 
after a Ca2+ removal and addback protocol in PVCs (Rietdorf et al., 2014), this thesis 
investigated if SOCE plays any role in PVCs. It is unclear whether SOCE plays any role in 
PVCs and whether they express CRAC channels. To investigate the role played by SOCE in 
PVCs, this thesis analysed the effects of BTP2 (an inhibitor of SOCE) on spontaneous Ca2+ 
transients (Chapter 4). 
 1.5.4. Molecular basis of excitation-contraction coupling 
1.5.4.1. Voltage gated Ca2+channels 
Ca2+ channels are the main mode of Ca2+ entry into cells in excitable cells. In cardiac 
tissue, VOCCs can be classified as L-type (low threshold type) and T-type (transient type) 
Ca2+ channels based on their physical and pharmacological studies. L-type channels are 
found in all cardiac cell types whereas T-type channels are mainly found in pacemaker, 
atrial and Purkinje cells. PVCs have been reported to express both L-and T-type Ca2+ 
channels (Chen et al., 2004, Logantha et al., 2010). These channels may play a role in the 
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release of spontaneous Ca2+ transients in PVCs. In PVCs, T-type Ca2+ channels are thought 
to be involved in their pacemaking and triggered activity (Chen et al., 2004), similar roles 
have also been suggested in SA node cells (Hüser et al., 2000). 
The basic structure of L-and T-type Ca2+ channels consists of 5 subunits – α1, α2, β, Ƴ and δ 
which unite in different combinations to form a channel in its native state (see Figure 
1.6). In mammals, 10 Cav subtypes have been identified and classified into three families 
Cav1, Cav2 and Cav3 on the basis of ion conducting α1 subunit (Van Petegem et al., 2005). 
Among these, the Cav1 channels (Cav1.1 – 1.4) are L-type high voltage activated channels 
co-assemble with auxiliary subunits including the extracellular α2δ, the intracellular β and 
the transmembrane Ƴ (Wu et al., 2016). Cav1.2 is the cardiac specific subunit. The 
intracellular β subunit increases channel expression and accelerates the channel 
activation and inactivation kinetics (Cheng et al., 2005). Structurally, Ca2+ channels have 4 
homologous domains, each consisting of 6 membrane spanning segments which are 
shown in Figure 1.6 below.  
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Figure 1.6. Basic structure of VOCCs. The Ca2+ channels consist of α1, α2, β, Ƴ and δ. The 
predicted α helices are depicted as cylinders, the lengths of lines correlate the lengths of 
polypeptides and the zigzag line on the δ subunit demonstrates its phosphatidylinositol 
anchor. Adapted from (Catterall 2011). 
 
Mutation studies on Ca2+ channels has led to proposal that the hairpin loop of the S5 / S6 
regions of domain III bends back into the membrane lining the channel pore. The P-loop 
of each domain with the glutamate residues contribute to the pore structure (Catterall 
and Swanson 2015). The fourth transmembrane region which contains a lot of positively 
charged arginine / lysine (coloured in yellow in Figure 1.6) acts as a voltage sensor. 
Several molecular mechanisms contribute to inactivation of VOCCs. Membrane 
depolarization decreases the open probability of channels available for opening from 1 at 
– 45 mV to 0 at 0 mV (Grant 2009).  Therefore, the open probability of VOCCs is lowest at 
hyperpolarised potentials and increases with depolarisation before decreasing again at 
potentials higher than – 45 mV. As mentioned before, in cardiac myocytes, the two Ca2+ 
channels which conduct current as they open are T-type and L-type. The T-type channels 
which are small conductance and rapidly inactivating. The L-type channels are activated 
with higher voltages producing a slowly, inactivating and longer lasting current. The 
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carboxyl terminus of the Ca2+ channel has multiple Ca2+ binding sites and Ca2+ calmodulin 
(CaM) dependent kinase activity (Grant 2009). Alterations of Ca2+ levels around the 
channel can modulate opening and closing of the channels. Ca2+ in the immediate vicinity 
of the channel and phosphorylation of CaM has been shown to inactivate the channel 
(Zhou et al., 1997, Qin et al., 1999). Conversely, reduction of Ca2+ in the vicinity of VOCCs 
caused by the re-uptake of Ca2+ back to the SR could result in the recovery of the channel 
inactivation (Grant 2009). Changes in the regulation and electrical remodelling of VOCCs 
during ageing may result in AF as described later on in this chapter. 
 
1.5.4.2. Ryanodine receptors 
The RyR is a Ca2+ permeable non-selective cation channel that releases SR Ca2+ in excitable 
and non-excitable cells. In mammals, there are three genes encoding RyR1, RyR2 and 
RyR3 isoforms. RyR1 is expressed in skeletal muscle, particularly in fast twitch muscle; 
RyR2 is expressed in cardiac myocytes. RyR3 is constitutively expressed in brain, skeletal, 
smooth muscle cells and in non-excitable cells (Guerrero-Hernandez et al., 2014). Both 
RyR1 and RyR2 play a central role in excitation contraction coupling but as RyR2 is the one 
that is highly expressed in cardiac cells, this thesis will mainly focus on RyR2. 
The RyR2 is a tetramer with molecular mass of 565 kDa per subunit, making RyRs the 
largest known Ca2+ channel protein. Based on sequence analysis, RyRs proteins contain at 
least two functional domains: a large N-terminal cytosolic domain containing many 
regulatory / binding sites and a C-terminal domain containing several hydrophobic 
domains, these binding sites and hydrophobic domains are shown in Figure 1.7 below. 
Four of those are the transmembrane domains (M1 – M4) whilst one, located between 
M3 and M4, forms the channel pore (Capes et al., 2011). Previous biochemical and cryo-
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EM studies revealed that four subunits unite to form a functional channel (Sharma et al., 
1998, Benacquista et al., 2000). 
 
Figure 1.7. Structure of RyR2. (A) A predicted structure of RyR2 with ancillary proteins 
and phosphorylation sites. In the lumen side of the SR; triadin, junctin and calsequestrin 
can all interact with RyR2 in the SR. In the cytosolic side, several phosphorylation sites 
and Ca2+ binding proteins are located. (B) A cryogenic EM structures of RyR2 in both the 
closed and open states which are superimposed relative to the transmembrane domain. 
The blue arrows indicate the overall shifts of the cytoplasmic region from the closed state 
to the open state (Adapted from Priori and Napolitano, 2017).  
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Opening of VOCCs after arrival of an AP causes a localised increase in the intracellular 
Ca2+ concentration, which in turn stimulates the release of Ca2+ from the SR through RyRs. 
Ca2+ levels in the SR must be restored to pre-release state before the RyRs can release 
Ca2+ again at the arrival of the next AP. This is accomplished by the re-uptake of Ca2+ into 
the SR via SERCA2a. Thus, the amount of Ca2+ released by the SR must equal the amount 
of Ca2+ taken up the SR during steady-state (Eisner et al., 2017). The open probability of 
RyRs is higher at a lower cytosolic Ca2+ concentration but is inhibited at higher Ca2+ 
concentration. Under steady conditions, Ca2+ concentrations in the range of 100 nM to 
approximately 10 µM activate all three RyRs (Bull and Marengo 1993). Complete Ca2+ -
dependent inactivation in isolated RyR2 channels occurs at very high Ca2+ concentrations 
(>10 mM), so its physiological relevance is questionable (Bull and Marengo 1993, Chu et 
al., 1993). This may reflect the existence of a low binding site that inhibits release, and a 
high binding site that stimulates the release (Capes et al., 2011). The effects of agonists 
like adenosine triphosphate (ATP), and inhibitory effects of Mg2+ influence the kinetics of 
Ca2+-dependent activation and inactivation (Suárez-Isla et al., 1990, Valdivia et al., 1995, 
Kasai and Ide 1996). However, the concentrations of these two ligands do not change 
substantially over a short period and therefore, they have been suggested to only play a 
significant role during a period of metabolic stress or intense muscle activity (Valdivia et 
al., 1995, Capes et al., 2011). 
SR luminal Ca2+ is tightly regulated by a number of proteins such as calsequestrin 2 
(CSQ2), junctin and triadin 1 (Györke and Györke 1998, Györke et al., 2004, Blayney and 
Lai 2009). Although significant progress has been made in understanding the molecular 
basis of RyR regulation by cytosolic Ca2+, less is known about the regulation via luminal 
Ca2+. However, dysregulation of RyRs by luminal Ca2+ has been implicated in pathological 
states like arrhythmias, Ca2+ overload and heart failure (HF) (Pritchard and Kranias 2009). 
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Single channel experiments have confirmed that the greater the luminal Ca2+ 
concentration, the more responsive RyR2 becomes to Ca2+ in the presence of ATP (Györke 
and Györke 1998, Györke et al., 2004). A specific Ca2+ sensitive luminal regulation site has 
been proposed on the receptor (Laver 2007).  It has also been proposed that luminal RyR2 
accessory proteins CSQ, triadin and junctin directly regulate the RyR2 channel’s sensitivity 
to luminal Ca2+ (Blayney and Lai 2009). Cardiac CSQ is a major Ca2+ binding protein in the 
SR that can bind up to 40 Ca2+ ions and undergoes conformational change upon Ca2+ 
binding (Györke et al., 2004, Blayney and Lai 2009). CSQ can interact with RyR either 
directly or via triadin and junctin. Since Ca2+ release rises steeply with an increased SR 
Ca2+ concentration, CSQ may play a role in Ca2+ buffering to regulate free luminal SR Ca2+ 
(Blayney and Lai 2009). Triadin and junctin, both of which have luminal and 
transmembrane regions, form a complex with CSQ that inhibits the open probability of 
RyRs when the luminal Ca2+ concentration is low and this inhibition is released with a rise 
in Ca2+ (Györke et al., 2004). Previous studies in adult ventricular myocytes have shown 
that the amount of CSQ expressed affected the functional size of the SR Ca2+ load (Györke 
et al., 2004, Blayney and Lai 2009, Pritchard and Kranias 2009). This regulation of the SR 
luminal Ca2+ by the CSQ-triadin-junctin complex remain the leading candidate for the 
mechanism of luminal Ca2+ regulation, however, it is still challenging to dissect out the 
possible contribution of each phenomena (Capes et al., 2011).  
 
1.5.4.3. RyR accessory proteins 
The large cytoplasmic domain of the RyR represents the modulatory region of the 
receptor and contains several binding sites for nucleotides and FK506 binding proteins; 
12-kDa FK506 binding protein (FKBP12) in RyR1, 12.6-kDa FK506 binding proteins 
(FKBP12.6) in RyR2 and both FKBP12 / FKBP12.6 in RyR3. Other characterised sites include 
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a CaM binding site; high and low affinity Ca2+ binding sites and phosphorylation sites 
(Wagenknecht et al., 1997, Sharma et al., 1998). 
FKBP binding proteins have been shown to be tightly associated with RyRs with up to 4 
FKBP binding proteins per channel. Different studies have demonstrated previously that 
both FKBP12 and FKBP12.6 can regulate channel activity and decrease the opening 
probability of the channel and hence stabilise the channel (Timmerman et al., 1993, 
Galfré et al., 2012). Further insights about the role of FKBP12s on RyRs came with the 
development of knockout mice for FKBP12 and FKBP12.6 genes. FKBP12 knockout mice 
showed severe increased open probability and channel conductance in single channel 
recordings (Shou et al., 1998).  Although most previous studies suggest that FKBP12.6 
binds to RyR2 to stabilise the channel, reducing the opening state of the channel and thus 
may offer a protective role (Wehrens et al., 2003, Lehnart et al., 2006, Shan et al., 2012); 
others have found different results (Stange et al., 2003, Xiao et al., 2004, Zhang et al., 
2009), so this topic still remains controversial. 
Another regulatory protein that interacts with RyRs is CaM, acting either directly or 
through Calmodulin kinase II (CaMKII). CaM is a Ca2+ binding protein containing four EF-
hand type Ca2+ binding motifs in the N- and C-terminal regions. Previous studies have 
shown that RyR1, RyR2 and RyR3 each have at least 3 CaM binding sites; two in the 
central portion of the protein and a third one on the C-terminal region (Guerrini et al., 
1995). CaM tightly binds the RyRs in both its Ca2+-bound (Ca2+-CaM) and Ca2+-free (apo-
CaM) states. The stoichiometry of CaM binding is 1 molecule of CaM per RyR subunit 
(Huang et al., 2012). Apo-CaM, the form of CaM that is not bound to Ca2+, weakly 
activates RyR1 whereas Ca2+-CaM inhibits it. In contrast, RyR2 is not activated by apo-
CaM but is inhibited by Ca2+-CaM at both low and high concentrations (Huang et al., 
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2012). For RyR3, Ca2+-CaM has been shown to potentiate the channel at low 
concentrations but inhibits the channel at higher Ca2+ concentrations (Yamaguchi et al., 
2005). 
The RyR is a major channel involved in excitation contraction coupling whose opening and 
closing is tightly regulated involving a number of proteins which binds to the channel 
either directly or affect it through phosphorylation. As RyRs opening and closing affect 
the SR and cytosolic Ca2+ concentrations, dysregulation of the channel can result in 
arrhythmias and other cardiac diseases. This makes the RyR a major target for drugs that 
seek to establish sinus rhythm (Kumagai et al., 2003, Vest et al., 2005, Zhu et al., 2005, 
Lehnart et al., 2006). 
1.5.4.4. Sarcoplasmic reticulum Ca2+ ATPase 
SERCA is an intracellular protein that uses energy in the form of ATP to actively re-uptake 
Ca2+ from the cytosol onto the SR, therefore brings about muscle relaxation (Periasamy et 
al., 2008). The three SERCA isoforms that have been described previously are SERCA1 
(ATP2A1), SERCA2 (ATP2A2) and SERCA3 (ATP2A3). Alternative splicing of these isoforms 
can give rise to further variants, for example, SERCA1 can be spliced into SERCA1a sub-
type which is expressed in adult skeletal muscles and SERCA1b that is in neonatal skeletal 
muscles, SERCA2a (in cardiac muscle) and SERCA2b (in all cell types) (Martin et al., 2002). 
The sub-type that is the most relevant to this thesis is the cardiac isoform, SERCA2a 
(Periasamy et al., 2008). Elevated Ca2+ levels in the cytosol are toxic to cardiac cells; 
therefore SERCA2a regulation is critical in maintaining normal physiology of the cardiac 
muscle. In fact, dysregulation of SERCA2a has been reported in several cardiac diseases 
like HF (Periasamy et al., 2008; Lipskaia et al., 2010, Park and Oh, 2013). The major 
regulator of SERCA2A in ventricular myocytes is PLN whereas in atrial myocytes and PVCs 
is SLN (Periasamy et al., 2008, Park and Oh, 2013). In dephosphorylated states, both PLN 
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and SLN act as inhibitors but release their inhibition when they get phosphorylated by 
Protein Kinase A (PKA) and CAMKII. As a consequence, Ca2+ transport increases. One of 
the effects of β adrenergic stimulation is through phosphorylation of PLN in ventricular 
myocytes or SLN in atrial myocytes or PVCs. SERCA2a is regulated not only through the 
phosphorylation states of PLN or SLN but also through their expression levels. Down-
regulation of PLN and SERCA2a in HF has been correlated with diastolic and systolic 
dysfunction (Bhupathy et al., 2007, Lipskaia et al., 2010). Similarly, reduced SLN protein 
expressions have been reported previously in human AF that resulted in an enhanced SR 
Ca2+ uptake (Shanmugam et al., 2011).  
In summary, down-regulation of SERCA2a mRNA / protein levels and altered 
phosphorylation of the channel is often reported in cardiac diseases like HF (Bhupathy et 
al., 2007, Lipskaia et al., 2010, Shanmugam et al., 2011). Hence, dysregulation of SERCA2a 
affects the SR Ca2+ handling and may lead to pathology. In this study, SERCA2a mRNA was 
quantified to elucidate whether the abnormal SR Ca2+ handling observed in HU-treated 
cells arose as a result of SERCA2a dysregulation (Chapter 5). Although the effects of 
SERCA2a deterioration / malfunction has been well documented in animal models, so far 
similar studies in humans are still infrequent and more studies are needed.  
 
1.5.4.5. Na+ / Ca2+ exchanger 
NCX is one of the mechanisms for the extrusion of Ca2+ out of cardiac myocytes. In the 
hearts of larger mammals like rabbits, dogs and humans, ~ 30 % of cytosolic Ca2+ is 
eliminated via NCX. In contrast, in mice and rats, up to 10 % of the Ca2+ is removed by 
NCX (Bassani et al., 1994, Pieske et al., 1999, Bers 2008). In its forward electrogenic 
mode, NCX extrudes 1 Ca2+ in exchange of 3 Na+, thus generating a net inward electrical 
current that depolarises membrane potential. Previously, the NCX has been shown to 
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play a role in Ca2+ homeostasis in PVCs, which will be described in detail later (Patterson 
et al., 2006, Namekata et al., 2009, Okamoto et al., 2012). NCX expression has been 
shown to be upregulated in AF, thus generating early afterdepolarizations (EADs) and 
delayed afterdepolarizations (DADs) and promoting arrhythmias (Patterson et al., 2006, 
Venetucci et al., 2007, Namekata et al., 2009, Okamoto et al., 2012) as described later in 
this thesis. 
1.5.4.6. Plasma membrane Ca2+ ATPase 
Another mechanism that is involved to the task of reducing elevated cytosolic Ca2+ levels 
to physiological basal Ca2+ levels in a cardiac myocyte is PMCA as briefly mentioned 
previously. The main role of PMCA is to remove cytosolic Ca2+ but in cardiac cells and 
most other cells; this role is quantitatively surpassed by other most powerful systems, i.e. 
SERCA and NCX (Bassani et al., 1994, Pieske et al., 1999, Bers et al., 2008). The PMCA 
channel has four isoforms which are PMCA1 – PMCA4. The two isoforms (PMCA1 and 
PMCA4) operate in all tissues while the other two (PMCA2 and PMCA3) are expressed in 
specialized tissues, such as the muscle and the brain (Crouch and Schulte, 1996, Guerini 
et al., 2005). Structurally, the channel contains 10 transmembrane domains and a 
cytosolic portion that contains A, N and P cytosolic domains. Unlike other Ca2+-ATPases, 
the PMCA channels has a 40-residue-long domain responsible for the binding of 
activatory phospholipids and a long C terminal tail (120 residues) that contains a CaM 
binding site, PKA site and two PKC sites (Chakraborti and Dhalla, Chapter 1, 1st ed. 2016). 
Functionally, PMCA transfers one Ca2+ across the plasma membrane using energy from 
ATP hydrolysis (Guerini et al., 2000). Under resting conditions, the C-terminal tail is 
proposed to interact with other cytosolic domain to maintain the channel in auto-
inhibition mode. Upon CaM binding, the channel undergoes a conformational change and 
freeing the channel from auto-inhibition (Chakraborti and Dhalla, Chapter 2, 1st ed. 2016). 
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Therefore, the binding of CaM to the channel is one of the ways the opening and closing 
of the channel is regulated depending on Ca2+ levels. In addition to CaM binding, PMCA 
contains sites for phosphorylation and therefore PKC and PKA can also activate the 
channel, but the physiological relevance of this is still unclear (Chakraborti and Dhalla, 
Chapter 2, 1st ed. 2016).  
1.5.4.7. The role of mitochondria in Ca2+ homeostasis 
In cardiac myocytes, mitochondria occupy 30 % - 40 % of the total cell volume reflecting 
the huge demands of the contractile machinery and some pumps like SERCA2a and PMCA 
for ATP (Skepper and Navaratnam, 1995; Piquereau et al., 2013; Yang et al., 2013). It has 
been suggested previously that apart from providing ATP, cardiac mitochondria may also 
play an important role in maintaining normal Ca2+ homeostasis (Drago et al., 2012, Liu et 
al., 2013, Boyman et al., 2014, Santulli et al., 2015). Mitochondria are known to 
accumulate Ca2+ during a period of cytosolic Ca2+ elevations; however, their role during 
Ca2+ cycling and buffering still remains controversial (Dedkova and Blatter 2013). Some 
studies (Maack et al., 2006, Drago et al., 2012) showed that mitochondria significantly 
contributed to the systolic Ca2+ rises in a beat-to-beat, whereas others (Lu et al., 2013, 
Boyman et al., 2014) found no significant contribution in Ca2+ by the mitochondria. The 
large negative potential (~ - 180 mV) across the inner mitochondrial membrane (IMM), 
creates a huge driving force for Ca2+ into the mitochondrial matrix from the cytosol. 
Mitochondria possess an elegant system of Ca2+ uptake and extrusions that allows the 
regulation of the mitochondrial Ca2+concentration. The best established method for 
mitochondrial Ca2+ uptake is through a selective channel called mitochondrial Ca2+ 
uniporter (MCU) down electrochemical gradient (Baughman et al., 2011, De Stefani et al., 
2011). Depending on the experimental conditions, the open probability of the channel 
can range from as high as 0.9 to as low as 0.09 with a single channel conductance of ~ 6 -7 
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pS (Baughman et al., 2011).  It is estimated that there are ~ 200 MCU channels per 
mitochondrion in cardiac myocytes. Previous studies using a knockdown of the MCU 
showed an increase in the amplitude of cytosolic Ca2+ transients which may suggest a role 
of Ca2+ buffering by the mitochondria in cardiac myocytes (Drago et al., 2012). The MCU is 
regulated by a number of activators and inhibitors which include divalent cations, 
adenine nucleotide, lanthanides and ruthenium compounds. RU360 is used 
experimentally to inhibit MCU. Apart from the MCU, other pathways of Ca2+ uptake have 
been proposed which are rapid mode of Ca2+ uptake (RaM), the mitochondrial ryanodine 
receptor type 1 (mRyR1) and the recently proposed leucine-zipper-EF-hand-containing 
transmembrane protein 1 (LETM 1). All the other pathways for Ca2+ uptake in the 
mitochondria still remain controversial and require further investigations see review 
(Dedkova and Blatter 2013).  
Just like in the SR, the mitochondrial Ca2+ influx must be balanced with the mitochondrial 
Ca2+ efflux. Mitochondrial Ca2+ efflux is believed to depend on mitochondrial Na+ -Ca2+ 
exchanger (NCLX) and Na+-proton exchanger (NHE). It has been suggested that NCLX 
extrude Ca2+ from the matrix as long as the Na+ that enters has a way to exit (Palty et al., 
2010). This is thought to be mediated by NHE. During Na+ overload, this balance can be 
compromised resulting in the production of reactive oxygen species (ROS) which is 
detrimental to the cell and will result in energy deficient (Nissim et al., 2017). A number 
of drugs like benzodiazepines have been shown to inhibit NCLX (Czyż and Kiedrowski 
2003, Ruiz et al., 2014). The majority of the data supports that NCLX is electrogenic as it 
exchanges 3 Na+ for 1 Ca2+. As an electrogenic, mitochondrial Ca2+ efflux will depolarise 
mitochondrial membrane potential by allowing Na+, this should reduce mitochondrial 
Ca2+ influx (Lukyanenko et al., 2009). The last of the system that is thought to be also 
involved in mitochondrial Ca2+ efflux is through an increase permeability of the IMM to 
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ion and solutes with molecular weight of up to ~ 1.5 kDa, this increase in permeability is 
known as the opening of mitochondrial permeability transition pore (mPTP) (Izzo et al., 
2016, Giorgio et al., 2017). The molecular identity of mPTP is still largely unknown, but it 
has been proposed to contain a voltage and Ca2+-dependent channel, high conductance 
and cyclosporin A (CsA) sensitive. The channel has been proposed to contain adenine 
nucleotide translocator (ANT), cyclophilin D (Cyp D), VDAC, hexokinase, creatine kinase, 
mitochondrial peripheral benzodiazepine receptor, Bcl-2, glycogen synthase and 
cytochrome c (Zorov et al., 2009). Some of these components of the mPTP that have been 
proposed are still controversial. The mPTP complex is activated by high matrix (Ca2+), 
oxidative stress and depolarization but, what still remains controversial, is whether mPTP 
can serve as a pathway for mitochondrial Ca2+ efflux. It should also be mentioned that 
ageing is also a critical factor contributing to the ability of tissues to resist damaging 
stress. There is an age-related impairment of the ability of the heart to resist stress, such 
as during ischaemia / reperfusion injury (Juhaszova et al., 2005, Wohlgemuth et al., 2014, 
Tocchi et al., 2015). The direct link between mPTP induction and oxidative stress-related 
cell death in cardiac myocytes reinforces the need for better understanding of the 
channel to prevent or limit the damage (Dedkova and Blatter 2013, Wohlgemuth et al., 
2014). 
Additionally, an increase in ROS is due to mitochondrial dysfunction which deteriorates 
during ageing and stressful conditions such as diabetes (Xi et al., 2005, Yang et al., 2006). 
An increase in ROS production has been shown to affect Ca2+ homeostasis by modulating 
the opening of channels that are cysteine rich. The effects of ROS on Ca2+ homeostasis will 
be discussed in detail later on. 
47 
 
1.5.4.8. Mitochondrial size/structure and numbers: their relevance in the cardiac 
function 
Cardiac mitochondria are the organelles responsible for energy in the heart in the form of 
ATP as mentioned above. Cardiac mitochondria are independent and distinct organelles 
that are highly organised between myofibres (intermyofibrillar mitochondria), near the 
nucleus (perinuclear mitochondria) and near the sarcolemma (sarcolemmal 
mitochondria) (Hoppel et al., 2009). These three sub-types of cardiac mitochondria are 
labelled in Figure 3.3 in Chapter 3. In this study, only intermyofibrillar mitochondria were 
analysed. These reside between the myofibres. Alterations in cardiac mitochondrial 
morphology and dynamics have been documented previously in cardiac diseases as well 
as in ageing (Feldman and Navaratnam, 1981; Ausma et al., 2001, Furuoka et al., 2001, 
Hoppel et al., 2009). The deteriorated mitochondria can be enlarged or decreased in size 
(Feldman and Navaratnam, 1981; Ausma et al., 2001, Gupta et al., 2010), increased / 
decreased in numbers (Feldman and Navaratnam, 1981, Terman et al., 2003). Another 
feature of abnormal mitochondria involve changes in the cristae appearance. Cristae are 
folds of the inner mitochondrial membrane. Most previous studies have shown that 
disrupted mitochondria appeared to have swollen and misfolded cristae (Furuoka et al., 
2001). Therefore, if mitochondria are disorganised, the energy output could be 
diminished and may result in higher ROS levels and abnormal Ca2+ handling that may in 
turn cause diseases. Hence, to investigate whether mitochondrial numbers and/or size 
are altered in PVCs during ageing; this study analysed mitochondrial structure by focusing 
on mitochondrial numbers and sizes in PVCs from 3 month- and 24 month-old mice 
(Chapter 3). 
1.5.5. Local and global Ca2+ transients 
Ca2+ is an almost ubiquitous messenger that is able to regulate a myriad of physiological 
processes, ranging from fertilisation to cell death (Bootman et al., 2006). This is achieved 
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by the ability of cells to use different mechanisms to modulate the duration, amplitude, 
frequency and spatiotemporal properties (Berridge 1997, Berridge et al., 1998, Bootman 
et al., 2006). Because of the differences in Ca2+ channels, buffers, Ca2+ binding proteins 
and morphology in cardiac myocytes, a Ca2+ signal can arise to be local or global and may 
develop to an AP in excitable cells, as explained below.  
PVCs, atrial and ventricular myocytes can generate local and global Ca2+ transients which 
arise either spontaneously or through a stimulus. Unlike atrial and ventricular myocytes, 
PVCs have a substantially higher frequency of spontaneous local and global Ca2+ 
transients (Rietdorf et al., 2014, Rietdorf et al., 2015). In an unstimulated cardiac 
myocyte, a local Ca2+ transient can spontaneously arise, lasting just 10 – 100 ms and be 
confined to an area of ~ 2 µm (Cheng et al., 1993, Cheng and Lederer 2008). These 
spontaneous local Ca2+ events arise with local openings of RyRs from one cluster or 
different clusters of RyRs to form a Ca2+ releasing unit (CRU). CRU is a cluster of RyRs in 
the SR membrane (Cheng and Lederer, 2008). The kinetics of the local Ca2+ release events 
can be modulated by the opening of RyRs: the frequency of local Ca2+ release events 
increases with a higher opening probability of RyRs. The frequency of local Ca2+ release 
events can also be increased by the activity of VOCCs. Their opening allows an influx of 
Ca2+ from extracellular medium down electrochemical gradient. Interestingly, 
depolarisation on itself is not enough to evoke a local Ca2+ release. This is supported by 
studies where depolarisation failed to evoke local Ca2+ events when extracellular Ca2+ was 
removed or replaced with Ba2+, showing that Ca2+ is needed to stimulate RyRs openings 
and initiate local Ca2+ release (Cheng and Lederer 2008, Maxwell and Blatter 2012, Sato et 
al., 2014).  
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During ageing and in diseased states, local and global Ca2+ events are modulated and may 
results in arrhythmias or diminished cardiac output as discussed later (Blatter et al., 2003, 
Cheng and Lederer 2008, Brochet et al., 2012). PVCs studied in this thesis show local and 
global Ca2+ release events, which can change during ageing, repeated electrical field 
stimulation (EFS), pharmacological interventions and ROS levels as explained later in 
Chapters 4 and 5.  
1.5.6. Differences in excitation-contraction coupling between PVCs, atrial and 
ventricular myocytes  
The three types of cardiac myocytes vary in their ultrastructure, described below, 
resulting in different spatiotemporal patterns of Ca2+ signalling observed. One of the most 
obvious differences between PVCs, atrial and ventricular myocytes is the absence or 
presence of T-tubules. T-tubules are invaginations of the sarcolemma of cardiac myocytes 
that occur at each Z-line. T-tubules bring VOCCs in close proximity to RyR2s and 
mitochondria and therefore an AP on the cell surface can simultaneously propagated to 
non-junctional RyRs that results in a faster global response. The example of this scenario 
is shown below in Figure 1.8 where the presence of T-tubules in a ventricular myocyte 
resulted in a faster response as denoted by the orange curve. Most atrial myocytes lack T-
tubules whereas ventricular myocytes contain an extensive T-tubules system, which can 
be revealed using membrane dyes such as di-8-ANNEPS (Lyon et al., 2009, Dibb et al., 
2013). However, recent evidence shows that T-tubules are found in atrial myocytes from 
larger mammals and the extent of T-tubular network is thought to be correlated with cell 
width; (Richards et al., 2011, Frisk et al., 2014). As the cell width is found to be higher in 
larger mammals, more atrial myocytes have T-tubules to facilitate faster propagation 
(Richards et al., 2011). Most atrial myocytes posses extensive “Z tubules” which are 
formed from internal SR membranes, but not the sarcolemma and therefore contains 
non-junctional RyRs which are not in close proximity with VOCCs (Bootman et al., 2006). 
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Just like in ventricular myocytes, immunostaining for RyRs in atrial myocytes revealed 
that most of the RyRs are located around the Z-lines of the sarcomeres (Bootman et al., 
2006).  
 
Figure 1.8. Different modes of Ca2+ signaling in cardiac myocytes. In ventricular 
myocytes, an AP is propagated down the T-tubules inside the cell to simultaneously 
activate Ca2+ sparks in all non-junctional zones, resulting in a faster efficient global Ca2+ 
transients orange curve). In atrial myocytes, the lack of T-tubules means the signals reside 
at the periphery and slowly propagate inside the cytosol via CICR, resulting in a slower 
response (blue curve). From (Berridge 2002). 
In the absence of T-tubules, VOCCs are only localised at the cell’s periphery in close 
apposition with junctional RyRs, but do not reach deep into the cytosol to contribute to a 
fast signal propagation. In contrast, the extensive T-tubular network in ventricular 
myocytes brings VOCCs in close proximity with non-junctional RyRs deep within the 
cytosol (Figure 1.8). T-tubules in ventricles allow local Ca2+ transients sites, which are 
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deep within the cytosol, to be recruited during an AP, thus resulting in fast, synchronised 
global responses (Figure 1.8 and Table 1.1).  
 
 PVCs Atrial myocytes Ventricular 
myocytes 
T-tubules Mostly lack T-tubules 
(Tsuneoka et al., 2012, 
Rietdorf et al., 2014).  
Mostly lack T-tubules 
but are found in atrial 
myocytes from larger 
mammals (Clarke et 
al., 2011, Frisk et al., 
2014). 
Prominent T-
tubular network 
(Lyon et al., 2009, 
Frisk et al., 2014). 
Connexins Express Cx40, Cx43 and 
Cx45 (Yamamoto et al., 
2006, Kugler et al., 2017). 
Express mainly Cx40 
and to a lesser extent 
Cx43 (Sun et al., 2008). 
Express mainly Cx43 
(Ou et al., 2005; 
Tribulova et al., 
2005). 
APs Less negative resting 
membrane potential 
compared to atrial and 
ventricular myocytes (~ - 
65 mV) with no plateau 
(Chen et al., 2002, Ehrlich 
et al., 2003, Okamoto et 
al., 2012).  
AP duration  < 200 ms. 
Less negative resting 
membrane potential may 
potentiates extra APs that 
may result in 
arrhythmias. 
Resting membrane 
potential is ~ - 75 mV, 
lacks a pronounced 
plateau (Chen et al., 
2002, Ehrlich et al., 
2003, Okamoto et al., 
2012). 
 
AP duration ~ 150 ms. 
 
Resting membrane 
potential is ~ - 75 
mV with a 
distinctive plateau 
(Chen et al., 2002, 
Ehrlich et al., 2003, 
Okamoto et al., 
2012).  
AP duration   ~ 200 
ms. 
 
Excitation-
contraction 
coupling 
Higher frequency of 
spontaneous global 
activity compared to 
atrial and ventricular 
myocytes (Rietdorf et al., 
2014, Rietdorf, et al., 
2015).  
Higher spontaneous 
activity may facilitate 
arrhythmias. 
Lower frequency of 
spontaneous global 
activity compared to 
PVCs (Berridge 2002). 
 
 
Lower frequency of 
spontaneous global 
activity compared 
to PVCs (Berridge 
2002). 
 
 
Table 1.1. Comparison of the structural, electrical and Ca2+ homeostasis features in PVCs, 
atrial and ventricular myocytes. 
Atrial myocyte Ca2+ signals initiate at the periphery immediately after depolarisation but 
are not propagated deep into the cytosol via T-Tubules. From this point on, factors like 
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the SR Ca2+ content and the presence of agents that increase the force of contraction of 
the heart, determine whether the signal will propagate further in the cytosol (Bootman et 
al., 2006).  
PVCs have been proposed to operate the same excitation contraction coupling machinery 
as atrial and ventricular myocytes (Tsuneoka et al., 2012, Rietdorf et al., 2014). 
Structurally, just like atrial myocytes, most PVCs lack an extensive T-tubule system (Leem 
et al., 2006, Rietdorf et al., 2014). However, Ca2+ signaling in PVCs is thought to resemble 
that of ventricular myocytes rather than atrial myocytes;  PVCs show global Ca2+ 
transients (i.e. ventricular-like) rather than peripheral Ca2+ signals (i.e. atrial-like) (Rietdorf 
et al., 2014), these features are compared in Table 1.1 above. The underlying reasons why 
PVCs are structurally similar to atrial myocytes, but Ca2+ signals that are akin to those in 
ventricular myocytes are not yet completely understood. 
1.6. Autophagy 
Autophagy is a housekeeping process by which cells degrade dysfunctional organelles, 
long-lived proteins, non-protein targets like lipids and carbohydrates and produces ATP 
(Deter and De Duve 1967, Lilienbaum 2013, Wang and Wang 2015). 
A basal level of autophagy occurs constitutively in cells and contributes to the cellular 
homeostasis in eukaryotic organisms (Deter and De Duve 1967). However, in response to 
stress like nutrient starvation, mitochondrial depolarisation, the presence of toxic protein 
aggregates or mechanical damage, autophagy can be upregulated (Graef and Nunnari, 
2011, Komatsu et al., 2005) and is generally considered to act as a pro-survival 
mechanism (Fulda, 2012). In contrast, during ageing (in the cardiac system) autophagy is 
generally downregulated (Kurz et al., 2007; De Meyer et al., 2010, La Rocca et al., 2012).  
53 
 
Three different types of autophagy can be distinguished: macroautophagy, 
microautophagy and chaperone-mediated autophagy (Klionsky, 2005; Kurz et al., 2007). 
Work in this thesis in Chapter 5 focussed on the process of macroautophagy, and the 
term ‘autophagy’ refers solely to macroautophagy.  
The process of autophagy, and tools for studying it, are illustrated in Figure 1.9. During 
autophagy, molecules and organelles that are targeted for degradation become 
surrounded by a double membrane. Once this membrane is closed and forms a vesicle 
around the molecules / organelles, it is called autophagosome. Mature autophagosomes 
fuse with lysosomes. The resulting autolysosome has an acidic pH, and the actual 
digestion takes place by acidic hydrolases. Autolysosomes are degraded and release 
nutrients like amino acids and fatty acids for use by the cell.  
As a result, the total number of autophagosomes present in a cell at any given time is 
determined by the rate of autophagosome formation and autophagosome degradation. 
This is described by term ‘autophagic flux’ and is a more accurate measure for the state of 
a cell than the level of basal autophagy.  
Autophagy in cells can be induced by mammalian target of Rapamycin (mTOR) inhibitors 
like rapamycin or pp242, or by starvation. To measure autophagic flux, it is necessary to 
also provide evidence that formation and degradation of the novel autophagosomes is 
taking place. This can be done using the chemicals shown in Figure 1.9: autophagosome 
formation can be inhibited by 3-Methyladenine (3-MA) and the degradation can be 
blocked by bafilomycin A1 or chloroquine. Both drugs inhibit the autophagosome 
degradation by inhibiting the autophagosome-lysosome fusion (Klionsky et al., 2016). 
To measure the autophagic flux in living cells, four counts of the number of 
autophagosomes are necessary: in the basal state, in presence of PP242 / rapamycin 
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alone (maximum induced level), PP242 / rapamycin + 3-MA (proving that de novo 
formation is taking place) and PP242 / rapamycin + bafilomycin/chloroquine (proving that 
degradation is taking place). The expected outcome of each drug application on the 
number of autophagosomes in a cell is indicated in Figure 1.9.  
 
Figure 1.9. The process of autophagy and the tools for studying it. Organelles that are 
targeted for degradation are enclosed by a double membrane and forms 
autophagosomes. 3-Methyladenine (3-MA) inhibits the formation of autophagosomes 
whilst drugs like pp242 induce the formation of autophagosomes. Mature 
autophagosomes fuse with lysosomes to form autolysosomes before they are being 
degraded. This process can also be inhibited with drugs like chloroquine, i.e. increases the 
number of autophagosomes. 
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1.7. Changes in the heart with disease or age 
1.7.1. Atrial fibrillation: general background 
Atrial fibrillation (AF) is the most sustained form of a cardiac arrhythmia which is more 
common in elderly population (Kopecky et al., 1987, Go et al., 2001). AF is characterized 
by un-coordinated atrial activation with consequent deterioration of atrial mechanical 
function. It is well established now that ectopic electrical activity originating from 
pulmonary vein sleeve cells (PVCs) and (Haissaguerre et al., 1998, Sueda et al., 2005) 
initiate AF. Prevalence of AF increases with age; only 0.1 % of AF cases occur in people 
aged 40 and above, 6 % in people over 65 years, 10 % in people over 80 years and above 
(Hayashi et al., 2002, Nattel et al., 2008). Prevalence of AF varies worldwide depending on 
the geographical location as shown below in Figure 1.10 (Schotten et al., 2011, Chugh et 
al., 2014, Shehab et al., 2017).  
 
Figure 1.10. World map showing age-adjusted rates (per 100,000 populations) of AF.  
Adapted from (Chugh et al., 2014). 
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In 2010, AF cases are reported to be the highest in North America. The AF incidence rates 
in North America for both men and women are 264.5 and 196.3 per 100000 respectively. 
The lowest cases are estimated in the Asia-Pacific region for both men (33.8 per 100000) 
and women (19.8 per 100000) as seen in Figure 1.9 above (Chugh et al., 2014).  
With our ever increasing ageing population, the prevalence of age-dependent cardiac 
diseases like AF will continue to rise in the future. In the USA, the prevalence of AF is 
estimated to escalate from 1.2 million cases in 2010 to 2.6 million cases in 2030 and to 
5.6 million by 2050 (Colilla et al., 2013). For unknown reasons, most studies find that AF is 
more common in men than women (Lloyd-Jones et al., 2004, Heeringa et al., 2006, 
Stefansdottir et al., 2011, Chugh et al., 2014).  
Although AF is not life threatening in itself, it contributes significantly to morbidity and 
mortality. AF is associated with increased risk of deaths, thrombo-embolic events and HF. 
Often, AF patients suffered from reduced quality of life, reduced exercise capabilities and 
left ventricular dysfunction (Cai et al., 2013). Over 70 % of AF patients have an underlying 
heart disease and nearly 20 -25 % of all strokes are caused by AF (Schotten et al., 2011; 
Shehab et al., 2017). A recent study looking at AF as cause of deaths in England between 
1995 and 2010 showed that when AF is regarded as a contributing cause of deaths, the 
other common contributing causes of deaths were stroke, pneumonia and myocardial 
infarction (Duncan et al., 2014). Additionally, AF is associated with a range of other health 
complications, for example, tachycardiomyopathy, hypertension obesity and diabetes 
mellitus (Schotten et al., 2011). 
Although mortality from other cardiovascular diseases have fallen considerably over the 
last 20 years or so, mortality from AF has increased steadily in both men and women as 
seen in Figure 1.11 below (Chugh et al., 2014, Duncan et al., 2014). This is partly because 
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of our increasing ageing population as more people live longer to develop AF and 
highlight the need to better treatments.  
 
Figure 1.11. Mortality associated with AF in both sexes in developed vs. developing 
world over the last two decades.  Mortality rate was higher in men than women in 
developed countries but higher mortality rates have been reported in women than men 
in developing countries. From (Chugh et al., 2014). 
 
AF diagnosis relies firstly on a physical examination and by performing an 
electrocardiogram (ECG). When AF episodes first occur, often they self-terminate and 
therefore might not be present when a doctor examines the patient and therefore 
complicates the diagnosis. If symptoms are present during when a doctor performs 
physical examination, often, irregular heart sounds or an irregular pulse can raise 
suspicion of AF. This, combined with clinical symptoms, helps the diagnosis. ECG traces 
from AF sufferers usually lack distinct P waves because of in-effective atrial contraction. 
Additionally, ECG traces from AF patients will often show irregular intervals, which lack 
repetitive patterns as shown in Figure 1.12 below: 
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Figure 1.12. Traces illustrating ECG traces from a healthy individual (sinus rhythm) and 
an individual with AF. The top trace shows an ECG trace of a heart beating in sinus 
rhythm with a clear P wave, QRS complex and a T wave. In contrast, the bottom trace 
from an AF patient shows an ECG lacking a P wave because of irregular atrial contraction 
(modified from Wakili et al., 2011). 
 
Clinically, it is acceptable to distinguish 5 types of AF based on presentation and the 
duration of arrhythmia. These 5 types of AF are first-diagnosed, paroxysmal, persistent, 
long-lasting persistent and permanent (Camm et al., 2010). Every patient who presents 
AF symptoms for the first time is considered having a first-diagnosed AF regardless of the 
symptoms and severity of arrhythmias. A patient is classified as having paroxysmal AF 
when AF episodes come and go and can last up to 7 days before self-terminating. Most of 
these episodes usually stop within 48 hours. Persistent AF refers to AF episodes that 
continue for longer than 7 days and can only be terminated by either a drug or direct 
current cardioversion (cardioversion means termination of AF by applying electrical shock 
to stop the arrhythmia and allow the normal pacemaker to resume function). Long-
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standing persistent AF is when episode lasts longer than a year and a suitable control 
strategy is needed. Permanent AF is when episodes are present all the time and both a 
patient and a physician accept that sinus rhythm is no longer achievable and treatments 
to convert to sinus rhythm have failed (Camm et al., 2010). Sinus rhythm is a term given 
to the normal rhythmical contraction of the heart where electrical stimuli are initiated at 
the SA node to evoke the cardiac cycle. 
Management of AF is mainly aimed at relieving the symptoms and preventing 
complications of diseases associated with AF, like the risk of having a stroke. To prevent 
the formation of blood clots, daily intake of blood-thinning drugs like warfarin and aspirin 
are usually prescribed to AF patients. After anti-coagulation, anti-arrhythmic drugs like 
flecainide, carvedilol and verapamil are often used to prevent arrhythmias; however, 
administration of these drugs may vary depending on the underlying cardiovascular 
diseases of the patient (Camm et al., 2010, Nottingham 2010). There are number of ways 
to classify anti-arrhythmic drugs but the most common way is the Vaughan Williams 
classification (1970) that categorises anti-arrhythmic drugs with respect to their 
mechanism of action (target), as shown in Table 1.2.  
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Class Mechanism 
of action 
Rate vs. 
rhythm 
Examples Risks 
Class I 
(class IA, 
class IB, 
class IC) 
Sodium-
channel 
blockers 
Rhythm 
control 
Disopyramide, 
Quinidine 
(class 1a), 
Lidocaine, 
Mexiletine 
(class 1b), 
Flecainide, 
Propafenone 
(class 1c) 
Hypotension, slowing of the 
ventricular rate, 
prolongation of the QT 
interval, worsening of heart 
failure, mortality 
Class II Beta-blockers Rate control Bisoprolol, 
Atenolol, 
Carvedilol, 
Propranolol 
Slow heartbeat, weight gain, 
may trigger asthmatic 
attacks 
Class III Potassium 
channel 
blockers 
Rhythm 
control 
Amiodarone, 
Dronedarone, 
Sotalol 
Systolic heart failure, 
hypokalaemia, moderate 
renal dysfunction, increased 
mortality 
Class IV Calcium 
channel 
blockers 
Rate control Diltiazem, 
verapamil 
Slow heart rate, low blood 
pressure 
Class V Sodium-
potassium 
ATPase 
blocker 
Rate control Digoxin Effective at rest and not 
during exercise, may 
interact with other drugs 
Table 1.2. Vaughan Williams classification of anti-arrhythmic drugs (1970). 
 
 
Class IA (Quinidine and Disopyramide) are effective in AF but have fallen out of favour 
due to their adverse effects including worsening of HF and increased mortality as 
presented in Table 1.2 above (Shukla and Curtis 2014). Class IC drugs like Flecainide are 
recommended for AF patients without structural heart disease. Class III drugs like 
amiodarone and Sotalol have been shown to be effective on restoring sinus rhythm by 
prolonging the latencies between APs and preventing spontaneous electrical 
depolarisations that are pro-arrhythmic. 
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Anti-arrhythmic drugs have been used extensively to manage AF but one should consider 
carefully the type of AF and associated underlying diseases before choosing a drug. 
Although these drugs are effective, they have various adverse effects, listed in Table 1.2, 
which reinforce the need for better pharmacological means. A number of drugs are now 
in clinical trials which have been shown to be effective in restoring sinus rhythm. 
Vernakalant which has recently been approved in Europe as an effective and selective 
class III anti-arrhythmic drug inhibits potassium channels in the atria and has minimal 
effects on the ventricles, leading to less pro-arrhythmic risks (Tsuji and Dobrev 2013). 
Vernakalant has also been shown to reduce pro-arrhythmic events in PVCs. In efficacy 
studies, Vernakalant was also found to be more potent than the most widely prescribed 
class III anti-arrhythmic drug; amiodarone (Tsuji and Dobrev 2013). Another drug that is 
currently being tested is JTV-519 / K201 which was shown to attenuate inducible AF in 
animals by reducing RyR2-induced Ca2+ leak. It could potentially be used in the treatment 
of AF ( Chen et al., 2008, Dobrev et al., 2012). JTV-519 has been tested in AF patients and 
was in phase II clinical trials but has had little success. Although JTV-519 affects mainly 
RyR2, it has been shown previously to have other targets and therefore further studies 
are needed (Kumagai et al., 2003). Several other drugs are being tested to treat AF which 
are now at the stage of pre-clinical or in clinical trials with a range of actions from 
inhibiting RyR2 to modulating gap junctions (Dobrev et al., 2012). 
The major surgical treatment for AF is catheter ablation, which has been used to treat 
heart rhythm disorders for over two decades (Ames and Stevenson 2006). Catheter 
ablation involves inserting two long thin tubes (catheters) usually via the groin, which are 
then guided through the blood vessels into the heart. A mapping catheter is used to 
identify atrial regions that show ectopic activity (e.g. the development of spontaneous 
action potentials (AP)), which are then targeted for ablation as illustrated in Figure 1.13.  
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Figure 1.13. Catheter ablation treatment in AF.  Two catheters are inserted from the 
groin and guided through blood vessels to the right atrium. They then need to puncture 
the atrial septum to enter the left atrium, in which the areas that trigger arrhythmias are 
usually found. Often those areas are in the pulmonary veins (labelled above as treated 
areas). The burning scars prevent ectopic activities arising from the PVCs to signal back 
into the atria, triggering AF (From Shapira et al., 2009). 
 
The catheters need to puncture the inter-atrial septum, which is one of causes of the 
side-effects and risks during the procedure. A radiofrequency electrical current is applied 
through the catheter to burn the targeted areas and electrically isolate the pulmonary 
veins from the left atrium (Figure 1.13). It has been reported that electrical ablation is 
successful in maintaining sinus rhythm for over a year in 90 % of AF patients, depending 
on the severity and the type of AF (Ames and Stevenson 2006). Unfortunately, the 
success rate is low for patients who have had the disease for many years, and for patients 
with underlying heart diseases (Ames and Stevenson 2006). Also, recurrences have been 
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reported in 15 % - 45 % of the cases and could cause serious complications like pulmonary 
vein stenosis, (De Maat et al., 2014, Nalliah et al., 2015). Repeated ablations are 
sometimes necessary to fully stop AF from re-occurring. 
Our understanding of the pathophysiology of AF has improved substantially over the past 
years mainly through an increased awareness of atrial remodelling (the term used for 
phenotypic alteration of the atrial chambers during disease). The mechanisms thought to 
be involved in maintaining AF are electrical and structural remodelling together with 
abnormal Ca2+ handling in both PVCs and atrial myocytes (Hove-Madsen, et al., 2004, 
Neef et al., 2010). Surprisingly, little is known about age-dependent changes in structure 
and Ca2+ homeostasis in PVCs and atrial myocytes, both of which contribute to the 
maintenance of AF.  
 
1.7.2. The cardiac action potential 
The main focus of this thesis investigated changes in the ultrastructure and Ca2+ 
homeostasis in cardiac myocytes during ageing. However, in order to understand the 
arrhythmogeneic events which will be described later, it is necessary to look at the 
cardiac AP, the channels and currents that maintain it and the differences of the AP 
characteristics in-between cardiac cells. The cardiac AP, which is generated by the 
coordinated openings and closure of ion channels, is much more complex than the AP in 
nerves and skeletal muscles. In the heart, APs last several 100 milliseconds (ms) and 
consist of several phases. The resting membrane potential of atrial and ventricular 
myocytes is around -75 mV whereas PVCs have a less negative resting membrane 
potential of around – 65 mV (Chen et al., 2002, Ehrlich et al., 2003, Okamoto et al., 2012). 
Ventricular APs which are different to those in atrial myocytes; they are longer in 
durations. Ventricular APs are also similar to purkinje fiber AP except they are smaller and 
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lack pacemaking activity. APs in the SA and AV node cells are similar to atrial APs but they 
lack a plateau and are much smaller. PVCs AP are thought to be similar to an atrial AP (see 
Figure 1.14). Ventricular APs include distinct 5 phases which include a large upstroke 
(phase 0), transient repolarization (phase 1), a plateau (phase 2), repolarization (phase 3) 
and resting level (phase 4). These 5 distinct phases and the contributing currents and 
channels are labelled in Figure 1.13. The rate of depolarisation (an initial upstroke phase 
during an AP) is determined by the rate at which Na+ ions enter the cytosol and differes 
between the various cell types found in the heart. In cells whose APs relies on Na+ 
channel openings, e.g. cardiac myocytes, skeletal muscles and neuronal cells, initial 
depolarizing currents are large, develop very fast but also show a quick inactivation.  
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Figure 1.14. Phases of the ventricular myocytes AP. Panel A, ventricular AP has 5 distinct 
phases which are phase 0 (an upstroke), phase 1 (transient repolarisation), phase 2 
(plateau), phase 3 (repolarisation) and phase 4 (resting membrane potential). Panel Bi 
(ventricular AP), panel Bii (atrial AP) and panel Biii (PV AP). 
 
For these reasons, Na+ currents are often referred to as fast inward currents (INa). In 
contrast, APs from SA and AV node cells rely on the openings of smaller (lower 
conductance) Ca2+ channels for the membrane depolarisation, resulting in a lower 
amplitude and slower upstroke during phase 0 of the AP.  
Opening of Na+ channels depolarises the cell to between +30 mV and +50 mV, at which 
point the channels inactivate. As the membrane potential depolarises, more and more 
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VOCCs are opening, including the T-type current which activates at -60 mV, and L-type 
VOCCs which activate between -40 and -30 mV. In the working cells of the atria, 
ventricles, purkinje and PVCs, L-type Ca2+ current (ICaL) contribute to the plateau phase of 
the AP (phase 2). This current also contributes to the depolarization of SA and AV nodes 
APs. At this point, various K+ channels start to open but their activation is relatively slow. 
The plateau phase is maintained by the equilibrium of influx and eflux of Ca2+ and K+ 
channels and eventually favouring repolarization and returs the membrane to resting 
potential (see Figure 1.14). The currents that repolarize cardiac myocytes (phase 3) as 
well as maintaining the resting pontential are carried out by several types of K+ channels, 
some are labelled in Figure 1.14. These currents are known as delayed rectifiers because 
they open after the initial depolarization. The inward rectifiers which open during diastole 
helps to bring and maintain the resting membrane potential (Figure 1.14).  
The Na+ / Ca2+ exchanger generates both outward and inward membrane currents (INCX) 
when it exchanges 1 Ca2+ for 3 Na+. Immediately after a myocyte depolarises, the 
exchanger generates an outward current which activates the reverse mode i.e. increases 
the efflux of Na+. This outward current contributes to the initial / transient repolarisation 
phase (phase 1). Conversely, the forward mode which efflux Ca2+ released during 
excitation-contraction coupling contributes to the plateau and repolarisation phases of 
the cardiac AP. This current is usually maximal toward the end of the refractory period 
and is the main contributor of afterdepolarization, one of the pro-arrhythmic events that 
will be discussed later in this Chapter.  
The description of the cardiac AP provided here is simplified, particularly with regards to 
the various K+ currents. Having said that, especially since this is not an 
electrophysiological study investigating changes in individual currents, this brief 
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description of the cardiac AP is sufficient in order to illustrate its importance for the 
arrhythmogenic events described in the following sections. 
1.7.2.1. Cellular pro-arrhythmic mechanisms: Automaticity and triggered activity 
Arrhythmias involve disturbances in the rhythm of excitation-contraction coupling events. 
Under pathological conditions like in AF and other cardiac diseases, arrhythmias can arise 
from a focal point at the cellular level to a tissue level and elicit remodelling  (Narayan 
2002, Koller et al., 2005, Nassal et al., 2015). Events that stimulate arrhythmias can be 
automatic (termed automaticity), triggered by a preceeding AP (termed triggered 
activity), re-entries and alternans. 
1.7.2.2. Enhanced automaticity 
This form of enhanced activity occurs when a myocyte with pacemaker activity, for 
example, PVCs, increase their spontaneous activity. This can be due to a lower threshold 
potential for the AP upstroke, or a less negative resting membrane potential like the one 
seen in PVCs (Chen et al., 2002, Ehrlich et al., 2003, Okamoto et al., 2012).  
1.7.2.3. Abnormal automaticity 
Abnormal automaticity occurs when cardiac myocytes are depolarised, allowing them to 
reach a threshold potential needed for AP and thus showing spontaneous APs in-between 
the rhythmical heart beat. In many cases, this enhanced activity does not allow for a 
sufficient recovery of Na+ channels before the next AP arrives. The depolarisation causing 
abnormal automaticity is often mediated by Ca2+ inward currents (Schotten et al., 2011).  
1.7.2.4. Triggered activity 
One of the most common arrhythmogenic events is triggered activity which arises 
through oscillations of the membrane potential. Once the membrane potential reaches a 
threshold potential, APs are triggered. Depending on the timing of the membrane 
potential oscillations, these events can be classified as “early” or “delayed” 
afterdepolarizations as seen below in Figure 1.15.  
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EADs are membrane potential oscillations occuring during phase 2 or 3 of the AP (Hirose 
and Laurita 2007, Liu et al., 2012). Several scenarios can explain the occurrence of EADs: 
(1) They may arise due to an increase in the AP duration which may provoke new APs and 
results in triggered activity (Figure 1.15 Ai). (2) β adrenergic stimulation, which elevates 
cytosolic Ca2+ and stimulates spontaneous SR Ca2+ release, can cause EADs. (3) A 
shortening of the AP duration (parasympathetic stimulation) whilst simultaneously the 
Ca2+ load of the cells is increased (sympathetic stimulation). In this situation, because of 
higher Ca2+ load, an AP generates a strong release of Ca2+ from the SR which lasts longer 
than AP duration and stimulates a strong inward rectifier INCX which may depolarise the 
membrane and may activate so called late-Phase 3 EADs (Figure 1.15 Bi). Late-Phase 3 
EADs have been documented previously in AF animal models (Hirose and Laurita 2007). 
Most EADs occur in slower heart rate and DADs occur in a period of higher heart rate or 
rapid pacing (Song et al., 2005). 
DADs are oscillations of the membrane potential occuring after full repolarizations of the 
triggering APs. DADs are favoured by conditions that trigger Ca2+ overload like in 
ischaemia, β adrenergic stimulation, low extracellular K+ concentration and in higher 
heart rate (Katra et al., 2007). Ca2+ overload is an extremely pathological high SR Ca2+ 
content which increases the probability of RyRs opening, the frequency of local  Ca2+ 
release events and the probability of global signal propagation (Song et al., 2015).  Excess 
Ca2+ released from the SR is removed from the cytosol to the extracellular fluid by the 
NCX which generates inward current INCX that depolarises the membrane and results in 
arrhythmias (Figure 1.15 Aii and Bii).  
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Figure 1.15. Cellular pro-arrhythmic events. Panel A shows schematic illustrations of EAD 
(Ai) and DAD (Aii). Panel B illustrates molecular events that leads to late phase 3 EAD (Bi) 
and DAD (Bii). SR Ca2+ release activates NCX current (INCX) which results in extra AP.  
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1.7.2.5. Re-entry 
Re-entry occurs when an AP fails to extinguish itself and activates a region that has 
recovered from the previous stimulus and is ready to be re-activated. During the normal 
cardiac cycle, an electrical signal that is initiated at the SA node cells propagates over the 
entire heart, causing a simultanoeus contraction of the whole tissue. This electrical 
impulse diminishes when all regions have been activated and are in a state of 
refractoriness. However, when regions recover before the signal stops, they can serve as 
a link to re-activate previously depolarised regions that have already recovered from the 
initial depolarisation, resulting in re-entry, an example of this is illustrated in Figure 1.16 
(Gaztañaga et al., 2012, Tse 2016).  
 
Figure 1.16. Re-entry and alternans. A re-entry is initiated when a signal that propagates 
through connected tissues travels through two different pathways, sites 1, 2 and 3 (panel 
Ai). However, when a signal reaches site 3 which is still in refractory, it causes a 
counduction block (panel Aii). When site 3 has recovered from a previous signal, this 
signal pathway then can then travel in one direction and activate sites 3, 1 and 2 and 
results in re-entry (panel Aiii). Panel B shows an example of alternating amplitudes of Ca2+ 
transients recorded during 2 Hz EFS, i.e. alternans. 
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There are many re-entry theories which can be divided into two main groups, these are 
either anatomical / classical or functional re-entry with different mechnisms. Since this 
study does not study re-entry mechanisms, the different theories will not be decsribed in 
detail. In PVCs, (Hassink et al., 2003) conducted histology in patients with and without a 
history of AF and found that the pulmonary veins in patients with a history of AF were 
associated with fibrosis, hypertrophy and severe disorganisation in structure that may 
facilitate re-entries. Additionally, (Arora et al., 2003) found a significant less conduction at 
the proximal pulmonary vein than in the rest of the left atrium. They also showed that 
these slow conduction regions within the pulmonary vein created a substrate for re-entry. 
Another study by (Hocini et al., 2002) found zones of activation delays in canine 
pulmonary veins that may facilitate arrhythmias. Together, the differences in conduction 
velocities, delays, propagation, and the in increase in fibrosis in pulmonary veins may act 
as a substrate for re-entry that will facilitate arrhythmias.  
1.7.2.6. Alternans 
Alternans are cyclic, beat-to-beat alternations in contraction force, AP duration and 
intracellular Ca2+ release during a period of constant stimulation, e.g. manifestings as 
alternating large and small amplitude Ca2+ transients. Alternans are known to occur 
during a period of high frequency stimulation either intrinsic pacemakers or by extrinsic 
stimulations, this is illustrated in Figure 1.16 B (Narayan 2002, Narayan et al., 2011). 
Cardiac alternans were initially described as mechanical and electrical alterations at the 
whole heart level and later at the cellular level. Cardiac alternans are now known to be 
pro-arrhythmic events that have been shown previously to precede the onset of AF 
episodes. Cardiac alternans have also been observed in ventricular arrhythmias and 
sudden cardiac deaths (Narayan 2002, Cutler et al., 2009). The mechanisms underlying 
this event are still poorly understood but studies in isolated cardiac myocytes and in 
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intact hearts have shed some light onto the subject. It is clear that at the cellular level, 
variations of AP duration result in alternans. These changes of the AP duration arise 
mainly because of dysregulated Ca2+ release. At resting heart rate, the SR Ca2+ release 
must be matched by the SR Ca2+ re-uptake that occurs primarily by the SERCA2a. One 
theory of alternans development links disturbances in SR Ca2+ re-uptake, especially during 
higher pacing rate, with diminished SR Ca2+ release and resulting alternans. Down-
regulation of SERCA2a has been shown to result in alternans (Cutler et al., 2009). In 
contrast, a previous study that used in vivo gene transfection to overexpress SERCA2a in 
myocytes showed the inhibition of alternans (Cutler et al., 2009). However, another study 
on SERCA2a overexpression in atrial myocytes found no effects on alternans (Nassal et al., 
2015).  
It is important to remember that the events underlying alternans may vary between atrial 
and ventricular myocytes because of the differences in structure, electrical characteristics 
and Ca2+ homeostasis. Most studies on alternans are done in ventricular myocytes, rather 
than in atrial myocytes. As mentioned above, over-expression of SERCA2a has been 
shown to inhibit alternans in ventricular myocytes whereas it failed to do so in atrial 
myocytes. One reason for this might be because of the lack of t-tubules and PLN in atrial 
myocytes (Kanaporis and Blatter 2017).  
In summary, there are several mechanisms both electrically and structurally within the 
PVs that may facilitate arrhythmias. These pro-arrhythmic events include a lower 
threshold for AP upstroke, the occurrence of alternans, increases in conduction blocks 
and deterioration in structural organisations of the PVCs. These mechanisms are 
worsened during ageing or in AF as described later in this thesis. Hence, in this study, the 
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presence of alternans were investigated in PVCs from 3 month- and 24 month-old mice 
(Chapter 4) and in NRVMs (Chapter 5) after EFS. 
1.7.3. Structural remodelling in AF and during ageing 
We have seen how cardiac myocytes are perfectly structured to allow an effective 
excitation contraction coupling. One example of this, described above, is the presence of 
T-tubules in greater abundance in ventricular myocytes than in atrial myocytes and PVCs. 
Hence, severe structural weakening that manifests either during ageing or in AF will 
diminish the cardiac output. Changes that have been documented in AF and during ageing 
will be discussed in detail below in sections 1.7.3.1 and 1.7.3.2. 
1.7.3.1. Structural changes in AF 
Clearly, structural alterations in the atria are not exclusively related to AF, but evidence of 
structural changes in the atria resulting from AF or they might have led to AF have been 
decribed. These changes include atrial fibrosis, atrial necrosis and changes in gap-
junctions (Boldt et al., 2006, Laky et al., 2011). Compelling evidence suggests that atrial 
fibrosis is one of structural remodelling in the development of AF. The molecular signaling 
changes underlying atrial fibrosis are not completely understood. Angiotensin II mediates 
fibrosis in a variety of cardiac diseases and studies on transgenic mice with cardiac-
restricted Angiotensin converting enzyme overexpression show marked atrial dilation, 
fibrosis and AF (Nattel et al., 2008). Angiotensin II works by activating Angiotensin type I 
and 2 receptors. Through downstream signaling pathways, they mediate fibroblast 
proliferation, cardiac hypertrophy and necrosis (Boldt et al., 2004, Nattel et al., 2008). 
Additionally, atrial fibrosis has been observed in patients with AF and other cardiac 
diseases (Schotten et al., 2011). In terms of PVCs, (Sun et al., 2008) showed an increase in 
interstitial fibrosis in AF dogs models with mitral regurgitations compared to control dogs. 
Supporting these findings is the study (Boldt et al., 2006) that showed that demostrated 
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that Angiotensin converting enzyme inhibitors were able to attenuate structural 
remodelling in patients with chronic AF. In all of the previous studies, fibrosis was found 
to be increased in AF animal models as summarised in Table 1.3 below. 
Another relevant factor for atrial remodelling is altered connexin expression. The main 
connexin sub-types expressed in cardiac myocytes are Cx40, Cx43 and Cx45 but the 
expression levels vary considerably depending on the cell type. Ventricular myocytes 
express mainly Cx43 whereas atrial myocytes highly express Cx40. PVCs have been shown 
to express Cx40, Cx43 and Cx45; however, the level of expression varies depending on the 
location of PVCs within the pulmonary vein (Chaldoupi et al., 2009, Kugler et al., 2017).  A 
previous study has shown a reduction in Cx40 expression levels in atrial appendages from 
AF-induced goats (Van Der Velden et al., 1998). In summary, previous results have shown 
that induction of AF in animal models resulted in altered distribution or a reduction of 
Cx40 whereas Cx43 mostly remained unchanged or increased (see Table 1.3 below) (Van 
Der Velden et al., 1998, Ausma et al., 2003, Yeh et al., 2006). The effects of connexin and 
fibrosis remodelling have been suggested to facilitate electrical tissue non-homogeneity, 
slowed conduction and electrical uncoupling, all of which are pro-arrhythmic indicators.  
In terms of the EM studies, previous studies have shown changes in atrial myocytes from 
AF-induced animals and in patients with AF. These changes include an increase in cell size, 
myolysis, perinuclear accummulation of glycogen and changes in mitochondrial size and 
number (Ausma et al., 1997, Thijssen et al., 2000, Ausma et al., 2001, Ausma et al., 2003). 
All of changes described are summarised in Table 1.3. 
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1.7.3.2. Structural changes during ageing 
“Everyone is the age of their heart” is a Guatemalan proverb that emphasises the link 
between ageing and cardiovascular diseases like AF (Hatch et al., 2011).  Although the 
prevalence of AF strongly increases with ageing, it is difficult to study the effects of age in 
humans due to the long time span of senescence and lack of human PV tissue in healthy 
young individuals. Therefore, most ageing studies have been done in animals. Here, some 
examples of the changes that are seen previously in atrial myocytes during ageing will be 
decribed.  
Structurally, age-dependent changes have been documented in atrial and ventricular 
myocytes from animals. In dogs, (Koura et al., 2002) showed an age-dependent increase 
in interstitial fibrosis and fatty infiltrates. Also, Cx43 becomes increasingly concentrated 
at end to end junctions between myocytes. Similarly, another study found an age-
dependent upregulation of apoptotic bodies which could hinder conduction (Boyle et al., 
2013). 
Most of the previous ageing studies in cardiac myocytes that focused on the structural 
changes analysed mitochondrial changes, myofilaments and the presence of dense bodies 
(lipofuscin). (Feldman and Navaratnam 1981) found an age-dependent increase in 
mitochondrial size in the aged atria. They found mitochondria to be swollen, combined 
with an increased presence of lipofuscin granules and an increased disorganisation of the 
myofilaments. Similarly, other studies have found a significant degeneration of the 
ultrastructure with swollen mitochondria and disrupted cristae, disorganised 
myofilaments and disruption of the nuclear membrane as summarised above in Table 1.3 
(Gupta et al., 2010). To the best of our knowledge, there are no studies that have been 
done in PVCs describing the effects of ageing on the ultrastructure. Therefore, this thesis 
will characterise structural remodelling in PVCs from mice during ageing (Chapter 3) and 
how these alterations affect the function (Chapter 4) and promotes arrhythmias. 
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 Ageing or AF Component and 
direction of 
change 
Species References 
Fibrosis  AF 
 
 AF 
 AF 
AF 
 
AF 
Ageing 
 Fibrosis ↑ 
 
 Fibrosis ↑ 
 Fibrosis ↑ 
 Fibrosis ↑ 
 
 Fibrosis ↑ 
 Fibrosis ↑ 
Humans 
 
Humans 
Goats 
Goats 
 
Dogs 
Dogs 
(Boldt et al., 2004, 
Boldt et al., 2006) 
Laky et al., 2011 
(Ausma et al., 2001) 
(Verheule et al., 2010) 
 (Sun et al., 2008) 
 
(Koura et al., 2002) 
Connexins AF 
 
AF 
 
AF 
 
AF 
 
Ageing 
Cx40 ↓ 
Cx43 ↓ 
Cx40 ↓ 
Cx43 → 
Cx40 ↓ 
Cx43 → 
Cx40 ↓ 
Cx43 ↑ 
Cx43 distribution 
changed 
Dogs 
 
Goats 
 
Goats 
 
Dogs 
 
Dogs 
(Sun et al., 2008) 
 
 (Van Der Velden et 
al., 1998) 
(Ausma et al., 2003) 
 
(Yeh et al., 2006) 
 
(Koura et al., 2002) 
Mitochondria AF 
AF 
 
 
AF 
Ageing 
 
Ageing 
 
 MN ? MS ↓↑ 
 MN ?  MS ↓ 
 
 
MN ? MS ↑ 
MN ? MS ↑ 
 
MN ? MS ↑ 
Goats 
Goats 
 
 
 Dogs 
 Mice 
 
 Rats 
 (Ausma et al., 1997) 
(Ausma et al., 2001) 
Laky et al., 2011 
 
 
(Gupta et al., 2010) 
(Feldman and 
Navaratnam 1981) 
 
Table 1.3. Summary of the structural changes during ageing and AF. 
MN = mitochondrial number   MS = mitochondrial size. 
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1.7.4. Changes in Ca2+ homeostasis in AF and during ageing 
As stated before, altered Ca2+ homeostasis in atrial myocytes and PVCs in AF and during 
ageing is one of the factors that facilitates AF. There has been an extensive research that 
focused on Ca2+ homeostasis remodelling during AF mostly in atrial myocytes and to a 
lesser extent in PVCs. Similarly, there are a lot of studies that have been conducted to 
investigate the effects of ageing on Ca2+ homeostasis in cardiac myocytes. Interestingly, to 
the best of my knowledge, there are studies that have been done to investigate the 
changes in Ca2+ homeostasis during ageing in PVCs. The findings so far that were seen in 
atrial myocytes and PVCs in AF and during ageing are presented below. 
 
 
1.7.4.1. Altered Ca2+ homeostasis in atrial myocytes and PVCs in AF 
Changes in the intracellular Ca2+ concentration are involved in a range of physiological 
processes including the beating of the heart and hence, any disruption in Ca2+ 
homeostasis could result in arrhythmias and AF. Ca2+ homeostasis in cardiac myocytes is a 
complex subject that involves a number of channels, Ca2+ binding proteins, kinases / 
phosphatases and organelles, all linking to several intracellular signalling pathways, as 
described in section 1.5. In AF, changes in VOCCs, RyR2s, SERCA2a, NXC, ROS and 
mitochondrial dysfunction have all been documented and will be outlined below. 
A number of studies have reported a decrease in the reduction of IcaL current, together 
with reduced mRNA levels and a lower epression of VOCCs in cardiac myocytes from AF 
(Lai et al., 1999, Mestre Prates et al., 2002, Klein et al., 2003, Schotten et al., 2003, 
Gaborit et al., 2005). These changes are likely to interfere with the morphology of APs, 
and it has been suggested that they may contribute to an increase in AP duration, thus 
inhibiting Ca2+ influx and that they could promote re-entry (Nattel and Harada 2014). 
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Antother important channel for cardiac Ca2+ signalling is the RyR. In AF, previous studies 
have suggested either no change in the expression levels or a significant reduction 
(Brundel et al., 1999, Lai et al., 1999, Neef et al., 2010). Even with unaltered expression 
levels, changes in the open propability of the RyR could affect their function in the cell. 
Several studied reported an increase in the opening probability of the channel which 
result in an increased SR Ca2+ leak, increased frequency of local and global Ca2+ events and 
hyperactivity that leads to arrhythmias (Vest et al., 2005, Neef et al., 2010, Voigt et al., 
2012).  
As the Ca2+ leak from the SR increases in AF patients and animal models (Vest et al., 2005, 
Neef et al., 2010, Voigt et al., 2012), one would expect SERCA2a function to increase as 
well. This was the case in one study that found an increase in SERCA2a function in atrial 
myocytes from AF patients (Shanmugam et al., 2011). However, this increase in SERCA2a 
function could be caused by the reduction in sarcolipin; an inhibitory protein of SERCA2a 
that is exclusively expressed in atrial myocytes (Shanmugam et al., 2011). The changes in 
SERCA2a function however are not conclusive. In contrast to the former study, (Voigt et 
al., 2012) reported a decrease in SERCA2a mediated Ca2+ removal even with an increase in 
SR Ca2+ leak. Therefore, results regarding the remodelling of SERCA2a in AF are 
inconsistent and require further investigations (Greiser et al., 2009, Greiser and Schotten 
2013). 
The most consistent feature in Ca2+ homeostasis remodelling in AF patients and in animal 
models is the upregulation of the NCX. NCX is the dominant mechanisms for the extrusion 
of Ca2+ out of the cardiac myocytes. In its forward electrogenic mode, the NCX extrudes 1 
Ca2+ in exchange of 3 Na+ and is thus generating a net inward electrical current that 
depolarises membrane potential. NCX expression has been shown to be upregulated in 
79 
 
AF, contributing to the generation of EADs and DADs and promoting arrhythmia 
(Patterson et al., 2006, Venetucci et al., 2007, Okamoto et al., 2012). 
Another important factor for modulating cardiac Ca2+ signalling is ROS levels that have 
been shown to be increased in AF animal models (Guo et al., 2014; Huang et al., 2017). 
An increase in ROS production by mitochondria has been shown to affect Ca2+ 
homeostasis by modulating the opening of channels that are cysteine rich through redox 
modifications (Cooper et al., 2013). (Cooper et al., 2013) showed that ageing significantly 
increased the SR Ca2+ leak through RyR2 via post-translational thiol oxidation of the 
receptor caused by mitochondrial ROS production. 
 
1.7.4.2. Changes in Ca2+ homeostasis in atrial myocytes during ageing 
As we saw with the structural changes, ageing is associated with a progressive 
deterioration in the cardiac output due to alterations in the structure of cardiac myocytes 
(Ausma et al., 2001, Ausma et al., 2003). Age-dependent remodelling results in a 
disturbed electrical and Ca2+ homeostasis that may in turn affects the contractions. These 
changes become more apparent during a period of higher energy demand, for example 
during exercise. The alterations that come with age vary between men and women 
(Feridooni et al., 2015); this supports the prevalence of data that shows AF to be more 
common in men than women. Nevertheless, Ca2+ homeostasis changes during ageing are 
similar to those found in AF (downregulation of IcaL and increased opening probability of 
RyRs due to either hyperphosphorylation or in direct effects of increased ROS). All these 
changes have also been reported in cardiac myocytes from aged animals (Zhu et al., 2005, 
Hatch et al., 2011). In addition to this, Wongcharoen et al., 2007 demonstrated a larger 
amplitude of DADs and longer AP duration in PV tissues from aged rabbits. Ageing also 
depolarised the resting membrane potential of PV tissues from aged rabbits and showed 
higher propensity for AP alternans as well as contractile alternans (Wongcharoen et al., 
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2007). Just like in AF animal models, RyR protein levels do not change with age (Zhu et al., 
2005, Rueckschloss et al., 2010). Most ageing studies in atrial myocytes have 
demonstrated a down regulation of SERCA2a in male animals but not in females. It has 
been suggested that this decrease contributes to a prolonged transient duration in 
myocytes from aged male animals (Feridooni et al., 2015, Herraiz-Martinez et al., 2015). 
Additionally, whilst the NCX inward current is found to be upregulated during ageing, 
most studies found no change in the NCX protein expression levels during ageing (Li et al., 
2007, Hatch et al., 2011, Feridooni et al., 2015). As a result of these changes, studies have 
reported an increase in the frequency of local and global Ca2+ transients, a reduced ability 
to follow electrical pacing, an increased presence of alternans, an increase in transient 
duration and a lower amplitude of the global Ca2+ transients (Hatch et al., 2011, Feridooni 
et al., 2015, Herraiz-Martinez et al., 2015). For further details about all of the changes in 
Ca2+ homeostasis during ageing and all of the differences between male and female AF 
animal models, please refer to review by (Feridooni et al., 2015). 
 
In summary, previous studies have shown that changes in the structure and Ca2+ 
homeostasis facilitate AF in atrial myocytes. Interestingly, similar studies in PVCs during 
ageing are still lacking. This thesis characterises changes in the structure and links them 
with changes in Ca2+ handling during ageing to elucidate how they might facilitate the 
occurrence of arrhythmias i.e. AF. 
 
1.8. Cellular ageing model with hydroxyurea  
Ageing can be defined as a progressive decline of the body to performs physiological 
functions and and a loss of repair mechanisms that may lead to a loss of function and an 
elevated risk of death (Dong et al., 2014, Zhai et al., 2017). Ageing research has attracted 
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a lot of interests over recent years to understand the molecular alterations that manifest 
during ageing. A review by (Lopez-Otin et al., 2013) highlighted nine hallmarks of ageing 
that may contribute to the ageing process. These hallmarks are genomic instability, loss of 
proteostasis, telomere attrition, epigenetic alterations, deregulated nutrient-sensing, 
mitochondrial dysfunction, stem cell exhaustion, cellular senescence and altered 
intercellular communication. This thesis will mainly focus on cellular senescence and 
mitochondrial dysfunction by attempting to induce ageing chemically with hydroxyurea 
(HU)  in Chapter 5. To understand the mechanisms underlying the cellular ageing process, 
most studies use cellular senescence as an ageing model (Park et al., 2000, Yeo et al., 
2000, Zhai et al., 2017). Cellular senescence can be characterised as a loss of repair 
mechanisms that lead to cellular DNA damage (Chen et al., 2007; Lopez-Otin et al., 2013). 
HU is widely used as a tumour therapeutic agent that has been suggested to exert its 
effects by inhibiting ribonucleotide reductase and prevents the reduction of 
ribonucleotides to deoxyribonucleotides and hence inhibits DNA synthesis (Krakoff et al., 
1968). HU incubation in cells effectively inhibits DNA repair mechanisms, induces DNA 
damage and senescent like phenotypes (Park et al., 2000, Yeo et al., 2000, Dong et al., 
2014; Zhai et al., 2017). Previous studies where they used HU to induce senescence in 
cells found an increased expression of p16, p21 and p53 which are found to be increased 
during ageing (Ressler et al., 2006). Similarly, HU treatment in neuronal, human diploid 
fibroblasts and cancer cells increased senescence, growth arrest and ROS levels, but no 
induction of apoptosis (Park et al., 2000; Yeo et al., 2000; Cooper et al., 2013; Dong et al., 
2014; Guo et al., 2014; Huang et al., 2017). To date, similar studies in cardiac myocytes 
are still lacking. Therefore, this study will try to establish a cellular ageing model with HU 
treatment in NRVMs. Traditionally, most ageing studies are done by analysing the 
changes in cells and tissues from young and old animals. However, these analysis are 
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time-consuming, costly and require animal sacrifices. Therefore, using an ageing model 
may prove an easier and a quicker way to study ageing. The benefits and limitations of 
studying ageing using either a traditional way (young vs. old animals), or an ageing model 
by inducing senescence chemically are summarised below in Table 1.4. 
Factors Young vs. old model An ageing model with HU 
Time Very time consuming, longer waits are 
needed for the animals to age 
naturally. For this study, (3-and 24 
month-old mice were used. Other 
studies, 2-and 32 month-old rats 
(Feldman and Navaratnam, 1981).  
It is relatively quick. For 
this model, HU was 
incubated for a maximum 
of 7 days. Other studies; Hu 
incubated for upto 9 days 
(Park et al., 2000); ≤ 28 
days (Yeo et al., 2000), ≤ 3 
days (Zhai et al., 2017). 
Cost Expensive as it involves buying and 
maintaining the animals. 
Cheaper and easier to 
maintain as cell lines can 
be used to induce 
senescence. 
Home Office 
license 
Required. This can also lead to the 
delay of experiments. 
Not necessary. 
Cell-to-cell 
communication 
Better as it mimicks the physiological 
environments. For example, in this 
study, PVCs within a pulmonary vein in 
lung slices. 
Poor can be achieved. For 
this study, NRVMs had a 
good cell-to-cell 
comunication because of 
gap-junctions. 
Reliability More reliable because changes 
analysed are from “natural ageing”. 
Less reliable. Although the 
changes are similar to 
those observed in naturally 
aged cells/tissues, as 
described before ageing 
involves alterations in 
different hallmarks and HU 
may ust be inducing 
senescence and not 
necessarily ageing. 
Scope of 
experiments 
Limited. Primary cells deteriorate very 
quickly and hence they need to be 
used for experiments quickly. This 
limits the range of experiments that 
can be performed. 
More experiments can be 
performed because cells 
can be viable for longer. 
Table 1.4. Comparisons of the advantages and disadvantages between naturally ageing 
models and chemically induced ageing models. 
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1.9. Aims 
The main aims of this study are: 
1. To compare and analyse the structure of PVCs, atrial and ventricular myocytes during 
ageing and how these age-dependent changes might facilitate the occurrence of 
arrhythmias like in AF. 
2. To provide a comprehensive description of Ca2+ homeostasis in PVCs. 
3. To analyse the changes in Ca2+ homeostasis and response to drugs in PVCs during 
ageing. 
4. An attempt to establish an ageing model chemically using Hydroxyurea (HU) in 
neonatal rat ventricular myocytes (NRVMs). 
5. To compare and analyse the changes in naturally aged PVCs and in chemically induced 
NRVMs to gain further understanding of the potential future treatments for the 
treatment of cardiac arrhythmias like AF. 
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Chapter 2: Materials and Methods 
2.1. Cell preparations 
2.1.1. Solutions and compounds in cell preparations 
2.1.1.1. Lung slice experiments 
sHBSS contained KCl 5.3 mM; KH2PO4 0.4 mM, NaCl 137.9 mM, NaH2PO4 0.3 mM, NaHCO3 
4.2 mM, D-Glucose 5.6 mM, MgCl2 0.5 mM, MgSO4 0.4 mM, CaCl₂ 1.3 mM, HEPES 20 mM 
and the pH was adjusted to 7.4 using NaOH.  
PBS was diluted from ready-mixed powder (Sigma-Aldrich, St. Louis) and contained 138 
mM NaCl and 2.7 mM KCl. The pH was adjusted to 7.4 using NaOH. 
4 % PFA:   Dissolve 0.4 g in 50 ml distilled water and 50 ml 0.2 M phosphate buffer inside 
a fume hood. The pH was adjusted using NaOH on a heated stirrer. 
2.1.1.2. Neonatal rat ventricular myocyte experiments 
 
Neonatal buffer contained NaCl 100 mM, KCl 5.4 mM, MgSO4 0.8 mM, D-glucose 1%, 
NaH2PO4.H20 0.8 mM, HEPES 20 mM. The pH was adjusted to 7.35 using NaOH. 
Plating medium contained 4 parts DMEM with 4.5 g / l D-glucose (Gibco, product number 
15235697), and 1 part M199 (Sigma-Aldrich, St. Louis), supplemented with 10% Donor 
horse serum (Gibco), 5% fetal calf serum (Gibco), 1 mM sodium pyruvate (Gibco), 1 mM 
MEM non-essential amino acids (Gibco), 1% antibiotic / antimycotic (Gibco) and 3 µM 
cytosine β-D-arafuranoside (ara-C, Sigma-Aldrich, St. Louis).  
Digestion buffer contained Pancreatin 0.2 mg / ml (Sigma-Aldrich, St. Louis), DNase 0.015 
mg / ml, activity ≥ 1500 units per mg (USBiological), and Collagenase type II (0.25 mg / ml, 
activity ≥ 125 units per mg. (Sigma-Aldrich, St. Louis). 
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2.1.2. Preparation of lung slices 
 
The C57/bl/6j mice aged 3 and 24 month-old were euthanised by Schedule 1, under the 
Animals Scientific Procedure Act (ASPA) 1986 as approved by the Institutional Animal 
Care and Use Committee of The Open University, UK. After opening the chest cavity, the 
lungs were inflated with ~ 1 ml of 37°C, 1.8 % low melting point agarose (Life 
Technologies, Carlsbad, CA) in Hank’s buffered salt solution (HBSS, composition given in 
Section 2.1.1.1) (Life Technologies, Carlsbad, CA) that was pH buffered to 7.4 using HEPES 
(sHBSS). The trachea was cannulated and the agarose was injected to inflate the lungs. 
Care was taken not to inflate the lungs to a volume above that of the rib cage. 
Immediately following the inflation, the lungs were covered with tissue paper wetted 
with ice cold sHBSS and the mouse was put in the fridge for few minutes to solidify the 
agarose inside the lungs. Solidified lungs were cut into 180 µm thick slices using a VF-300 
microtome (Precisionary Instruments Inc., Greenville, NC). Lung slices were collected into 
sHBSS and inspected for the presence of PVCs using a light microscope with low 
magnification. PVs were generally distinguishable from arteries by these criteria: the vein 
is not next to an airway and or / striated cells can be observed in the cells surrounding the 
vein. For EM and immunofluorescence studies the slices were fixed with 4 % 
paraformaldehyde for 24 hours in the fridge. After 24 hours they were washed twice in 
HBSS, and kept in HBSS in the fridge until used. Or, for functional studies, slices were put 
in Dulbecco’s Medium Eagle Medium (DMEM) supplemented with antibiotics / 
antimycotics and 10 % foetal bovine serum and kept in a humidified tissue culture 
incubator at 37°C with 5 % CO₂. Slices were used within 48 hours of preparation. 
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Figure 2.1. Lung slices preparation and use. Steps of the lung slices preparation are 
shown. The slices were either fixed with 4 % paraformaldehyde to preserve the 
ultrastructure and used for structural studies or kept in DMEM culture medium for up to 
48 hours and loaded with fluorescent indicators for live-cell studies.  
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2.1.3. Preparation of neonatal rat ventricular myocytes 
 
Rat pups aged 2 – 5 days were sacrificed according to Schedule 1 by cervical dislocation 
followed by destruction of the brain under the Animals Scientific Procedure Act (ASPA) 
1986 as approved by the Institutional Animal Care and Use Committee of the Open 
University, UK. After opening the chest cavity, the pup’s hearts were removed with 
scissors and placed in ice-cold 1X neonatal buffer (composition given in Section 2.1.1.2) 
before being minced into ~ 1mm³ cubes using a razor blade. The neonatal buffer was 
removed and 5 ml digestion buffer containing collagenase type II (Worthington, UK), 
pancreatin (Sigma-Aldrich, St. Louise) and DNase I (USBiological) (composition given in 
Section 2.1.1.2) was added to the minced hearts. They were transferred into one 50 ml 
falcon tube using a sterile cut-off 3 ml plastic Pasteur pipette and incubated at 30°C for 10 
minutes with gentle stirring (190 rpm). After 10 minutes, minced hearts were gently 
triturated, allowed to settle and the supernatant was removed and discarded. 5 ml of 
fresh digestion buffer was added and the minced hearts were incubated for 20 minutes at 
30°C with gentle stirring (190 rpm). The minced hearts were then triturated and the 
supernatant containing isolated cells was placed in a Falcon tube containing 30 ml plating 
medium (composition given in Section 2.1.1.2) and incubated at 37°C in a humidified cell 
culture incubator. Another 5 ml digestion buffer was added to the minced hearts and 
they were again incubated at 30°C for 20 minutes with gentle agitation. After 20 minutes, 
the minced hearts were triturated and supernatant added in a tube containing plating 
medium which will now fill up to ~ 40 ml and should contain ~ 10 ml of cell suspension in 
digestion buffer. The contents of this tube were filtered through a 100 µm cell strainer 
(CorningTM) to separate the heart chunks from the isolated cells. The filter was rinsed with 
10 ml fresh plating medium to collect all the isolated cells and the cells were centrifuged 
at 1200 rpm for 5 minutes. The resulting pellet was resuspended in a falcon tube with 10 
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ml plating medium and incubated at 37°C; this will be tube 1. Meanwhile, the above 
mentioned steps resulting in collecting the isolated myocytes in tube 1 are repeated to 
collect tubes 2 and 3. The resuspended cell pellets from tube 1-3 were combined and pre-
plated in a T175 flask (Greiner Bio-one, UK) and pre-plated for an hour at 37°C to allow 
fibroblasts, which adhere to cell-culture surfaces much more readily than cardiac 
myocytes, to adhere and reduce their number in the cell suspension. Cells not stuck down 
are collected in the medium, centrifuged at 1200 rpm for 5 mins. This pellet, containing 
the cardiac myocytes, is resuspended in a 15 ml plating medium in a falcon tube. Cells 
were counted and seeded at a density 9.0 x 10⁴ cells / ml on either 1 % gelatin-coated 
(Sigma-Aldrich, St. Louis) six well plates or 25 µM / ml laminin (Sigma-Aldrich, St. Louis) 
coated 16 mm coverslips (VWR International Ltd) and placed at 37°C, 5 % CO2 in a 
humidified incubator. After 24 hours, the plating medium was exchanged to remove any 
debris on top of cells. When indicated, hydroxyurea (HU) (Sigma-Aldrich, St. Louis) was 
added on day 2 after the preparation, once the cells were beating synchronously. 
 
2.2. Immunofluorescence 
2.2.1. Solutions and compounds used in immunofluorescence 
 
Permeabilisation buffer: 0.2 % Triton (Sigma-Aldrich, St. Louis) in PBS. 
Blocking buffer: 0.1 % Triton in PBS supplemented with 10 % bovine serum albumin (BSA) 
(Sigma-Aldrich, St. Louis). 
Washing buffer: 0.1 % Triton in PBS. 
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Antibody Concentration Source 
RyR2 1:50 A kind gift from Prof. 
Vincenzo Sorrentino 
Cx40 1:100 St. John’s lab, UK 
Cx43 1:100 Abcam, UK 
Alexa Fluor 488 goat anti 
rabbit 2°Ab 
1:500 Life Technologies, 
Carlsbad, CA 
Alexa Fluor 568 goat anti 
rabbit 2°Ab 
1:500 Life Technologies, 
Carlsbad, CA 
Phalloidin iFluor (488) 1:250 Stratech, UK 
Table 2.1. Indicators and antibodies used for immunofluorescence. 
 
 
2.2.2. Immunofluorescence in lung slices 
 
Immunostaining was performed on lung slices that were previously fixed with 4 % PFA. 
Lung slices were permeabilised in permeabilisation buffer for 2 hours to allow the entry 
of the antibodies from the extracellular medium into the cytoplasm. To block unspecific 
binding of proteins, lung slices were incubated in blocking buffer for further 2 hours. After 
that, slices were incubated with RyR2 primary antibodies (1:50 dilution), Cx43 antibodies 
(1:100 dilution) or Cx40 antibodies (1:100 dilution) in 1 % BSA / 0.1 % Triton overnight at 
4°C. After being washed six times with washing buffer (5 minutes for each wash) to wash 
off any unspecifically bound antibodies, slices were incubated for an hour with an Alexa-
Fluor 568 goat anti rabbit secondary antibody (1:500 dilution) in 1 % BSA / 0.1 % Triton 
(Life Technologies, Carlsbad, CA) at RT. All steps following the addition of secondary 
antibodies were performed in the dark to protect the slices from light which will cause 
photo bleaching of the fluorescent dye conjugated to the secondary antibody. Slices were 
washed again with washing buffer four times and twice with PBS to remove any Triton 
before mounting the samples. Slices were then stained with 488 Phalloidin-iFluor 
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(Stratech, UK), diluted 1:200, for 2 hours to stain the myofilaments. Finally, the stained 
slices were mounted on slides with Prolong Gold Mounting Medium (Life Technologies, 
Carlsbad, CA) overnight at RT. Afterwards, slices were stored at 4°C until use.  
2.2.3. Microscope settings for immunofluorescence 
 
Immunofluorescence images were taken on a Zeiss 510 META Laser Scanning Microscopy 
(LSM) confocal microscope (Carl Zeiss, Germany). All images were taken using the 
following settings: x, y planes, 12-bit images, 1024 x 1024 pixels, unidirectional scan and 
63X magnification. The specimens were excited with an Argon/2 laser (wavelength 488 
nm) and HeNe1 (wavelength 561 nm). The optical slice thickness was set at 2.0 µm.  
2.2.4. Immunofluorescence image analysis 
 
Image analysis was performed using ImageJ (National Institutes of Health, Bethesda, 
Maryland). Opening the images using the LSM toolbox ensured the correct scale bar 
settings. 
2.2.4.1. Analysis of RyR localisation 
 
ImageJ was used to measure the distance between striations. The distance between 5 
striations was measured using the line hand tool, and the measured value was divided by 
5, giving the average distance between striations. This measurement was performed in 3 
regions per PV per slice for each age group.  
2.2.4.2. Analysis of Connexin localisation 
 
For Cx40 and Cx43 analysis, connexin and phalloidin intensities were measured in ImageJ 
using the particle analysis tool. First, the threshold in the phalloidin image was adjusted 
so only the cytoplasm was visible. Using the particle analysis tool, this value was used to 
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measure the area of the image filled by cells. Secondly, the threshold in the connexin 
images was adjusted to overlay the areas with positive staining. Using the particle 
analysis tool the number of positive particles and their average size were extracted. The 
number of particles was then normalised to the cell area in the image. The average values 
in 3 regions per PV (slice) of 3 animals per group were plotted using Prism 6.0.  
2.3. Electron microscopy 
2.3.1. Solutions and compounds in electron microscopy 
 
0.2 M phosphate buffer contained 36 mM NaH2PO4.H2O (VWR International Ltd, 
Australia) and 164 mM Na2HPO4 (Fisher Scientific Ltd, UK).  
0.1 M phosphate buffer contained 18 mM NaH2PO4.H2O (Sigma-Aldrich, St. Louis) and 82 
mM Na2HPO4 (Sigma-Aldrich, St. Louis). 
2 % PFA (Sigma-Aldrich, St. Louis) contained 666.67 mM PFA in 50 ml distilled water and 
50 ml 0.2 M phosphate buffer. 
Storage solution contained: 124.05 mM ethylene glycol (Sigma-Aldrich, St. Louis), 725.5 
mM sucrose (Fischer Scientific Ltd, UK) and ~ 350 ml 0.1 M phosphate buffer. 
Epon medium resin was prepared by mixing 20 ml of Agar 100 resin, 16 ml of dodecenyl 
succinic anhydride (DDSA), 8 ml of benzyl dimethylamine (BDMA) and 1.3 ml of methyl 
nadic anhydride (MNA).  All of the compounds used to prepare Epon were purchased 
from Agar Scientific Ltd, Essex, UK. 
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2.3.2. Processing of lung slices and NRVMs for electron microscopy 
 
For EM studies, it is important to preserve the ultrastructure as close to the in vivo 
situation as possible. In this thesis, the ultrastructure in PVCs (lung slices), atria, ventricles 
and NRVMs was studied. Atria and ventricles were cut into small strips before fixation. 
NRVMs were gently scraped off the surface, pelleted by centrifugation and the pellet was 
fixed. Lung slices, atria and ventricles were fixed with 4 % PFA overnight whereas NRVMs 
were fixed with 4 % PFA for 15 minutes. Lung slices and NRVMs were then washed twice 
in PBS and kept in the fridge until use. After primary fixation, slices, atria and ventricles 
were post-fixed with 1 % osmium tetroxide for 1 – 2 hours and 30 minutes for NRVMs. All 
cells were then washed three times with 0.1 M phosphate buffer before undergoing 
ascending dehydration with acetone. The Table 2.2 below lists the AnalaR reagents and 
dehydration times used: 
 
AnalaR reagent Dehydration time 
 Lung slice and NRVMs Atria and Ventricles 
30 % acetone 5 min 10 min 
50 % acetone 5 min 10 min 
70 % acetone 5 min 10 min 
90 % acetone 5 min 10 min 
100 % acetone 10 min 20 min 
100 % acetone over a 
molecular sieve 
10 min 20 min 
Table 2.2. List of AnalaR reagents and dehydration times. 
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Lung slices, atria, ventricles and NRVMs were then incubated in 50:50 epoxy resins: 
acetone and left overnight on a rotating mixer. The following day, the tissues were 
incubated in a freshly prepared epoxy resin for 2 - 4 hours on a rotating mixer without 
caps to allow excess acetone to evaporate. Soon after, lung slices were removed from the 
epoxy resin and laid flat between clean aclar sheets. Weights were put on top of the aclar 
sheets whilst-polymerising them at 60°C for 24 - 48 hours. Simultaneously, capsules with 
unique identification codes were filled with epoxy resin and polymerised for 24 - 48 hours 
at 60°C. Once they are polymerised, each capsule with a unique code was stuck on top of 
aclar layer with a lung slice and left to polymerise at 60°C for 24 hours before sectioning. 
Atria, ventricles and NRVMs were put in moulding wells containing epoxy resin and were 
polymerised at 60°C for 24 - 48 hours. For atria and ventricles, unique codes were stuck to 
the bottom of each moulding wells to identify the tissues. For NRVMs, codes were stuck 
to the bottom of Eppendorf tubes. 
After dehydration and embedding, the tissues were sectioned using a Leica ultracut 
microtome (UCT; Leica Microsystems Ltd). For lung slices, a trapezoid shape is made 
around the pulmonary vein using a razor blade whereas for the atria and ventricles, a 
trapezoid shape can be made anywhere in the tissue. Semithin sections are cut ~ 0.5 µm 
in thickness on an ultramicrotome using glass knives and collected on plastic boats. A 
sable paint brush was used to transfer each semi-thin section to a microscope slide, dried 
on a hot plate and stained with 1 % toluidine blue for ~ 3 minutes until a gold rim is visible 
around the drop of stain. Once they are stained, toluidine blue was washed off with 
distilled water and the section was examined on a light microscope. Using a diamond 
knife, ultra-thin sections were cut ~70 nm in thickness and collected on copper grids (2 x 1 
mm – Agar Scientific Ltd, UK) and left to dry in petri dishes with filter paper. After drying, 
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ultrathin sections were counter-stained with 4 % uranyl acetate for 30 minutes and lead 
citrate for 10 minutes with three washes with deionised water in between. Imaging was 
done using a JEOL 1400 TEM (JEOL, Japan). 
2.3.3. Transmission electron microscope settings 
 
A JEOL 1400 Transmission electron microscope was used for taking electron microscope 
images. An 80 kV electron beam gun was used for excitation and images were taken with 
a XR60 camera (Advance microscopy techniques (AMT), Woburn, MA, USA). The spot size 
was set at 2 µm. The software used for taking images was AMTV600 (AMT, Woburn, MA, 
USA). 
2.3.4. Electron microscopy image analysis 
 
Electron micrographs were analysed using ImageJ by setting the scale using the scale bar 
from the EM images. Images that showed post mortem changes (i.e. severe loss of 
myofibrils, myofibrils appearing stretched and the presence of extracellular spaces) were 
excluded from the analysis. Low magnification images (<1000X) were also excluded from 
the quantifications as it was difficult to see the outline of organelles like mitochondria. 
2.3.4.1. Analysis of mitochondrial number and size 
 
Mitochondria were outlined manually in ImageJ to measure their area. In addition, the 
number of mitochondria per image was counted. Counting of mitochondria was done 
manually by visual inspection of the images and converted to the number of 
mitochondria per 50 µm². For both lung slices and NRVMs studies, only intermyofibrillar 
mitochondria were analysed because of the lack of sufficient images to analyse number 
and size of perinuclear and sarcolemmal mitochondria. Three images from three animals 
per age group were analysed for each, PVCs, atrial and ventricular myocytes. Overall, ~ 90 
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mitochondria were analysed from 3 animals per age group. In NRVMs images, 22 images 
from 2 litters per group were analysed. For the statistical analysis, the average 
mitochondrial size per image or the absolute number of mitochondria per 50 µm² were 
compared. As dehydration can shrink the tissue, we used the distance between 
sarcomeres as an indicator for possible shrinkage. The average distance between 
sarcomeres in cardiomyocytes and PVCs is 1.8 µm, a fact that we confirmed using 
immunofluorescence staining in lung slices that underwent less processing (Chapter 3). 
This distance can be used as a molecular ruler (Soeller and Cannell, 1999). The ‘shrinkage 
factor’ for each image was calculated by dividing the expected sarcomere length (1.8 µm) 
with the actual sarcomere length. The ‘shrinkage factor’ was applied for calculating the 
mitochondrial area. Table and graphs were plotted using Microsoft Excel and GraphPad 
Prism 6.0. 
2.3.4.2. Analysis of the organisation of myofibres 
 
The organisation of myofibres and width of sarcomeres was analysed in ImageJ as 
described in detail in Chapter 3, section 3. 6.1.1.  
 
2.4. Ca²⁺ imaging 
2.4.1. Solutions and compounds for Ca2+ imaging 
 
sHBSS see Section 2.1.1.1. 
Calcium-sensitive fluorescent indicator: Cal-520TM AM (Stratech, UK). 
Drugs were purchased from various suppliers: BTP2 / YM - 58433 (Tocris, UK), carvedilol 
(Enzo Life Sciences, USA), dantrolene (Tocris, UK), Isoproterenol (Sigma-Aldrich, St. Louis), 
JTV – 519 (Sigma-Aldrich, St. Louis), Propranolol (Sigma-Aldrich, St. Louis), Norepinephrine 
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(Sigma-Aldrich, St. Louis), SN-6 (Tocris, UK), trolox (Sigma-Aldrich, St. Louis) and verapamil 
(Sigma-Aldrich, St. Louis). 
 
 
2.4.2. Indicator loading and microscope setting for imaging lung slices 
 
For imaging experiments, lung slices were mounted on custom built chambers sealed 
with silicon grease. A fine nylon mesh was placed on top of the slices to allow solution 
changes without moving the slice (see Figure 2.2 below). 
 
Figure 2.2. Imaging chamber and components needed to measure changes of Ca2+ in 
PVCs within a lung slice. An example of a set-up of an imaging chamber used to measure 
changes in Ca2+ in slices. The chamber contains a nylon mesh to stop a slice moving whilst 
changing solutions and platinum electrodes which were connected to a Grass instrument 
simulator SD9.  
 
The Ca²⁺ indicator was used in its AM-ester form to allow good loading into the cells. The 
AM-ester group mask the charged groups of the indicator, which enables the charged 
indicator molecule to cross the plasma membrane by diffusion. Once inside the cell, the 
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ester groups are cleaved off the indicator by endogenous cytoplasmic esterases to 
generate the active Ca2+ -sensitive indicator. This process is called de–esterification. Upon 
Ca²⁺ binding, the emission intensity of the dye alters. In case of Cal-520, it increases. 
These changes in fluorescence can be detected, calibrated and interpreted as fluctuations 
in the intracellular Ca²⁺concentration.  
For these experiments, lung slices were loaded with 10 µM Cal-520TM AM (AAT Bioquest, 
USA) in sHBSS for 1 hour at room temperature in the dark. The loading solution also 
contained 0.1 % Pluronic F127 (Life Technologies) to aid the indicator transfer over the 
cell membrane and 200 µM sulfobromophthalein (Sigma), to prevent dye leakage from 
the cells. The loading was then followed by a de-esterification period of at least 30 
minutes in the presence of sulfobromophthalein. Imaging was performed on the Zeiss 
510 META Laser Scanning Microscope (LSM) (Carl Zeiss, Germany). 
Cal-520TM AM was excited at 488 nm and the emitted fluorescence was collected with a 
bandpass filter at wavelengths above 505 nm. The numerical aperture was set at 2.0 µm. 
Videos were collected at 10 Hz (10 frames per second), 120 x 120 pixels and imaged with 
a 63X oil immersion objective. Line scans were performed at ~ 333 Hz (333 frames per 
second).  
All images were taken using the following settings: x, y planes, 12-bit images, 1024 x 1024 
pixels, unidirectional scan and 63X magnification on an oil immersion objective. The 
specimens were excited with an Argon/2 laser (wavelength 488 nm) and HeNe1 
(wavelength 561 nm). Image analysis was performed using ImageJ (National Institutes of 
Health, Bethesda, Maryland). 
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For EFS, pulses of sine wave current of ~ 4.2 - 8 mAmps, 60 V and 10 ms duration were 
applied using a Grass Instruments SD9 simulator and platinum electrodes placed at each 
end of the slice (Figure 2.2 above). The stimulation frequency was set at 1 Hz, 3 Hz or 5 
Hz.  
 
2.4.3. Indicator loading and microscope setting for imaging NRVMs 
 
NRVMs grown on laminin coated glass coverslips were mounted on custom built imaging 
chambers sealed with silicon grease (Corning). No nylon mesh was necessary to keep the 
cells in place as these adhered to the laminin-coated glass coverslips.  
NRVMs were loaded with 10 µM Cal-520TM AM (AAT Bioquest, USA) in presence of 0.1 % 
Pluronic F127 (Life Technologies, UK) for 30 minutes in the dark at RT, followed by a 30 
minutes de – esterification period. Imaging was performed at the Leica widefield 
epifluorescence imaging system, using a 20X air objective (numerical aperture 0.4) (Leica, 
UK). 
Cal-520TM AM was excited at 488 nm and the emitted fluorescence was collected at 
wavelengths above 505 nm, the Kd for Ca
2+ affinity is 320 nM. 
For EFS, NRVMs were stimulated with 60 V, 10 ms duration pulses generated by a Grass 
Instruments SD9 simulator set to 2 Hz. Platinum electrodes were placed at the opposing 
sides of the imaging chamber.   
Videos were collected at a frequency of 12 – 20 frames per second using 4 x 4 binning. 
The intensity was set at 5, the gain at 10, the exposure time at 50 ms.  
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2.4.4. Ca2+ imaging analysis  
 
2.4.4.1. Analysis of the spontaneous activity and pacing in lung slices 
 
To assess the frequency of the spontaneous activity and the ability of PVCs to follow EFS, 
line scans were collected for 18 seconds on the confocal microscope. The experiments 
were performed as follows:  
1.  Slices were paced with 1, 3 and 5 Hz for 12 second. 
2  6 seconds recording without any EFS.  
Phase 1 allowed to see whether the slices can respond to EFS pulses with regular 
responses and to analyse whether EFS suppressed the frequency of the spontaneous 
activity. Phase 2 showed whether the EFS affects the frequency of spontaneous activity 
following after cessation of the pulses in PVCs from 3 and 24 month-old mice, and to see 
if any APs occur after the end of the EFS.  
ImageJ was used to open LSM files and the experiments were analysed as illustrated in 
Figure 2.3. Regions of interests (ROIs) were placed inside the cells and in the background 
(Figure 2.3B) and the changes in fluorescence over time in the ROIs were extracted. 
Fluorescence profiles, similar to the traces in Figure 2.3, were plotted in GraphPad Prism 
6.0, and the changes in fluorescence at any given time (F) was normalised to the 
minimum fluorescence (F0) and then expressed as F/F0 (Figure 2.3D). To assess the 
frequency of Ca²⁺ waves (Figure 2.3C-E) these were counted over time, calculated as 
transients per second and expressed in Hz. To assess the percentage of PVCs following 
pacing, 3 different regions along the PV were imaged per slice. Successful pacing was 
defined as PVCs responding to all EFS pulses in a continuous train of pulses. Whether a 
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Ca2+ transient was a response to an EFS pulse was judged by the appearance of vertical 
lines in line scan images or the rate of rise of the Ca2+ transients as described in Table 4.1. 
For quantification of the average percentage of PVCs following pacing per slice was 
analysed. To compare the level of activity and the pattern of responses to EFS in slices 
from 3 and 24 month-old mice, the number of slices showing an activity below or above 
0.5 Hz was counted. To compare pattern of responses to EFS, the number of slices 
showing regular responses, alternans or irregular responses (defined in Chapter 4, Section 
4.5 was counted. 
To calculate the amplitude of the Ca2+ transients, the changes in F/F0 were calculated as 
follows: maximum amplitude of the transient – minimum amplitude of the transient. 
These were called  ∆ F/F0.  The calculation was done manually in GraphPad Prism 6.0 by 
measuring amplitudes of the Ca2+ transients (Figure 2.3E). To avoid bias, for cells with a 
frequency of > 0.6 Hz (> 10 transients / 18 seconds imaging period) and variable 
amplitudes of global Ca2+ transients, ∆ F/F0 was calculated for a minimum of 10 global Ca
2+ 
transients to measure an accurate average amplitude. For PVCs with a frequency of < 0.6 
Hz, all of the Ca2+ transients were measured to calculate the average ∆ F/F0. The transient 
amplitude contributed to the classification into local Ca2+ transients or Ca2+ wave as 
explained in detail in Figure 4.2 and Table 4.1.  
The transient durations (TD50) was calculated as the time it takes for Ca
2+ transients to 
reach half maximal amplitude. It was calculated by measuring the time differences (T1 – 
T2) for ∆ F/F0 to reach the half maximal value (Figure 2.3E).  
All data were presented as means ± S.E.M. of the activity per slice. Details of the 
statistical analysis were given with the Figures.  
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Figure 2.3. Ca2+ imaging analysis. Panel A illustrates loading of the cells with fluorescent 
Ca2+ indicators, B the setting or regions of interest (ROI), C the Ca2+ traces as change in 
absolute fluorescence over time, which will be normalised to the minimum fluorescence 
(F0) found in the same cell, shown in D. E illustrates the various parameters of the Ca
2+ 
transients that were quantified.  
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2.4.4.2. Analysis of the spontaneous activity and pacing in NRVMs 
 
A minute before imaging, NRVMs were paced at 2 Hz for 10 seconds to balance possible 
differences in the SR Ca2+-content between control and HU-treated cells. NRVMs were 
imaged as follows:  
1.  10 seconds pre EFS. 
2.  10 seconds with 2 Hz EFS. 
3.  10 – 30 seconds post EFS. 
This protocol allowed to quantify the frequency of the spontaneous Ca2+ transients before 
applying pacing (phase 1), the ability of NRVMs to follow electrical pacing (phase 2) and 
the frequency of the spontaneous Ca2+ transients after 2 Hz EFS (phase 3). For analysis, 2 
– 3 regions per coverslip were imaged as described above on 3 coverslips per condition 
from 3 separate litters. ImageJ was used for opening LSM files. Ca2+ traces were plotted 
using GraphPad Prism 6.0 and data were presented as means ± S.E.M. of the activity per 
coverslip.  
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2.4.4.3. Analysis of drug effects in lung slices 
 
For analysing the effects of various drugs, mentioned in Chapter 4.4, videos were 
collected on the confocal microscope to analyse the spontaneous activity before and 
after drug treatments as follows. The line-scans were 18 seconds long and taken at a rate 
of 333 frames per second.  
Run 1 (before drug treatment):  
1. 18 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
2. 18 seconds long, 12 seconds with application of 1 Hz EFS and 6 seconds where no 
stimulus was applied. 
 
Following Run 1, the lung slices were superfused with a drug on stage and left for a 10 
minutes period before starting Run 2.  
Run 2 (after drug treatment):  
1. 18 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
2. 18 seconds long, 12 seconds with application of 1 Hz EFS and 6 seconds where no 
stimulus was applied. 
ImageJ was used to open the files and ROIs were selected to measure the changes in 
cytosolic Ca²⁺ on the same cells over time for Run 1 and Run 2. For the analysis, 3 - 5 slices 
per animal were analysed in 4 - 5 animals per age group. Data were presented as means ± 
S.E.M. for the activity per slice. 
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2.4.4.4. Analysis of drug effects in NRVMs 
 
To analyse the effects for various drugs in NRVMs, listed in Chapter 4.4, videos were 
taken to compare the spontaneous Ca²⁺ transients pre and post 2 Hz EFS, and the ability 
of cells to follow 2 Hz EFS. The recording in NRVMs lasted 50 seconds with an image 
acquisition frequency of 12 frames per second as follows:   
Run 1 (before drug treatment):  
1.  10 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
2.  10 seconds with application of 2 Hz EFS. 
3.          30 seconds where no stimulus was applied to the cells. 
Following Run 1, the lung slices were superfused with a drug on stage and left for a 10 
minute period before starting Run 2.  
Run 2 (after drug treatment):  
4.  10 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
5.  10 seconds with application of 2 Hz EFS. 
6.  30 seconds where no stimulus was applied to the cells. 
 
For quantification, 6 coverslips were imaged per condition from 2 litters. Data were 
presented as means ± S.E.M. of the activity per coverslip.  
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2.5. Assessing mitochondrial membrane potential in NRVMs 
 
2.5.1. Solutions and compounds for measuring the mitochondrial membrane 
potential 
 
JC-10 (AAT Bioquest, USA). 
MitoTracker (579 nm / 599 nm; excitation / emission) (Life Technologies, USA). 
Anti-, Oligomycin (Sigma-Aldrich, St. Louis). 
2.5.2. Microscope settings for assessing the mitochondrial membrane Potential 
To measure the mitochondrial membrane potential, the cells were stained with 50 µM JC-
10 (AAT Bioquest, USA) for 30 minutes. To avoid artefacts in the results caused by 
different loading, the loading conditions were kept similar and to the exact timings. 
Following the staining period, NRVMs were briefly washed with HBSS before being 
imaged on the Leica imaging system. JC-10 was excited at 450-490 nm (green images)/ 
590-650 nm (red images) and emission was measured above 650 nm to visualise healthy 
and depolarised mitochondria. Additionally, NRVMs were also stained with 100 nM 
MitoTracker (579 nm / 599 nm; excitation / emission) (Life Technologies, USA) for 30 
minutes to stain all mitochondria regardless of the state of their membrane potential. 
Antimycin and Oligomycin (5 µM) were added on stage to depolarise mitochondria. 
2.5.3. Analysis assessing the mitochondrial membrane potential 
 
Image analysis was done in ImageJ. Regions of interest were placed inside cells. The 
change in fluorescence over time were measured and plotted in GraphPad Prism 6.0. For 
analysis, 5 – 10 images were taken per coverslip from 3 coverslips on 3 separate days for 
each condition. Data were presented as means ± S.E.M. of the fluorescence (arbitrary 
units) values per cell. 
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2.6. ROS Measurements 
2.6.1. Solutions and compounds for measuring ROS levels 
 
ROS Brite TM (AAT Bioquest, USA). 
Antimycin (Sigma-Aldrich).  
 
2.6.2. Measuring Basal ROS levels in lung slices 
 
2.6.2.1. Microscope settings for measuring basal ROS levels in lung slices 
 
To investigate the basal levels of ROS in PVCs from 3 and 24 month-old mice, slices were 
incubated with 50 µM ROS Brite TM (AAT Bioquest, USA) for 30 minutes before being 
imaged on the Zeiss 510 META laser scanning microscope. ROS Brite was excited with 488 
nm and emission was measured above 515 nm.  
2.6.2.2. Analysis of measuring basal ROS levels in lung slices 
 
The LSM files were opened with ImageJ. PVCs were outlined and the average 
fluorescence intensity was measured in the whole cells from 3 and 24 month-old mice. 
For the basal fluorescence, the average of the background subtracted first 10 images was 
calculated. 3 slices per animal were analysed and a total of 3 animals per group were 
examined. Data were presented as means ± S.E.M. of fluorescence per slice. 
2.6.3. Measuring basal and inducible ROS levels in NRVMs 
2.6.3.1. Microscope settings for measuring basal and inducible ROS levels in 
NRVMs 
Control and HU treated NRVMs were incubated with 50 µM ROS Brite TM (AAT Bioquest, 
USA) for 30 minutes and imaged with a Leica widefield imaging system. ROS Brite TM was 
excited at 488 nm and emission was measured above 515 nm. NRVMs were imaged for 
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120 seconds at a frequency of 25 frames per second with a 20X objective, numerical 
aperture 0.4.  
2.6.3.2. Analysis of measuring basal and inducible ROS levels in NRVMs 
For the basal fluorescence, the average of the background subtracted first 10 images was 
calculated. The inducible fluorescence was measured by normalising the background 
subtracted fluorescence at any given time (F) to the minimum fluorescence (observed at 
the beginning of the experiment) (F0) and expressed as F/F0. ROS production was induced 
by addition of 10 µM antimycin 10 seconds after starting the imaging experiment. ImageJ 
was used to open LIF files. The cells were outlined and used as ROIs, and changes in their 
fluorescence were analysed. Data were presented as means ± S.E.M. of fluorescence per 
coverslip. 
 
2.7. Autophagy assay in NRVMs 
2.7.1. Solutions and compounds for the autophagy assay 
 
CYTO-ID kit (Enzo). 
Loading buffer plating medium (see Section 2.1.1.2), supplemented with 1 mM non-
essential amino acids (Gibco) and 1 mM sodium pyruvate (Gibco).  
Nutrient rich medium contains the assay buffer (Enzo) supplemented with 1 mM non-
essential amino acids (Gibco) and 5% FBS.  
2.7.2. Microscope settings for the autophagy assay 
 
Autophagy was measured in control and HU treated NRVMs by using a CYTO-ID 
autophagy detection kit (Enzo Life Sciences) and followed the protocol as per 
manufacturer’s instructions. The cells were removed from the incubator and placed into 
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loading buffer before staining with the autophagy kit for 30 minutes according to the 
manufacturer’s instructions. For the measurement of basal autophagy, cells were stained 
immediately after removing them from the incubator and placing them into loading 
buffer. In order to see whether autophagy can be induced, and to what extent, NRVMs 
were treated with 5 µM pp242 (Tocris, UK) for 2 hours in nutrient rich medium, before 
staining with the autophagy kit for 30 minutes / for the last 30 minutes the autophagy 
stain was added to the PP242 containing medium. Cells were then imaged with a 63X 
objective (numerical aperture 1.40) on the Leica widefield imaging system. The green 
detection dye was excited with 488 nm and emitted fluorescence was collected at 
wavelengths above 505 nm.  
 
2.7.3. Analysis of the autophagy assays 
 
For quantification, 5 - 6 coverslips per condition (control or HU-treated) from 3 litters 
were imaged on day 1, 4 and 7 after HU addition. ImageJ was used to open LIF files. 
Autophagosomes were counted using the particle analysis and nucleus counter plugins in 
ImageJ. Data were presented as means ± S.E.M. of the number of autophagosomes per 
region.  
2.8. Western blotting 
2.8.1. Solutions and Compounds for western blotting 
 
Lysis buffer: (Tris – HCl 20 mM, 1% Triton x-100, NaCl (Sigma-Aldrich, St. Louis) 150 mM, 
Na3VO4 (Sigma-Aldrich, St. Louis) 2µM, leupeptin (Sigma-Aldrich, St. Louis) 2µg / ml, 
protease inhibitors cocktail concentration 2 µM (Sigma-Aldrich, St. Louis), pH 7.6. 
Tris Buffered Saline (TBS): 10 mM Tris-HCL and 150 mM NaCl, pH 7.6. 
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TBS-T: 0.1% Tween-20 and TBS. 
Transfer buffer: (1X transfer buffer contains 5 % 20X transfer buffer solution (Novex, Life 
Technologies, Carlsbad, CA) with 20 % methanol and distilled water). 
Blocking buffer: TBS – 0.1 % Tween + 5 % Marvel milk powder. 
2.8.2. Cell lysis and protein quantification 
 
NRVMs grown in T175 flasks were dislodged gently using a cell scraper (Fisher Scientific 
UK Ltd) and resuspended in ice-cold PBS. Cells were centrifuged at 2500 rpm for 5 
minutes at 4°C and pellets were stored at - 80°C. For protein measurement, pellets were 
resuspended in lysis buffer and lysed for 30 minutes on ice at a rotating platform. Protein 
concentrations were determined using a Bradford assay (BIO-RAD, UK) according to the 
manufacturer’s instructions. 2 µl of the undiluted samples were quantified. The BSA 
standard curve contained absorbance values with different concentrations of BSA. 
Absorbance was measured at 595 nm using a plate reader (FLUOstar OPTIMA, BMG 
LABTECH). The standard curve was plotted in GraphPad Prism 6.0. 
2.8.3. SDS polyacrylamide gel electrophoresis (SDS PAGE) 
 
10 % SDS PAGE gels were made a few days prior to use by pouring separating gel solution 
into an empty cassette, 1.0 mm thickness (BIO-RAD, UK) and allowed to solidify for 1 
hour. Drops of 70 % Ethanol were added on top to remove any bubbles that forms on top 
of the separating gel solution. Once the separating gel solution had solidified, stacking gel 
solution was then poured on top and comb inserted to generate 12 wells and left to 
solidify. The gels were wrapped in tissue paper moisturised with running buffer to 
prevent the gels from drying out and stored at 4°C until use. The separating and stacking 
mixes used to make a single 10 % SDS gel were: 
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8 ml of 10 % separating gel                               5 ml of 6 % stacking gel 
3.8 ml ddH20                                                        2.9 ml ddH20 
2 ml 40 % Acrylamide (BIO-RAD)                     0.75 ml 40 % Acrylamide (BIO-RAD) 
2 ml 1.5 M Tris pH 8.8                                       1.25 ml 0.5 M Tris pH 6.8 
80 µl 10 % SDS                                                    50 µl 10 % SDS 
80 µl 10 % APS                                                    50 µl 10 % APS 
8 µl TEMED (BIO-RAD)                                      5 µl TEMED (BIO-RAD) 
 
Just prior to running the SDS-PAGE gel, the frozen protein samples were thawed and 
diluted in denaturing solution to achieve an equal loading of 14.6 µg of protein per well. 
4X sample buffer (NuPage LDS sample buffer 4X, InvitrogenTM, UK) was added to the 
samples. The samples were heated at 90°C for 5 minutes to denature the proteins before 
being loaded into wells. For a molecular marker lane, 5 µl of molecular marker 
(InvitrogenTM, UK). The electrophoresis tank was set-up and filled to 2/3 depth with 
running buffer and samples were electrophoresed for 45 – 60 minutes at 150 V. 
2.8.4. Semi-dry transfer procedure 
 
The gel cassette was removed from the electrophoresis tank. The SDS gel with proteins 
was taken out of the cassette and put in Tris Buffered Saline (TBS) whilst the PVDF 
membrane (Amersham Pharmacia Biotech, UK) was prepared. The PVDF membrane was 
activated by immersion in methanol for 15 seconds, and then kept for 2 minutes in water 
before placing it into transfer buffer. Proteins were transferred from the gel to the PVDF 
membrane by sandwiching a gel with the PVDF membrane in-between transfer buffer-
soaked Whatman filter papers and sponges. The sandwich was then soaked in transfer 
buffer and the transfer was performed by a semi-dry procedure using a POWERPAC 1000 
(Bio-Rad, UK) set at 20 V for 2 hours.  
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2.8.5. Immunostaining (western blotting) 
 
Following the transfer, the PVDF membrane was removed from the transfer system and 
exposed to PonceauS Red (Boehringer Mannheim, Germany) to check for protein 
transfer. The positions of the molecular weight markers were labelled on the PVDF 
membrane. Blotting membrane was then incubated in blocking buffer for an hour at RT.  
The blotting membrane was subsequently exposed to primary antibodies diluted in 5 % 
marvel skimmed milk in TBS-T at 4°C overnight. Table 2.3 below lists the primary 
antibodies used in this study. 
 
 
Antibody and 
isoform 
Concentration Source Catalogue 
number 
Troponin T, 
polyclonal rabbit 
1:200 CUSABIO CSB-
PA10047A0Rb 
SERCA2a, polyclonal 
rabbit 
1:200 CUSABIO CSB-
CL002333DO 
PARP1, polyclonal 
rabbit 
1:200 Abcam Ab151794 
 
Advanced glycation 
end products, 
polyclonal rabbit 
1:100 CUSABIO CSB-
PA14209A0Rb 
p53, polyclonal 
rabbit 
1:200 St. John’s laboratory STJ94890 
Table 2.3. List of the antibody used. 
 
 
 
The primary antibodies were removed and membrane washed (6 x 5 minutes) with TBS – 
T. The membrane was incubated for 1 hour with HRP-conjugated secondary goat anti 
rabbit antibodies, diluted 1:5000 in 5 % marvel in TBS – T. The blots were then washed 
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again with TBS – T (6 x 5 minutes) before being treated with super signal 
chemiluminescent substrate (Thermo Scientific) for 5 minutes. Images were taken on a 
GelDoc system (Syngene, Cambridge UK). 
2.8.6. Western blotting analysis 
 
Western blots were repeated 3 times for all antibodies tested. Images from the GelDoc 
system were open with ImageJ and bands were measured and normalised against the 
intensity of Troponin T in the same lane. Graphs were plotted on GraphPad Prism 6.0 and 
data were presented as means ± S.E.M. 
 
2.9. Summary of the statistical analysis used in this study 
 
Student’s unpaired t-test: This test was performed whilst analysing two different 
variables. In this study, EM data on mitochondrial numbers and sizes in PVCs from 3 and 
24 month-old mice were analysed using unpaired t-tests. It was also used for the Ca2+ 
imaging analysis (young vs. old), ROS (young vs. old) and immunofluorescence (young vs. 
old) experiments. 
Paired t-test: This test was performed when analysing the effects of pharmacological 
tools on the frequency of Ca2+ transients in PVCs from both age groups. As the effects of 
pharmacological inhibitors were tested at different time-points on the same cells i.e. PVCs 
in young and old animals or in NRVMs whilst testing pharmacological drugs, paired 
analysis was conducted. 
One way ANOVA: This test is performed when we analysed three different variables as in 
Chapter 5. Those variables were control, 50 µM HU and 500 µM HU treatment. Ca2+ 
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imaging, autophagy and mitochondrial membrane potential experiments in control, 50 
µM HU and 500 µM HU treated cells were analysed usning a One way ANOVA. 
Fisher’s Test: EFS-induced pacing in PVCs during ageing was measured as categorical date 
(yes/no), and was therefore analysed using a Fisher’s test. 
For PVCs data, each lung slice was used as an experimental unit. For experiments on 
NRVMs, each coverslip was used as an experimental unit. For ANP granules / 
mitochondrial data, lung slices (PVCs) and heart sections (atrial and ventricular myocytes) 
were used as an experimental unit. All data are expressed as means ± S.E.M. 
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Chapter 3: A comparative study of the structure of rat 
pulmonary vein sleeve cells, atrial and ventricular myocytes 
during ageing 
3.1. Introduction 
Alterations in the structure of cardiac myocytes have been suggested to occur during 
ageing and the development of cardiac dysfunction. It is likely that changes in atrial 
myocytes and PVCs contribute to the susceptibility to arrhythmias such as AF, which 
increases in both incidence and severity with ageing. Despite evidence for morphological 
alterations of atrial and ventricular cardiac myoctes occuring during ageing and disease, 
as described in Chapter 1, structural studies of PVCs during AF or ageing are still limited, 
and to our knowledge no systematic study comparing atrial, ventricular and PVC cardiac 
myocyte structures has been performed.  
The work presented in this Chapter describes the structure of PVCs in situ within murine 
lung slices. The structure of PVCs is compared with those of atrial and ventricular cardiac 
myocytes. Electron microscopy (EM), light microscopy and confocal immunofluorescence 
were used to characterise specific structural and morphological aspects of these cell 
types, and to examine the expression of key proteins involved in cardiac excitation-
contraction coupling. These analyses were performed using 3 month- and 24 month-old 
mice for each of the cells types, in order to explore putative changes within the cells that 
may underlie an ageing-related decline in cardiac function. 
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3.2. Aims of this Chapter 
This work described in this Chapter had three main aims: 
(1) To undertake a detailed structural characterisation of PVCs using light microscopy, 
EM, and confocal imaging. 
(2) To investigate differences in excitation-contraction coupling and the Ca2+ signalsome 
of PVCs from young and old mice. 
(3) To provide a side-by-side comparison of the structure of atrial, ventricular and PVC 
cardiac myocytes, and to explore putative structural and functional changes occurring in 
each of the cell types during natural ageing. 
 
3.3. The morphology of murine lung slices, and identifying PVCs within a lung 
slice 
Murine lung slices are an established model that allow PVCs to be studied whilst retaining 
features such as viability, position, orientation and connections relative to surrounding 
cells within the pulmonary veins (Rietdorf et al., 2014) (described in Chapter 2, section 
2.1.1). A low magnification bright-field image of a lung slice is shown in Figure 3.1A, 
depicting many of the typical structures seen within a lung slice; pulmonary vein(s), 
airways, alveolar tissue and pulmonary arteries.  
Pulmonary veins are usually readily distinguishable from pulmonary arteries and airways 
because they are surrounded by an obvious layer of muscle cells. This muscle layer is the 
sheath of PVCs. However, the correct identification of PVCs was essential for this project, 
and a number of obvious morphological and positional differences were used to 
determine the presence of PVCs around a pulmonary vein. For example, PVCs are 
striated, and depending on the cutting angle used to make the lung slice, the striated 
pattern of PVCs was visible under a light microscope with sufficient magnification (Figure 
3.1B and C). Striated cells are absent from the pulmonary arteries and airways. 
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Furthermore, the striated PVCs typically displayed spontaneous contractions. 
Additionally, pulmonary arteries are closely associated with an airway and tend to be 
collapsed in lung slices; a feature that is not seen with pulmonary veins (Figure 3.1A). 
Airways can clearly be identified as having a lining of epithelial cells with beating cilia. 
The lung slice image presented in Figure 3.1A shows transverse sections through two 
pulmonary veins, with both veins having obvious PVCs around their outer circumferences.  
In common with many pulmonary vein slices, the thickness of the PVC layer is not the 
same around the whole circumference of either vein (Figure 3.1A). Previous studies have 
established that the PVC layer can vary in thickness and coverage around a pulmonary 
vein (Ho et al., 2001, Mueller-Hoecker et al., 2008). A further reason for the difference in 
thickness of the PVC layer is that the cut used to make the slice was not fully transverse 
to the long axis of the pulmonary vein vessel, but rather at an angle. Based on the 
position and diameter of the veins shown in Figure 3.1A, it is possible to determine that 
this slice was from a site close to the hilus region, shortly after the main pulmonary vein 
has branched into two. Whilst it was possible to generally ascribe the position of the 
lungs / pulmonary vein from which a slice originated, this study did not examine 
differences between PVCs along the longitudinal section of the vein (e.g., hilus versus 
periphery). Rather, this study was focussed on whether the PVC sleeves were uniform or 
heterogeneous around the circumference of a vein. For this, slices were chosen for 
analysis in which the pulmonary veins were obviously transversely cut, such as that 
shown in Figure 3.1. 
Similar to other veins, pulmonary veins have endothelial cells facing the vein lumen, and a 
thin layer of smooth muscle cells underneath the endothelial cells. The endothelial cells 
can be seen under the light microscope following toluidine blue staining, as shown in 
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Figure 3.1B and C. In contrast to the PVCs, the smooth muscle cells are poorly visible 
under a light microscope without staining, but can clearly be identified in EM images.   
Although PVCs were often highly evident in lung slices, this study used a combination of 
the following criteria to formally identify cells as PVCs: (1) PVCs were associated with 
(usually surrounding) a blood vessel, (2) PVCs displayed spontaneous contractions, (3) 
PVCs were not located next to an airway, and (4) PVCs were striated (normally evident in 
both light and electron microscopy). It should be noted that the presence of striations 
depended on the angle at which the slice was cut, as discussed below.  
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Figure 3.1. Light microscopic images of a lung slice. Panel A shows a representative low 
magnification image of a lung slice, containing two pulmonary veins (PVs), an airway, a 
pulmonary artery and alveolar tissue. Panel B shows a semi-thin lung slice section of a 
pulmonary vein and the surrounding alveolar tissue. Panel C shows a higher magnification 
of a semi-thin section of the same pulmonary vein as in B. The endothelial layer (EL) and 
the PVCs (asterisks) are clearly visible. The semi-thin sections were stained with 1.5% 
toluidine blue for 2 minutes. Scale bar in all panels represent 100 µm. 
120 
 
3.4. Organisation, orientation and structure of PVCs 
Each mouse lung slice preparation yielded tens of different slices to examine, and it was 
possible to obtain slices in which pulmonary veins had been cut at various angles relative 
to the microtome. The representative low magnification transmission electron 
microscope (TEM) image shown in Figure 3.2A depicts a pulmonary vein with PVCs 
located around the outer circumference of the vessel lumen (the areas of PVCs are 
indicated using red and blue lines). Regions of PVCs from Figure 3.2A are shown at a 
higher magnification in Figures 3.2B and C.   
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Figure 3.2. The general structure of PVCs. Panel A is a low magnification electron 
micrograph of a pulmonary vein. The scale bar represents 10 µm. Panel B a higher 
magnification image of PVCs containing myofibres with clearly visible Z-lines, imaged 
from the area outlined in blue in Panel A. Panel C is a higher magnification image of PVCs 
containing myofibres without obvious Z-lines, due to cutting the the slice at an angle in 
which the z-lines were not evident. The image is taken from the region outlined in red in 
Panel A. The scale bars in Panels B and C represent 500 nm. 
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At the lower magnification, shown in Figure 3.2A, both regions of PVCs appear quite 
similar in terms of cell thickness and contrast. However, the higher magnification images 
presented in Figures 3.2B and C illustrate a feature of PVCs that was frequently observed 
in this study; the orientation of the PVCs was not the same around the circumference of a 
vessel. The image shown in Figure 3.2B depicts PVCs containing myofibres with clear Z-
lines. In contrast, the image shown in Figure 3.2C presents PVCs in which Z-lines were not 
clearly visible. The images in Figures 3.2B and C are of PVCs surrounding the same 
pulmonary vein, cut at the same angle and treated similarly in every way. The reason for 
the different appearance of the PVCs is that they had a different orientation relative to 
the vessel and the cut. The region of PVCs outlined in blue Figures 3.2A and B displays 
obvious Z-lines because the cells were oriented with their long axis perpendicular to the 
long axis of the vein. In contrast, the cells outlined in red in Figure 3.2A and C were 
oriented so their long axis was parallel to the long axis of the vein, and consequently, no 
Z-lines (or longitudinal myofibres) are visible.  
A more detailed view of PVCs within a slice, and their surrounding cells, is shown in Figure 
3.3. The portion of a pulmonary vein captured in Figure 3.3A depicts the different layers 
of cells in the wall of a pulmonary vein; a layer of endothelial cells is facing the vein 
lumen, followed by a layer of smooth muscle cells between the endothelial cells and the 
PVCs. The cytoplasm of PVCs is densely filled with myofilaments, which are important for 
contractile activity. However, of the three PVCs visible in Figure 3.3A, only one of them 
(outlined in blue) shows myofibres with clear Z-lines. Similar to the situation described for 
Figure 3.2 above, the PVC outlined in yellow was cut at an angle perpendicular to the 
direction of the myofilaments. Such a perpendicular cut of the myofilaments is evident on 
closer inspection of the EM images. For example, the region of the PVC bounded by the 
dashed yellow box in Panel 3.3A shows two circular bundles of myofilaments end-on. The 
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third PVC (outlined in red) appears to be orientated at an angle that is intermediate 
between the other two PVCs. This is evident from the appearance of slight Z-lines that are 
faint and discontinuous. The images presented in Figures 3.2 and 3.3 typify the 
heterogeneous alignment of the PVCs around a pulmonary vein vessel. Moreover, the 
heterogeneous alignment was not only evident around different parts of the pulmonary 
vein, as illustrated in Figure 3.2, but was visible in adjacent PVCs (Figure 3.3). These 
observations are consistent with other reports suggesting that the alignment of PVCs 
along a pulmonary vein is heterogeneous (Hocini et al., 2002, Mueller-Hoecker et al., 
2008).  
During the course of this study, through examining numerous EM images, it became 
evident that PVCs contain three distinct sub-populations of mitochondria, which can be 
seen in Figure 3.3B. Perinuclear mitochondria (outlined in orange) were localised near the 
nucleus, and tended to be smaller and more rounded in shape compared to other 
mitochondria. In contrast, the inter-myofibrillar mitochondria (outlined in blue) were 
found between the myofibril bundles, and were mostly oval in shape. The inter-
myofibrillar mitochondria were the most abundant sub-population of mitochondria found 
in PVCs. The third sub-population of mitochondria were found in the sub-sarcolemmal 
region, underneath the sarcolemma (outlined in red). In higher magnification EM images, 
glycogen granules could be seen in the cytoplasm of PVCs (groups of them are outlined in 
green in Figure 3.3C). As in atrial and ventricular cardiac myocytes, intercalated discs 
were found at the junctions between neighbouring PVCs (Figure 3.3D). Intercalated disks 
are thought to be sites where intercellular communication occurs via gap junctions, 
thereby allowing individual cardiac myocytes to work as a single functional unit or a 
syncytium (Ou et al., 2005; Tribulova et al., 2005). Intercalated discs can easily be 
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identified within EM images by the ‘zig-zag’ appearance of the non-electron-dense 
junctions as shown in Figure 3.3D. 
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Figure 3.3. Ultrastructural aspects of PVCs. Panel A is a representative TEM image 
showing the endothelial cell layer facing the vein lumen, followed by a layer of smooth 
muscle cells and then layers of PVCs. Panel B illustrates different sub-populations of 
mitochondria within a PVC. Panel C shows examples of Z-lines and glycogen granules 
within a PVC. Panel D illustrates that PVCs are connected via intercalated discs. The scale 
bars in all panels represent 500 nm.   
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3.5. Expression and localisation analysis of RyRs and connexins in PVCs  
 
3.5.1. Expression and localisation of RyR2 in PVCs from 3 month- and 24 month-
old mice 
In atrial and ventricular cardiac myocytes the distance between Z-lines has a consistent 
spacing of 1.8 µm (Soeller and Cannell, 1999). It has been shown previously that is also 
true for PVCs from young mice (Rietdorf et al., 2014), but it is unknown if RyR expression 
or SR structure changes within the PVCs of ageing animals. To examine putative 
alterations in RyR2 localisation or expression, the distance between Z-lines (i.e., 
sarcomere length) in PVCs from 3 month- and 24 month-old mice was quantified (Figure 
3.5). PVCs were stained with phalloidin (an F-actin stain) and immunolabelled using anti-
RyR2 antibodies in conjunction with fluorescently-labelled secondary antibodies 
(described in detail in Chapter 2, section 2.3). Examples of phalloidin- and RyR2-labelled 
PVCs are shown in Figure 3.4A and B. It is evident that the RyR immunofluorescence 
labelling had a regular striated appearance in PVCs from both the young and old animals 
(Figure 3.4Aii and Bii). RyR2 expression is greatest at the Z-lines in cardiac myocytes, so 
the bright immunolabelled RyR striations indicate the positions of the Z-lines and 
underlying SR (Bootman et al., 2006). Merging the phalloidin- and RyR2-labelled images 
revealed that the Z-lines occurred within gaps in the F-actin staining (Figure 3.4Aiii and 
Biii). PVCs therefore have a similar structure to atrial and ventricular cardiac myocytes; Z-
lines where RyR2 are densely clustered, which signify the edge of sarcomeres, and dense 
F-actin within the areas between the Z-lines where the contractile filaments are located.  
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Figure 3.4. Regular striated RyR2 expression in PVCs from both,3 month- and 24 month-
old mice. The panels show representative images of cells stained with phalloidin (F-actin) 
and immunolabelled using an antibody that recognises RyR2 (red). Panels Ai - iii represent 
PVCs from 3 month-old mice, and Panels Bi - iii represent PVCs from 24 month-old mice. 
The scale bars in Panels Ai and Bi represent 5 µm. 
 
 
Specific labelling of RyR2 provided a means to measure the spacing between Z-lines 
(sarcomere length), as depicted in Figure 3.5A – B. In brief, the distance between the 
peak of RyR2 immunolabelled from one Z-line to the next (e.g., arrow in Figure 3.5 Aii) 
was measured using ImageJ (described in detail in Chapter 2, section 2.3.2). The average 
distance between Z-lines in 3 month- and 24 month-old mice was 1.74 ± 0.1 and 1.79 ± 
0.1 µm, respectively (Figure 3.5C), indicating that there were no significant changes in the 
spacing between Z-lines or the length of sarcomeres. 
128 
 
 
Figure 3.5. Measuring the distance between Z-lines in PVCs from 3 month- and 24 
month-old mice. Panel Ai is a representative image of a PVC that was immunolabelled 
with anti-RyR2 antibodies, and shows that RyR2 was expressed in a striated manner in 
PVCs. Panel Aii is an enlargement of region bounded by the turquoise box shown in Panel 
Ai. The distance between two adjacent Z-lines is indicated by the white double headed 
arrow. Panel B shows the RyRs immunofluorescence intensity profile along the cell region 
denoted by the pink dotted line in Panel Ai. The peaks represent the Z-lines (striations 
seen in light microscope images and EM images), where RyR2 are most abundant. Panel C 
is a quantitative representation of the average distance between Z-lines in PVCs from 3 
month- and 24 month-old mice, calculated as the average distance over 5 sarcomeres per 
analysed cell. The data represent the mean ± S.E.M. P = 0.44, calculated using an 
unpaired Student’s t-test, n = 7 slices from 3 animals for both 3 month- and 24 month-old 
groups (i.e., 21 slices in total for each age group). 
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3.5.2. Cx43 and Cx40 localisation in PVCs from 3 month- and 24 month-old mice 
 
 A number of studies have shown that cardiac diseases can be associated with a change in 
the expression of connexins (e.g., Cx43 and Cx40), which are crucial for intercellular 
communication and electrical continuity between cardiac myocytes (Ou et al., 2005; 
Tribulova et al., 2005).  Altered connexin expression has been associated with an 
increased predisposition for arrhythmias. Previous studies have shown that PVCs express 
Cx43, Cx40 and Cx45 (Yeh et al., 2003, Xiao et al., 2016, Kugler et al., 2017), and as for 
other cardiac myocytes they likely to be responsible for intercellular propagation of 
messengers and electrical impulses. As described in Chapter 1, the triggering of AF by 
PVCs requires electrical signals originating in the pulmonary veins outside the heart to 
propagate into the left atrial chamber. Given that connexins underlie the spreading of 
electrical signals between cells, and that PVCs trigger more AF during ageing, the 
expression of connexins was examined in 3 month- and 24 month-old mice (Figures 3.6 
and 3.7).  
The PVCs within mouse lung slices obtained from the young and old animals were stained 
with phalloidin to provide a marker for sarcomeres, cell borders and junctions between 
cells (Figures 3.6Ai - Di), and immunolabelled using antibodies specific for Cx43 and Cx40 
(Figures 3.6Aii – Dii). By merging the phalloidin staining and connexin immunolabelling 
(Figure 3.6Aiii – Diii), it was evident that Cx43 was localised at the cell-cell junctions, and 
was also present on the sarcolemma along the lateral sides of the PVCs with cells from 
both 3 month- and 24 month-old animals (Figures 3.6A and B). The number of distinct 
spots showing Cx43-immunolabelled pixels, and their average area of the immunolabelled 
spots, were quantified using ImageJ. There was no statistically significant difference for 
either of the parameters when comparing the PVCs from the young and old mice (Figure 
3.7A). 
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Cx40 showed a weaker expression in PVCs compared to Cx43 (Figure 3.6C and D). 
Moreover, Cx40 immunolabelling was found mostly along at cell-cell junctions, with 
relatively little evidence of Cx40 on the lateral parts of the sarcolemma. In contrast to 
Cx43, there was a difference in the Cx40 immunolabelling of PVCs from the young and old 
mice:  the number of Cx40-immunolabelled spots was significantly reduced in PVCs from 
24 month-old animals compared to PVCs from 3 month-old animals (Figure 3.6C and D 
and Figure 3.7Bi). In fact, Cx40 immunolabelling was not always detectable in slices when 
using the same image acquisition parameters as for Cx43-immunolabelled cells. The 
average area of Cx40-immunolabelled spots tended to be smaller in PVCs from 24 month-
old cells compared to cells from 3 month-old animals, but this was not statistically 
significant (Figure 3.7Bii).  
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Figure 3.6. Cx43 and Cx40 expression in PVCs from 3 month- and 24 month-old mice. 
Panels A and B show representative images of phalloidin-stained and Cx-43 
immunolabelled PVCs from 3 month- (Panel A) and 24 month-old mice (Panel B). Panels C 
and D show representative images of Cx40 staining in 3 month- (Panel C) and 24 month-
old mice (Panel D). The scale bars represent 20 µm. 
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Figure 3.7. Quantification of Cx43 and Cx40 expression in PVCs from 3 month- and 24 
month-old animals. Panel A shows quantitation of the number of Cx43-immunolabelled 
spots (i), and average area of the Cx43-immunolabelled spots (ii) in young and old 
animals. Panel B shows quantitation of the number of Cx40-immunolabelled spots (i), and 
average area of the Cx40-immunolabelled spots (ii) in young and old animals. The data 
are presented as mean ± S.E.M. Statistical significance was calculated using an unpaired 
Student’s t-test, * denotes P < 0.05. For Cx43, n = 27 - 29 slices from 4 animals for both 3 
month- and 24 month-old groups. For Cx40, n = 7- 8 slices from 2 - 3 animals for both 3 
month- and 24 month-old groups.  
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3.6. Ultrastructural changes in cardiac myocytes during ageing 
3.6.1. Ultrastructure of PVCs from 3 month- and 24 month-old mice  
3.6.1.1. Myofibre structure 
The structure of myofibres within PVCs from young and old mice was examined using 
high magnification TEM of fixed cells. The EM images of PVCs were quantitated using a 
number of parameters to provide an objective measure of myofibre content and 
organisation, as illustrated in Figure 3.8. Specifically, the following parameters were 
measured: 
1. Sarcomere width, which was measured as the distance across myofibre bundles 
(denoted by blue arrows in Figure 3.8Ai - Aii). 
2. The offset between Z-lines in neighbouring sarcomeres, which could indicate 
displacement of myofibres (denoted by red arrows in Figure 3.8Bi - Bii) 
3.  The angle between neighbouring Z-lines, which could indicate misalignment of 
myofibres (denoted by dark red arrows in Figure 3.8Ci - Cii).  
4. The percentage of Z-lines disorganisation (Index of disorganisation) was calculated 
by using the following formula: 
Index of disorganisation = (Z-line offset/sarcomere width) x 100 (Figure 3.8D) 
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Figure 3.8. The parameters used to analyse the organisation of myofibres in PVCs from 
3 month- and 24 month-old mice. Sarcomere width is indicated by the blue lines with 
double arrowheads, and was measured as the distance across myofibre bundles (Panels 
Ai and Aii). The offset was measured as the lateral distance between the Z-lines of 
adjacent myofibre bundles, as indicated by red arrows (Panel Bi and Bii). The black dotted 
extrapolated line was used to indicate the point at which the neighbouring Z-line is 
located. The angle between neighbouring Z-lines was measured by as indicated by dark 
red labelling (Panels Ci and Cii). Panels Di and Dii illustrate how percentage of Z-lines 
disorganisation was calculated. The scale bars represent 500 nm. 
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The results of the analysis of myofibre structure in PVCs from 3 month- and 24 month-old 
animals are presented in Figure 3.9. It is evident that there was a significant difference in 
sarcomere width in PVCs from 3 month- and 24 month-old mice (Figure 3.9A). However, 
there were no changes in any of the criteria used to characterise the organisation of 
myofilaments: neither the offset (Figure 3.9B), the angle between the Z-lines (Figure 3.9 
C), nor the percentage of disorganised Z-line (Figure 3.9D) were significantly different 
between 3 month- and 24 month-old mice. 
 
 
Figure 3.8. Quantitation of myofibre structure in PVCs from 3 month- and 24 month-old 
mice. Panels A - D present quantitative analysis of myofibre structure and organisation in 
TEM images obtained using PVCs from 3 month- and 24 month-old mice. The data are 
presented as mean ± S.E.M. Statistical significance was calculated using an unpaired 
Student’s t-test, * denotes P < 0.05. n = 4 slices from 4 animals for both 3 month- and 24 
month-old groups. 
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3.6.1.2. Mitochondria  
A striking difference in PVCs structure and organisation between the 3 month- and 24 
month-old groups concerned mitochondria. TEM images of PVCs from 3 month- and 24 
month-old mice in which mitochondria have been outlined are presented in Figures 3.10 
and 3.11. It is evident that at both ages mitochondria were highly abundant between 
myofibres within the PVCs. To avoid bias, all inter-myofibrillar mitochondria within an 
image were analysed, however, only few were outlined in oranges in Figures 3.10 and 
3.11 for presentational purposes. Quantitation of mitochondria number and the average 
area of individual mitochondria revealed that the organelles were more abundant and 
larger in PVCs from the older animals (Figures 3.11 and 3.12).  A qualitative difference 
that was evident in the TEM images what that the mitochondria in PVCs from 3 month-
old animals tended to be oblong or ovoid shaped organelles that were present in linear 
arrangements (Figures 3.10 A and 3.11 A). In contrast, the mitochondria in PVCs from 24 
month-old animals were sometimes less evidently in linear arrangements, and tended to 
be more circular and tightly packed together (Figures 3.10 and 3.11B).  
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Figure 3.9. Mitochondria, and the absence or presence of lipofuscin and 
autophagosomes, within PVCs from 3 month- and 24 month-old mice. Panel A shows a 
representative TEM image of a PVC from a 3 month-old mouse showing well aligned and 
regularly-shaped mitochondria (outlined in orange) between the myofilaments. Panel B is 
a representative TEM image of a PVC from a 24 month-old mouse illustrating 
mitochondria (outlined in orange),  lipofuscin (outlined in blue) and autophagosomes 
(outlined in red). The scale bars represent 500 nm. 
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Figure 3.10. TEM images of PVCs from 3 month- and 24 month-old mice. Panels Ai – Avi 
are representative TEM images of PVCs from 3 month-old mice. Panels Bi – Bvi are 
representative TEM images of PVCs from 24 month-old mice. The PVCs from 24 month-
old animals showed an increase in mitochondrial area (outlined in orange) (Bi, Bii and 
Biv), and an increased presence of lipofuscin granules (outlined in blue) (Biii). The scale 
bars in all panels represent 1 µm. For quantification, all inter-myofibrillar mitochondria 
were analysed and not just those outlined here. 
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Figure 3.11. Quantification of mitochondrial number and area in PVCs from 3 month- 
and 24 month-old mice. Panel A indicates the number of mitochondria within PVCs, 
whilst Panel B shows the average mitochondrial area. The data are presented as mean ± 
S.E.M.  Statistical significance was calculated using an unpaired Student’s t-test, *** 
denotes P < 0.001, **** P < 0.0001 n = 4 slices from 4 animals for both 3 month- and 24 
month-old groups. 
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3.6.1.3. Lipofuscin  
In addition to the greater mitochondrial number and augmented mitochondrial area, 
there was an increased appearance of lipofuscin granules in PVCs from 24 month-old 
mice. The electron dense lipofuscin granules are obvious in Figure 3.10B (outlined in 
blue), and were only observed in the PVCs from 24 month-old animals. None of the 52 
TEM images of PVCs from 3 month-old animals that were analysed in this study contained 
any evidence lipofuscin. Whilst, 10 out of 52 TEM images (19.2 %) of PVCs from 24 
month-old mice showed at least one area containing lipofuscin granules. The average 
area occupied by lipofuscin granules in the 24 month-old animals was 0.3 ± 0.1 µm2 
(Figure 3.13).  
The results obtained from the analyses of the PVC TEM images for 3 month- and 24 
month-old animals are collated in Table 3.1. 
 
Figure 3.12. Average area of lipofuscin granules in PVCs from 24 month-old mice. The 
data are presented as mean ± S.E.M. n = 4 slices from 4 animals. 
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Parameter PVCs from 3 
month-old 
mice 
PVCs from 24 
month-old 
mice 
Change Statistical 
significance 
Sarcomere 
width 
2.1 ± 0.2 µm 2.7 ± 0.1 µm Increase 
 
(p = 0.02) 
N = 4 slices 
from 4 animals 
Offset 
between Z-
lines 
0.6 ± 0.1 µm 0.5 ± 0.1 µm n.s. 
 
(p = 0.71) 
N = 4 slices 
from 4 animals 
Angle between 
Z-lines 
15.6 ± 1.2 ° 16.3 ± 1.3 ° n.s. 
 
(p = 0.68) 
N = 4 slices 
from 4 animals 
Z-lines showing 
disorganisation 
27.7 ± 2.6 % 23.3 ± 2.1 % n.s. 
 
(p = 0.19) 
N = 4 slices 
from 4 animals 
 
Mitochondrial 
number 
14.2 ± 0.9 19.6 ± 1.2 Increase 
 
(p = 0.001) 
N = 4 slices 
from 4 animals 
Mitochondrial 
area 
0.7  ± 0.03 µm2 1.0 ± 0.1 µm2 Increase 
 
(p = 0.0001) 
N = 4 slices 
from 4 animals 
Lipofuscin 
granules 
N/A 0.3 ± 0.1 µm2 N/A N/A 
N = 4 slices 
from 4 animals 
Table 3.1. Comparison of ultrastructural parameters measured in PVCs from 3 month- 
and 24 month-old mice. This table shows a side by side comparison of the PVC 
ultrastructural parameters presented in Figures 3.9 – 3.12.  
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3.6.2. Ultrastructure of atrial myocytes in 3 month- and 24 month-old mice 
Atrial cardiac myocytes are similar in structure to PVCs in that they have myofibre 
bundles interspersed with mitochondria. TEM images of atrial cardiac myocytes from 3 
month- and 24 month-old animals are shown in Figures 3.14 and 3.15. A characteristic 
feature of atrial cardiac myocytes is that they contain atrial natriuretic peptide (ANP)-
containing vesicles (sometimes called ‘atrial specific granules’) that can be released in 
response to atrial pressure and other stimuli (Berkenfeld et al., 2005; 2012) to reduce 
blood pressure. ANP granules were visible in TEM images of atrial myocytes as circular 
electron dense granules (Figures 3.14 and 3.15). Neither the number of ANP granules, nor 
their area, was different in atrial myocytes from 3 month- and 24 month-old mice (Figure 
3.16).  
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Figure 3.13. Ultrastructure of atrial myocytes from 3 month- and 24 month-old mice. 
Panel A is a representative TEM image of an atrial myocyte from a 3 month-old mouse, 
which demonstrates the presence of ANP granules (outlined in red). Panel B is a 
representative TEM image of an atrial myocyte from a 24 month-old mouse, which 
demonstrates the presence of lipofuscin granules in addition to ANP granules. Lipofuscin 
granules were rarely observed in TEM images of atrial myocytes from 3 month-old mice. 
Both Panels show an abundance of inter-myofibrillar mitochondria, outlined in orange. 
The scale bars represent 500 nm. 
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Figure 3.14. TEM images of atrial myocytes from 3 month- and 24 month-old mice. 
Panels Ai – Avi show examples of TEM images of atrial myocytes from 3 month-old mice. 
Panels Bi – Bvi show examples of TEM images of atrial myocytes from 24 month-old mice. 
Mitochondria are outlined in orange, ANP granules are outlined in red, and lipofuscin 
granules are outlined in blue. The scale bars in all panels represent 1 µm. 
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Figure 3.15. Quantification of the number and area of ANP granules in atrial cardiac 
myocytes from 3 month- and 24 month-old mice. Panel A shows the number of granules 
within a TEM image normalised against cell area. Panel B shows the area of ANP granules 
in atrial myocytes from 3 month- and 24 month-old mice. The data are presented as 
mean ± S.E.M. Statistical significance was calculated using an unpaired Student’s t-test. n 
= 4 slices from 4 animals for both 3 month- and 24 month-old groups. 
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3.6.2.1. Myofibre structure 
 
To examine the effect of ageing on atrial cardiac myocyte structure, TEM images of atrial 
cells from 3 month- and 24 month-old mice were characterised in a similar manner to 
that used for PVCs (see Section 3.6.1.1). In contrast, the results obtained from PVCs 
(Figure 3.9 and Table 3.1); there was no significant difference in the sarcomere width in 
atrial cardiac myocytes from 3 month- and 24 month-old mice (Figure 3.17A). 
Furthermore, there were no significant alterations of the offset between Z-lines, angle 
between Z-lines or proportion of Z-lines showing disorganisation in atrial myocytes from 3 
month- and 24 month-old mice.   
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Figure 3.16. Quantitation of myofibre structure in atrial cardiac myocytes from 3 
month- and 24 month-old mice. Panels A - D present quantitative analysis of myofibre 
structure and organisation in TEM images obtained using atrial cells from 3 month- and 
24 month-old mice. The data are presented as mean ± S.E.M. Statistical significance was 
calculated using an unpaired Student’s t-test, * denotes P < 0.05. n = 4 slices from 4 
animals for both 3 month- and 24 month-old groups. 
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3.6.2.2. Mitochondria 
 
In contrast to the analyses of PVCs, where the number of inter-myofibrillar mitochondria 
were increased in 24 month-old mice (Table 3.1 and Figure 3.12), there was no change in 
the number of inter-myofibrillar mitochondria in atrial cardiac myocytes between the 3 
month- and 24 month-old mice (Figure 3.18A). However, similar to the results obtained 
with PVCs (Table 3.1 and Figure 3.12), the area of inter-myofibrillar mitochondria in atrial 
cardiac myocytes significantly increased in 24 month-old animals (Figure 3.18B).  
 
 
 
Figure 3.17. Quantification of mitochondrial number and area in atrial cardiac myocytes 
from 3 month- and 24 month-old mice. Panel A indicates the number of mitochondria 
within atrial myocytes, whilst Panel B shows the average mitochondrial area. The data are 
presented as mean ± S.E.M. Statistical significance was calculated using an unpaired 
Student’s t-test, * denotes P < 0.05. n = 4 slices from 4 animals for both 3 month- and 24 
month-old groups. 
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3.6.2.3. Lipofuscin  
 
Whereas PVCs from 3 month-old mice showed no lipofuscin granules, there were evident 
lipofuscin granules in a small proportion of atrial cardiac myocytes from 3 month-old 
animals. Lipofuscin granules were present in 4 out of 46 TEM images (8.7 %; present in 2 
out of 4 slices analysed) from 3 month-old animals. The number of lipofuscin granules 
increased to 15 out of 46 images (32.6 %, present in 4 out of 4 slices analysed) for 24 
month-old animals. When calculating the total area lipofuscin granules in all of the TEM 
images, there was no significant difference between the two age groups (Figure 3.19). 
The results obtained from the analyses of the atrial cardiac myocyte TEM images for 3 
month- and 24 month-old animals are collated in Table 3.2. 
 
 
Figure 3.18. Average area of lipofuscin granules in atrial cardiac myocytes from 3 
month- and 24 month-old mice. The data are presented as mean ± S.E.M. Statistical 
significance was calculated using an unpaired Student’s t-test. n = 4 slices from 4 animals 
for both 3 month- and 24 month-old groups. 
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Parameter Atrial 
myocytes from 
3 month-old 
mice 
Atrial 
myocytes from 
24 month-old 
mice 
Change Statistical 
significance 
(p value)  
Sarcomere 
width 
2.6 ± 0.2 µm 2.5 ± 0.2 µm n.s. p = 0.62 
N = 4 slices 
from 4 animals 
Offset 
between Z-
lines 
0.6 ± 0.1  µm 0.5 ± 0.1 µm n.s. p = 0.29 
N = 4 slices 
from 4 animals 
Angle between 
Z-lines 
14.6 ± 1.0  ° 16.6 ± 1.3 ° n.s. p = 0.24 
N = 4 slices 
from 4 animals 
 Z-lines  
disorganisation 
22.2 ± 21.6  % 22.1 ± 1.8 % n.s. p = 0.4 
N = 4 slices 
from 4 animals 
Mitochondrial 
number 
21.9  ± 0.9 22.7 ± 0.9 n.s. p = 0.52 
N = 4 slices 
from 4 animals 
Mitochondrial 
area 
0.5 ± 0.02  µm2 0.6 ± 0.03 µm2 Increase p = 0.02 
N = 4 slices 
from 4 animals 
Lipofuscin 
granules 
0.54 ± 0.08 
µm2 
0.76 ± 1.0 µm2 n.s. P = 0.13 
N = 4 slices 
from 4 animals 
Table 3.2. Comparison of ultrastructural parameters measured in atrial myocytes from 3 
month- and 24 month-old mice. This table shows a side by side comparison of the atrial 
myocytes ultrastructural parameters presented in Figures 3.14 – 3.19.  
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3.6.3. Ultrastructure of ventricular myocytes in 3 month- and 24 month-old mice 
Similar analyses to those undertaken for PVCs and atrial cardiac myocytes were also 
performed for TEM images of ventricular cardiac myocytes from 3 month- and 24 month-
old animals. Examples of ventricular cardiac myocyte TEMs from young and old animals 
are shown in Figures 3.20 and 3.21. Similar to the other cell types, ventricular myocytes 
have bundles of myofibres interspersed with linearly arranged mitochondria. 
3.6.3.1. Myofibre structure 
To examine the effect of ageing on ventricular cardiac myocyte structure, TEM images of 
ventricular cells from 3 month- and 24 month-old mice were characterised in a similar 
manner to that used for PVCs (see Section 3.6.1.1). In contrast the results obtained from 
PVCs (Figure 3.9 and Table 3.1), and similar to the data obtained with atrial cardiac 
myocytes (Figure 3.17 and Table 3.2), there was no significant difference in the sarcomere 
width in ventricular cardiac myocytes from 3 month- and 24 month-old mice (Figure 
3.22A). However, there were significant alterations of the offset between Z-lines, angle 
between Z-lines, or proportion of Z-lines showing disorganisation in ventricular myocytes 
from 3 month- and 24 month-old mice (Figure 3.22B – D).   
An interesting finding with ventricular myocytes was that they appeared to be the most 
regular structure in 3 month-old animals, but also showed the highest degree of change 
in 24 month-old animals. For example, in 3 month-old animals 16.4 ± 1.4 % of the Z-lines 
that showed disorganisation, which is lower than any of the other types of myocytes at 
either age. The proportion of disorganised Z-lines in ventricular myocytes increased 
significantly in the 24 month-old animals to 28.1 ± 3.2 %, which is the highest degree of 
disorganisation in any cell type at either age (Figure 3.22D). 
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Figure 3.19. Ultrastructure of ventricular cardiac myocytes from 3 month- and 24 
month-old mice. Panels A and B show representative TEM images of ventricular 
myocytes from 3 month- and 24 month-old mice respectively. Both Panels show an 
abundance of inter-myofibrillar mitochondria (outlined in orange), and shows how Z-line 
offsets and angles between Z-lines were measured. The scale bars represent 500 nm. 
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Figure 3.20. TEM images of ventricular myocytes from 3 month- and 24 month-old mice. 
Panels Ai – Avi are examples of TEM images of ventricular myocytes from 3 month-old 
mice. Panels Bi – Bvi are examples of ventricular myocytes TEM images from 24 month-
old mice. Mitochondria are outlined in orange; locations, where sarcomere width and Z-
line offsets were measured, are indicated by blue and red lines. The scale bars in all 
panels represent 1 µm. 
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Figure 3.21. Quantitation of myofibre structure in ventricular cardiac myocytes from 3 
month- and 24 month-old mice. Panels A - D present quantitative analysis of myofibre 
structure and organisation in TEM images obtained using ventricular cells from 3 month- 
and 24 month-old mice. The data are presented as mean ± S.E.M. Statistical significance 
was calculated using an unpaired Student’s t-test, * and ** denote P < 0.05 and P < 0.01, 
respectively. n = 4 slices from 4 animals for both 3 month- and 24 month-old groups. 
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3.6.3.2. Mitochondria  
In contrast to the results obtained from PVCs (Figure 3.12 and Table 3.1) and atrial 
myocytes (Figure 3.18 and Table 3.2), there were no differences in either the 
mitochondrial parameters measured from 3 month- and 24 month-old mice in ventricular 
myocytes (Figure 3.23).  
 
 
Figure 3.22. Quantification of mitochondrial number and area in ventricular cardiac 
myocytes from 3 month- and 24 month-old mice. Panel A indicates the number of 
mitochondria within ventricular myocytes, whilst Panel B shows the average 
mitochondrial area. The data are presented as mean ± S.E.M. Statistical significance was 
calculated using an unpaired Student’s t-test. n = 4 slices from 4 animals for both 3 
month- and 24 month-old groups. 
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3.6.3.3. Lipofuscin 
Similar to the observations described above for PVCs (Figure 3.13) and atrial myocytes 
(Figure 3.19), ventricular myocytes from 3 month-old mice had fewer lipofuscin deposits 
than 24 month-old animals. Of 40 ventricular TEM images examined from 3 month-old 
mice, only 1 cell showed evidence of lipofuscin (lipofuscin was evident in 1 out of 40 
electron micrographs analysed from 4 animals). In contrast, 6 out of 40 TEM images from 
ventricular myocytes of 24 month-old animals showed lipofuscin granules (lipofuscin was 
evident in 3 out of 4 animals). The size of the lipofuscin granules in ventricular myocytes 
from 24 month-old animals is shown in (Figure 3.24), and was similar to those observed in 
PVCs (Figure 3.13) and atrial myocytes (Figure 3.19).  
 
Figure 3.23. Average area of lipofuscin granules in ventricular cardiac myocytes from 3 
month- and 24 month-old mice. The data are presented as mean ± S.E.M. n = 4 slices 
from 4 animals for both 3 month- and 24 month-old groups. 
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Parameter Ventricular 
myocytes from 
3 month-old 
mice 
Ventricular 
myocytes from 
24 month-old 
mice 
Change Statistical 
significance 
(p value) 
Sarcomere 
width 
3.6 ± 0.3  µm   2.8 ± 0.2 µm n.s. p = 0.22 
N = 4 slices 
from 4 animals 
Offsets 
between Z-
lines 
0.5 ± 0.03  µm  0.8 ± 0.1 µm Increase p = 0.02 
N = 4 slices 
from 4 animals 
Angles 
between Z-
lines 
9.7 ± 1.3 ° 20.8 ± 2.6 ° Increase p = 0.002 
N = 4 slices 
from 4 animals 
Percentage of 
Z-lines 
disorganisation 
16.4 ± 1.4 % 28.1 ± 3.2 %  Increase p = 0.04 
 
N = 4 slices 
from 4 animals 
Mitochondrial 
number 
19.0  ± 1.1 20.9 ± 1.1 n.s. p = 0.22 
N = 4 slices 
from 4 animals 
Mitochondrial 
size 
1.0 ± 0.04 µm2   1.0 ± 0.05 µm2  n.s. p = 0.98 
N = 4 slices 
from 4 animals 
Lipofuscin 
granules 
3.27 µm2 2.15 ± 1.0 µm² N/A N/A, one value 
for PVCs from 
young mice. 
N = 4 slices 
from 4 animals 
Table 3.3. Comparison of ultrastructural parameters measured in ventricular myocytes 
from 3 month- and 24 month-old mice. This table shows a side by side comparison of the 
ventricular myocytes ultrastructural parameters presented in Figures 3.20 – 3.24.  
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3.7. Comparison of the structure of cardiac myocytes from 3 and 24 month-old 
mice 
3.7.1. Comparison of the myofibre organisation from PVCs, atrial and ventricular 
myocytes from 3 and 24 month-old mice 
 
Comparative data, showing the angle between Z-lines for PVCs, atrial and ventricular 
myocytes from 3 month- and 24 month-old mice is presented in Figure 3.25. It is evident 
that ventricular myocytes from 3 month-old mice displayed the smallest angle between 
neighbouring Z-lines. The Z-line angle did not significantly change in atrial myocytes or 
PVCs from 24 month-old mice. However, the Z-line angle in ventricular myocytes from 24 
month-old mice was significantly increased (Figure 3.25).  
The values for the ‘offset between Z-lines’ and the percentage of ‘Z-lines showing 
disorganisation’ were lower for ventricular cardiac myocytes from 3 month-old mice, 
compared to their PVC and atrial cardiac myocyte counterparts (c.f. Tables 3.1, 3.2 and 
3.3). These data indicate that of the three cell types investigated ventricular cardiac 
myocytes from young animals had the highest level of alignment between myofibres. 
However, ventricular cardiac myocytes also show the strongest deterioration of myofibre 
alignment with ageing. The myofibres within PVCs and atrial myocytes are not as well 
organised as in ventricular cardiac myocytes in young animals, but their organisation does 
not significantly deteriorate.   
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Figure 3.24. Organisation of myofilaments in PVCs, atrial and ventricular myocytes in 3 
month- and 24 month-old animals. The average angles between Z-lines in PVCs, atrial 
and ventricular myocytes from 3 month- and 24 month-old mice. The data presented as 
mean ± S.E.M., and were analysed using one-way ANOVA. n = 4 slices from 4 animals per 
age group. * indicates P < 0.05, and ** indicates P < 0.01.    
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3.7.2. Comparison of the mitochondria from PVCs, atrial and ventricular myocytes 
from 3 and 24 month-old mice 
 
Comparative data, showing the number of mitochondria and mitochondrial area for PVCs, 
atrial and ventricular cardiac myocytes from 3 month- and 24 month-old mice is 
presented in Figure 3.26. A similar number of mitochondria was found in atrial and 
ventricular cardiac myocytes from both 3 month- and 24 month-old animals. However, 
PVCs from 3 month-old animals contained significantly less mitochondria than atrial and 
ventricular cardiac myocytes from the same age group (Figure 3.26A). Evidently, the 
number of mitochondria in PVCs increased significantly during ageing (Figure 3.26A).  
 
Atrial myocytes had the smallest mitochondria in both 3 month- and 24 month-old 
animals, whereas ventricular myocytes had the biggest mitochondria in both age groups 
(Figure 3.26B). However, only the mitochondria within PVCs showed a significant change 
in size between 3 month- and 24-month old animals (Figure 3.26B). These data suggest 
that the mitochondria within PVCs become both more numerous and larger during 
ageing.  
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Figure 3.25. Comparison of mitochondrial number and area in PVCs, atrial and 
ventricular cardiac myocytes in 3 month- and 24 month-old mice. Panel A shows 
mitochondrial number in PVCs, atrial and ventricular myocytes. Panel B shows 
mitochondrial area in PVCs, atrial and ventricular myocytes. The data are presented as 
mean ± S.E.M. Statistical significance was calculated using one-way ANOVA, *, **, and 
*** denote P < 0.05, P < 0.01, P < 0.001, respectively. n = 4 slices from 4 animals for both 
3 month- and 24 month-old animals. 
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3.8. Summary  
1. Criteria were developed for identifying PVCs within mouse lung slices. In particular, 
PVCs are the only striated, spontaneously contractile cells associated with blood vessels 
running through the lung slices (section 3.3). 
 
2. The blood vessels around which PVCs were found had an inner layer of endothelial cells 
that were surrounded by smooth muscle cells. The PVCs were located outside the smooth 
muscle cells. The thickness of a PVC layer, and the extent to which it ran around the 
circumference of a vessel, varied substantially from slice to slice (section 3.3). 
 
3. Due to variation in the orientation of PVCs, Z-lines were not always evident. In fact, 
neighbouring PVCs within a slice could have different orientations relative to each other 
(section 3.4). 
 
4. PVCs have different sub-populations of mitochondria. Specifically, perinuclear, inter-
myofibrillar and sub-sarcolemmal mitochondrial populations were distinguished on the 
basis of spatial separation within PVCs. Mitochondria were more abundant and larger in 
PVCs from 24 month-old mice, compared to cells from 3 month-old animals (sections 3.4 
and 3.6.1). 
 
5. At the level of the light microscope, there were no differences in RyR2 expression, or 
localisation, in PVCs from 3 month- or 24 month-old animals (section 3.5.1).  
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6. PVCs express connexins, and have typical intercalated disk structures, which likely 
underlie cell-cell communication and spread of electrical signals. Cx43 expression was the 
same in PVCs from 3 month- or 24 month-old mice, but Cx40 expression decreased in the 
older animals (section 3.5.2). 
 
7. Several different parameters were analysed to compare the sarcomeric structure of 
PVCs, atrial and ventricular myocytes from 3 month- and 24 month-old mice. All three cell 
types had a similar sarcomeric organisation, and only ventricular myocytes showed 
increased sarcomeric disorganisation in the older animals. Of the three cell types studied, 
ventricular cardiac myocytes were the most organised cells in the 3 month-old mice, but 
were the most disorganised in the 24 month-old animals (section 3.7.1).  
 
8. Lipofuscin was more evident in PVCs, atrial and ventricular cardiac myocytes from 24 
month-old mice, compared to cells from 3 month-old animals (sections 3.6.1.3, 3.6.2.3 
and 3.6.3.3). 
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3.9. Discussion 
3.9.1. Using mouse lung slices for studying PVC structure 
The work described in this Chapter sought to undertake a comparative characterisation of 
the structure of PVCs, atrial and ventricular cardiac myocyte in young and old mice. The 
rationale for this investigation was the established clinical link between ageing, cardiac 
myocyte remodelling and arrhythmias (Hayashi et al., 2002; Nattel et al., 2008). The 
principal cell type under investigation in this study was PVCs, which are known to 
participate in the genesis of AF (Haissaguerre et al., 1998; Sueda et al., 2005). It has been 
demonstrated that pro-arrhythmic electrical signals can originate from the PVCs in the 
pulmonary vein sleeves, but the mechanism(s) causing these electrical signals to arise is 
unclear. Moreover, the structural and functional changes that occur within ageing PVCs to 
make them more prominently trigger AF in older people are unknown. Critical factors that 
are believed to be involved in the genesis and maintenance of AF within atrial cardiac 
myocytes are electrical remodelling, structural remodelling and changes in Ca2+ 
homeostasis (Ausma et al., 2001, Chen et al., 2002, Hocini et al., 2002, Shanmugam et al., 
2011, Nattel et al., 2013), and it is plausible that the same factors underlie the propensity 
of PVCs to be pro-arrhythmic. Previous studies have examined the structures of PVCs and 
atrial myocytes from human AF patients (Boldt et al., 2004; Boldt et al., 2004, Laky et al., 
2011) and animal models of AF (Ausma et al., 1997, Thijssen et al., 2000, Ausma et al., 
2001, Ausma et al., 2003), but not during ageing. Given the impact of aberrant electrical 
signalling on atrial function, there is a clear need to understand PVCs from structural and 
functional perspectives.  
 
To analyse the effects of structural changes during ageing in PVCs, lung slices from 3 
month- and 24 month-old mice were analysed. In this study, C57/BL/6J mice were used as 
an ageing model. Using mice rather than humans in ageing research has a number of 
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benefits including a shorter life span, similar genetic backgrounds, controlled nurturing 
environments and the ability to do experiments using cells from animals of a specific age 
(Vanhooren et al., 2013; Nkuipou-kenfack et al., 2017). Additionally, longitudinally studies 
are easier to conduct in mice than humans. Mice are known to reach the age of 30 – 32 
months and anything ≥ 24 months is interpreted as advancing age, whilst 3 - 4 months is 
considered as young (Fahlström et al., 2011). C57/BL/6 aged mice have been shown 
previously to be susceptible to age-dependent hearing loss, changes in cognitive function, 
altered sensorimotor-dependent behaviours and weight loss, but not cardiac function 
(Fahlström et al., 2011). In mice, the sleeves of PVCs continue into the lungs, and hence 
lung slices were used in this study (Ho et al., 2001, Mueller-Hoecker et al., 2008). Lung 
slices contain pulmonary veins with PVCs, smooth muscle cells and endothelial cells, in 
addition to pulmonary arteries and airways. A significant advantage of lung slices is that 
they preserve cellular niches where PVCs are viable and do not deteriorate. Moreover, 
the slices maintain cell-cell contacts and cellular orientations that resemble in situ 
physiological positions (Rietdorf et al., 2014). This study used a combination of the 
following criteria to formally identify cells as PVCs: (1) PVCs were associated with (usually 
surrounding) a blood vessel, (2) PVCs displayed spontaneous contractions, (3) PVCs were 
not located next to an airway, and (4) PVCs were striated (normally evident in both light 
and EM) (Figure 3.1). These criteria provided a reliable method for correctly identifying 
PVCs. Addition confirmation of the identification of PVCs came from 
immunohistochemical studies where staining of PVCs with phalloidin also presented 
striated expression (Figures 3.4 and 3.6). 
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3.9.2. Expression of RyR2 in PVCs from 3 month- and 24 month-old mice 
The expression and localisation of RyR2 within 3 month- and 24 month-old PVCs was 
investigated using immunofluorescence and confocal imaging. The data presented in this 
Chapter indicates that neither the sarcomere arrangement nor RyR2 localisation was 
different when comparing PVCs from 3 month- and 24 month-old mice (c.f. Figures 3.4 
and 3.5). Whilst immunofluorescence, as performed in this study is not strictly 
quantitative, by using the same immunostaining protocol, antibody dilutions and image 
acquisition parameters, it is possible to assess immunostaining intensity between 
samples. There was no evident difference in the levels of fluorescence, suggesting that 
not only the localisation, but also the RyR2 expression levels are unaltered between the 
age groups. These data support the results of several studies performed using atrial and 
ventricular myocytes from rodents that examined RyR2 changes with age. Most of these 
studies found no change in the levels of RyR2 expression with age (Rueckschloss et al., 
2010, Turdi et al., 2010). 
 3.9.3. Expression of connexins in PVCs from 3 month- and 24 month-old mice  
The expression and localisation of connexins within 3 month- and 24 month-old PVCs was 
investigated using immunofluorescence and confocal imaging. PVCs in our study 
expressed both, Cx40 and Cx43. Of these connexins, Cx43 gave a stronger staining (both, 
regarding the intensity and the number of positive slices) than Cx40 (Figure 3.6). This 
study found a significant reduction in Cx40 staining in PVCs during ageing, but no change 
in Cx43 staining between young and old mice (Figure 3.7). A reduction in Cx40 may result 
in altered electrical conduction that could promote arrhythmias. Previous results have 
shown that induction of AF with electrical pacing in animal models resulted in altered 
distribution or a reduction of Cx40, whereas Cx43 remained unchanged or increased 
(Elvan et al., 1997, Velden et al., 1999, Van der Velden et al., 2000, Ausma et al., 2003, 
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Yeh et al., 2006). These studies, together with our study, suggest that connexin 
expression is remodelled during ageing or in AF. 
3.9.4. Comparison of PVCs with atrial and ventricular myocytes  
A number of previous studies have been conducted using atrial myocytes to investigate 
the effects of ageing in facilitating AF (Boldt et al., 2004a; 2005b, Laky et al., 2011). 
Similar studies are limited in PVCs and there has been no side-by-side comparison of the 
ultrastructure of PVCs with atrial and ventricular myocytes. Therefore comparisons of the 
structure of PVCs, atrial and ventricular myocytes were undertaken using 3 month- and 
24 month-old mice. Similar to atrial and ventricular myocytes, PVCs express RyR2 in a 
striated, sarcomeric pattern with myofilament bundles between the Z-lines. Additionally, 
they also have three sub-populations of mitochondria which are perinuclear, inter-
myofibrillar and sub-sarcolemmal (Figure 3.3). The EM study demonstrated that PVCs 
within a pulmonary vein can be oriented at different angles relative to each other (Figure 
3.2), which could plausibly impact on the propagation of action potentials. Similar to atrial 
myocytes in rodents, PVCs mostly lack T-tubules (Tsuneoka et al., 2012, Rietdorf et al., 
2014). PVCs are different to atrial and ventricular myocytes in that they show a higher 
frequency of spontaneous Ca2+/ electrical signals and have been reported to have a less 
negative resting membrane potential (Chen et al., 2002, Ehrlich et al., 2003, Okamoto et 
al., 2012). The increase in the spontaneous activity, less negative resting membrane 
potential and PVCs orientation are some of the factors that may lead to arrhythmias. 
 
3.9.5. Changes in myofibres in PVCs, atrial and ventricular myocytes from 3 
month- and 24 month-old mice 
Putative structural changes of myofibres within cardiac myocytes from young and old 
mice were examined using high magnification TEM of fixed cells. Previous studies have 
demonstrated an increase in spacing between myofibres or loss of myofibres (myolysis) in 
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atrial myocytes from AF animal models (Ausma et al., 1997, 2001). The loss of myofibres 
observed in AF might facilitate the occurrence of arrhythmias as it may hinder electrical 
conduction and alter Ca2+ homeostasis. Thus, in this thesis, changes in myofibres during 
ageing in PVCs, atrial and ventricular myocytes during ageing were analysed. The EM 
images of cardiac myocytes were quantitated using a number of parameters to provide 
an objective measure of myofibre content and organisation (Figure 3.8). The criteria used 
for this study were sarcomere width, offset between Z-lines, angle between Z-lines and 
percentage of disorganisation (illustrated in Figure 3.8). By analysing these parameters, it 
was possible to quantitate possible changes in myofibre structure during ageing. There 
was a significant difference in sarcomere width in PVCs from 3 month- and 24 month-old 
mice (Figure 3.9A). However, there were no changes in any of the other criteria used to 
characterise the organisation of myofilaments (Figure 3.9). In atrial myocytes, there was 
no significant difference in any of the parameters measured in cells from 3 month- and 24 
month-old mice (Figure 3.17). In ventricular myocytes, there was no significant difference 
in the sarcomere width from 3 month- and 24 month-old mice (Figure 3.22A), but there 
were significant alterations of the offset between Z-lines, angle between Z-lines, or 
proportion of Z-lines showing disorganisation in ventricular myocytes from 3 month- and 
24 month-old mice (Figure 3.22B – D).  Comparison of the three cell types indicated that 
ventricular cardiac myocytes from young animals had the highest level of alignment 
between myofibres. However, ventricular cardiac myocytes also showed the strongest 
deterioration of myofibre alignment with ageing. The myofibres within PVCs and atrial 
myocytes were not as well organised as in ventricular cardiac myocytes in young animals, 
but their organisation did not significantly deteriorate during ageing (Figure 3.25). 
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3.9.6. Changes in mitochondria in PVCs, atrial and ventricular myocytes from 3 
month- and 24 month-old mice 
To analyse putative mitochondrial changes during ageing of PVCs, TEM images of PVCs 
from 3 month- and 24 month-old mice were examined (Figures 3.10 and 3.11). At both 
ages mitochondria were highly abundant between myofibres within the PVCs. 
Quantitation of mitochondrial number and the average area of individual mitochondria 
revealed that the organelles were more abundant and larger in PVCs from the older 
animals (Figures 3.11 and 3.12). Unlike the situation in PVCs, mitochondria in atrial 
myocytes were enlarged but did not increase in number during ageing (Figure 3.26). 
There were no significant mitochondrial changes in ventricular myocytes from young and 
old mice (Figure 3.23). In the three cardiac myocytes studied, PVCs showed the biggest 
changes in mitochondrial number / morphology. Similar to our findings, previous studies 
in AF animal models have demonstrated either an increase or a drecrease of 
mitochondrial size in atrial myocytes. For example, in a canine AF model mitochondrial 
size increased (Morillo et al., 1995), whereas a goat AF model was associated with an 
increase in mitochondrial number and a decrease in mitochondrial size (Ausma et al., 
1997). An age-dependent increase in atrial myocyte mitochondrial size has been reported 
in rats (Feldman and Navaratnam 1981). These data, together with ours, suggest that 
mitochondria may remodel during ageing. 
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3.9.6.1. Limitations to 2D mitochondrial analysis 
Although 2D mitochondrial analysis conducted here suggested changes in mitochondria 
during ageing, particularly in PVCs, these results need to be confirmed further by doing a 
3D analysis. The analysis performed in this study measured mitochondrial area in TEM 
images using ImageJ, however, mitochondrial volume was not calculated. As 
mitochondria are organised in the myocyte at different angles relative to the imaging 
plane, deriving areas from 2D TEM images is problematic and conducting 3D 
mitochondrial analysis should be of great interest to strengthen the results. 
 
3.9.7. Changes in lipofuscin in PVCs, atrial and ventricular myocytes from 3 
month- and 24 month-old mice 
The TEM analysis of PVCs, atrial and ventricular myocytes indicated an increase in the 
appearance of lipofuscin granules in cardiac myocytes from aged mice. In PVCs none of 
the TEM images from 3 month-old mice showed any lipofuscin granules whereas 10 out 
of the 52 TEM images had lipofuscin deposits in PVCs from 24 month-old mice (Figure 
3.13). Similar results were also found using atrial and ventricular myocytes, where more 
lipofuscin granules were found in TEM images obtained from 24 month-old mice (Figures 
3.19 and 3.24). It has been suggested that lipofuscin interferes with normal cellular 
functioning, most importantly autophagic clearance of damaged organelles and cell 
products. Increased amounts of lipofuscin have been linked to various pathological 
conditions such as lysosomal storage diseases, tumours and malnutrition (Terman et al., 
2004b; Jung et al., 2007). The increased lipofuscin seen in cardiac myocytes from old mice 
in this study would suggest an age-related decrease in lysosomal degradation and/or 
defective autophagy in cells from old mice as it is described in the reviews by (Terman et 
al., 2004a; Terman et al., 2005).  
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In summary, the main alteration in PVCs during ageing were increased sarcomere width, 
reduced Cx40 expression, more mitochondria, which were also enlarged, and the 
presence of lipofuscin. Of the three cardiac myocytes analysed, PVCs appeared to show 
the most mitochondrial alterations during ageing, whereas ventricular myocytes 
presented the most disruption to the alignment of myofibres between young and old 
animals. The changes in mitochondria seen in PVCs, coupled with the observations of an 
increased presence of lipofuscin granules, are consistent with a hypothesis in which PVCs 
from older animals have deteriorating homeostasis. It is plausible that these structural 
and biochemical changes contribute to the mechanisms whereby PVCs become more 
profoundly pro-arrhythmic during ageing. However, further studies are required to 
characterise the impact of these changes on the physiological functions within PVCs. 
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Chapter 4: Characterisation of Ca²⁺ signalling in PVCs 
4.1. Introduction 
As outlined in Chapter 1, ageing- and AF- induced changes in Ca2+ signalling in atrial 
myocytes, as well as structural and functional remodelling, have been extensively studied 
(Brundel et al., 1999, Lai et al., 1999, Mestre Prates et al., 2002, Vest et al., 2005, Neef et 
al., 2010, Voigt et al., 2012). Despite the importance of PVCs for onset and maintenance 
of AF, relatively little research has been focussed on the events occurring in PVCs that 
lead to AF. Ca²⁺ signalling is an intriguing aspect of PVC function, as a number of studies 
have demonstrated their propensity to display spontaneous Ca²⁺ signals (Logantha et al., 
2010, Rietdorf et al., 2014, Rietdorf et al., 2015, Xiao et al., 2016) that may disrupt 
responses to rhythmic action potentials and contribute to ectopic electrical activity 
(Haissaguerre et al., 1998, Sueda et al., 2005, Tsuneoka et al., 2012). The reasons why 
PVCs show such profound spontaneous Ca²⁺ signalling are unclear, but it is plausible that 
aberrant Ca²⁺ signals contribute to pro-arrhythmic activity. Moreover, an increase in 
spontaneous Ca²⁺ signalling with ageing, coupled with a concomitant reduction in the 
fidelity of electrical signalling, could underlie the increased PVC-dependent AF observed 
in older individuals. The work in this Chapter therefore sought to probe mechanisms 
responsible for causing spontaneous Ca²⁺ signals within PVCs from 3 month- and 24 
month-old mice, with the intention of highlighting ways in which the fidelity of PVC 
electrical signalling could be improved. To date, an investigation into ageing-induced 
changes in Ca²⁺ signalling in PVCs has not been undertaken. 
The structural studies described in Chapter 3 (section 3.6.1) indicated that PVCs from 24 
month-old mice had changes in morphology and organisation that may allude to altered 
cellular function. For example, 24 month-old mice had an increase in both number and 
size of mitochondria in comparison to PVCs from 3 month-old mice. However, whilst EM 
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images are suitable for analysing the characteristics of cells and organelles, it is not 
possible to determine whether there are functional differences. Previous studies have 
established that aspects of mitochondrial function do deteriorate during ageing in rat 
hearts (Petrosillo et al., 2009; Duicu et al., 2013) and in ventricular myocytes and tissues 
(Jian et al., 2011, Barton et al., 2017). For example, there is an increased production of 
ROS (Cooper et al., 2013, Guo et al., 2014, Huang et al., 2017). As described in the 
Chapter 1, mitochondria have important roles in cardiac myocyte energy production and 
Ca2+ homeostasis (Drago et al., 2012, Liu et al., 2013, Boyman et al., 2014, Santulli et al., 
2015), so alteration in mitochondrial function or number could plausibly impact on 
spontaneous Ca²⁺ signalling and lead to pro-arrhythmic effects. The studies presented in 
this Chapter therefore also sought to determine if there were detectable changes in 
mitochondrial function and ROS production within PVCs during ageing. 
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4.2. Aims of this Chapter 
The work presented in this Chapter compared Ca2+ signalling, mitochondrial function and 
ROS production in PVCs from 3 month- and 24 month-old mice. The specific aims were:  
(1) Characterise Ca²⁺ signalling in PVCs from 3 month- and 24 month-old mice. In 
particular, the following aspects were investigated:  
 Spontaneous Ca²⁺ signalling. 
 The ability of PVCs to following electrical pacing. 
 The role of components of the PVC Ca2+ signalsome (e.g. VOCC, NCX, SOCE and 
RyR) in Ca²⁺ signalling and homeostasis. 
 (2) Examine the involvement of mitochondria in Ca2+ signalling within PVCs from 3 
month- and 24 month-old mice.   
(3) Investigate the production of ROS and its consequences for EC-coupling, in PVCs from 
3 month- and 24 month-old mice. 
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4.3. Analysis of spontaneous and EFS-induced Ca²⁺ transients in PVCs  
4.3.1. Measuring Ca²⁺ signals in PVCs  
A key aim in this study was to compare Ca²⁺ signalling within PVCs from 3 month- and 24 
month-old mice in order to highlight ageing-induced changes in cell behaviour that might 
explain why PVCs have a greater propensity to trigger AF in older individuals. The single-
wavelength fluorescent Ca²⁺ indicator Cal-520 was used to visualise Ca²⁺ signals in PVCs 
within lung slices. This indicator was found to give a consistent loading within the PVCs, 
and preliminary studies carried out in the laboratory indicated that Cal-520 was the most 
resistant of the currently available single wavelength indicators with respect to organelle 
compartmentation, leakage and bleaching (Rietdorf et al., 2014). Moreover, fluorescence 
from Cal-520 was visible in cells with a resting Ca²⁺ concentration (thus making the cells 
sufficiently visible to focus on), and had an appropriate dynamic range to enable 
detection of Ca²⁺ signals of variable amplitudes with good temporal resolution and signal 
to noise (Figure 4.1). 
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Figure 4.1. Visualisation of Ca2+ signals within PVCs using Cal-520. Panels A shows an 
image of Cal-520-loaded PVCs (outlined in red and blue) within a pulmonary vein next to 
an endothelial layer (outlined in yellow). The cells were loaded with Cal-520 using the 
protocol described in Chapter 2. The PVCs sequestered Cal-520 (or any Ca2+ indicator) 
more readily than their neighbouring smooth muscle cells, which aided in their 
identification in imaging experiments. The montage of images in panels B-I was captured 
sequentially at 0.1 second intervals, and illustrate the typical visualisation of a Ca2+ wave 
propagating through the top PVC (outlined in red, panels B-E). In panel F, the wave moves 
into the bottom cell (outlined in blue) at 400 msec, and moves into the opposite direction 
(panels F-I). The scale bar denotes 20 µm.  
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To capture and visualise the Ca²⁺ signals occurring within PVCs, different imaging 
techniques and forms of representation have been used. Confocal video microscopy of 
whole fields of PVCs provided 2-dimensional (2D) recordings of Ca²⁺ signals over time in 
the form of sequentially-captured images (Figure 4.1). An advantage of video microscopy 
is that the whole area of many PVCs can be visualised simultaneously so that any discrete, 
localised Ca²⁺ signals are not missed. However, due to the number of pixels being scanned 
to form the 2D images, the rate of image acquisition was relatively slow (typically 10 Hz in 
this study). Moreover, it is cumbersome to display montages of images to illustrate Ca²⁺ 
signals that occurred.  
An alternative to video microscopy is line-scanning, where a line is drawn across a field of 
view and is repeatedly scanned. The consecutive lines are stacked in a temporal sequence 
so that Ca²⁺ signals can be seen over time. A line-scan provides a 2D result, but with one 
spatial dimension (usually vertical) and one time dimension (usually horizontal). Examples 
of line-scans are shown below. The key advantage of line-scanning is speed (typically 333 
Hz in this study), which is particularly useful for fast Ca²⁺ signals, such as those occurring 
within PVCs. The drawback of line-scanning is that the scanned line is preselected before 
an experiment is initiated, and it is possible to miss Ca²⁺ signals if they occur outside the 
line of pixels being scanned. It is conceivable to derive pseudo-line-scans from 2D video 
microscopy image sequences by using post-analysis tools to sample an area/line within 
the captured field over successive frames. Preliminary experiments in this study showed 
that the propagation speed and frequency of Ca²⁺ signals in PVCs were sufficiently rapid 
to warrant the need for line-scanning in most situations. A description of how 
experiments involving video microscopy or line-scanning of PVCs were set up is presented 
in Chapter 2.  
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4.3.1.1. Identifying different types of Ca2+ signals in line scans 
At the inception of the imaging experiments in this study, it became obvious that PVCs 
often displayed complex mixtures of Ca2+ signals with different spatial and temporal 
characteristics (Figure 4.2). Since a key aim of this study was to understand mechanisms 
that may cause PVCs to trigger arrhythmic activity, it was critical to be able to distinguish 
spontaneous Ca2+ signals and EFS-triggered Ca2+ signals, and thereby examine the 
influence of spontaneous Ca2+ signals on the fidelity of electrical pacing.   
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Figure 4.2. Distinguishing different types of Ca2+ signals in PVCs. The cartoon of cells in 
Panel A illustrates how the line to be repeatedly scanned would be typically placed across 
adjacent cells (the scanned line is denoted by the vertical dashed black line). A typical 
line-scan plot is shown in Panel A, with the spatial dimension through the cells being 
vertical, and the time dimension running horizontally from left to right. The horizontal 
dashed white lines indicate the boundary between the cells. All of the Ca2+ signals evident 
in the line-scan plot were due to spontaneous activity (as no EFS was applied). The traces 
below the line-scan show how the cytosolic Ca2+ concentration changed over the duration 
of the recording. The traces were derived by averaging pixel intensities along the line-
scan plot at the regions indicated by the arrows, and are presented as the change in 
fluorescence intensity (F/F0) over time. Local Ca
2+ transients are indicated by orange 
squares behind the traces. Whereas, Ca²⁺ waves are identified by blue squares behind the 
traces. Panel B shows a cartoon of cells with the typical placement of a line for scanning, 
a representative line-scan, and corresponding Ca2+ traces. In this case, the PVCs displayed 
synchronous EFS-induced Ca2+ transients. The timing of EFS pulses (1 Hz) is indicated by 
the series of black arrows above the line-scans. Panels C and D show a quantitative 
summary of the properties of local Ca2+ transients, Ca²⁺ waves, and EFS-induced Ca2+ 
transients that were observed in the series of experiment that yielded the data shown in 
Panels A and B. The scale bar represents 20 µm. 
 
181 
 
 
 
 
 
 
 
182 
 
Characteristic Ca²⁺ signals are illustrated by the line-scans presented in Figure 4.2. For the 
purposes of this study, Ca2+ signals were classified into three types to allow qualitative 
and quantitative analysis: 
(1) Local Ca2+ transients. These brief Ca2+ signals are most likely the PVC equivalent of 
Ca2+ sparks that have been identified in atrial and ventricular myocytes (Cheng et al., 
1993, Bootman et al., 2006, Cheng and Lederer 2008, Herrai-Martinez et al., 2015). 
However, they were not identified as Ca2+ sparks using formal criteria in this study, and 
are therefore referred to as local Ca2+ transients. In a line–scan plot, local Ca2+ transients 
were evident as discrete circular/comet-shaped changes in Cal-520 fluorescence 
intensity, which remained spatially limited and did not propagate through a cell (Figure 
4.2A). Local Ca2+ transients occurred in different regions of a cell at various times, 
although not all PVCs displayed local Ca2+ transients. Another distinguishing factor of local 
Ca2+ transients was their amplitude and rate of rise, which were lower than that of Ca²⁺ 
waves or EFS-induced Ca2+ transients (described below) in the same cell (Figure 4.2C and 
D). Due to their lesser amplitude, local Ca2+ transients typically have a light blue/turquoise 
appearance in line-scans, as per the calibration spectrum shown in Figure 4.2A. 
(2) Ca²⁺ waves. In contrast to local Ca2+ transients, Ca²⁺ waves did propagate away from 
their initiation site, and were therefore typically visible in line-scans as changes in Cal-520 
fluorescence intensity with ‘/’, ‘\’ or ‘<’ shapes (Figure 4.2A). The initiation site for Ca²⁺ 
waves was the first point along the temporal axis at which the fluorescence intensity 
increased (i.e. a change from deep blue colour towards a warmer colour in the line-scan 
plots).  
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Ca2+ waves were heterogeneous even within a single PVC. Ca2+ waves could propagate 
either entirely, or partially, through a PVC. This is illustrated by the line-scan in Figure 
4.2A (upper cell); four ‘/’-shaped Ca2+ waves that travelled through the cell from bottom 
to top are evident, along with a Ca2+ wave that started to spread but halted near the 
middle of the line-scan. Successive Ca2+ waves could originate at different initiation sites 
within a PVC (Figure 4.3), and propagate from end to end, or from the middle of the cell 
to each end (Figures 4.4). If Ca2+ waves collided they annihilated each other (Figure 4.4). 
Analysis of Ca2+ waves within PVCs from 3 month-old animals indicated that 48.1 ± 13% of 
cells displayed a single initiation point for all Ca²⁺ waves. Whereas, in 51.9 ± 13% of the 
PVCs multiple Ca²⁺ wave initiation points were observed (n = 10 slices from 4 animals). 
The majority of Ca2+ transients (77.4 ± 9.9%; n = 10 slices from 4 animals) initiated at only 
one site, which was typically close the end of a cell, and propagated through the cell in 
one direction only. The average propagation velocity of Ca2+ waves was 77 ± 7 µms-1 (n = 
10 slices from 4 animals), although the speed of Ca²⁺ waves varied between PVCs. Despite 
PVCs expressing connexins (Chapter 3 section 3.5.2: Cx43 and Cx40 localisation in PVCs 
from 3 month- and 24 month-old mice) and being electrically coupled (Yeh et al., 2003; 
Xiao et al., 2016; Kugler et al., 2017), Ca2+ waves tended to stop at cell boundaries. 
However, in some cases, the arrival of a Ca2+ wave at the sarcolemma of a PVC would 
trigger a Ca2+ wave in an adjacent cell.  
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Figure 4.3. Ca2+ waves initiating at different sites within a PVC. Panel A shows PVCs in a 
lung slice loaded with Cal-520. The montages of images in Panels B and C show successive 
Ca2+ waves travelling through the same PVC, outlined with a white dashed line in panels 
A-C. The Ca2+ waves had different initiation points (red arrowheads in the top row of both 
Panels). Some activity in other cells is visible in the montage. The scale bar represents 20 
µm.  
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Figure 4.4. Ca2+ waves propagating in different directions within PVC. The montages of 
images in Panels A and B show Ca2+ waves propagating through PVCs. The Ca²⁺ wave in 
Panel A originated near the centre of the cell, and then split into two Ca²⁺ waves that 
travelled to either end of the cell simultaneously. In contrast, Panel B illustrates a cell 
with multiple Ca²⁺ wave initiation sites. The Ca²⁺ waves travelled towards each other, and 
collided at ~300 ms before annihilating each other. The cell boundaries are indicated with 
a white dotted line. The scale bar represents 20 µm.  
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(3) EFS-induced Ca2+ transients. The third type of Ca2+ signal discussed in this study is Ca2+ 
transients induced by depolarisation of PVCs using EFS (Figure 4.2B). EFS-induced Ca2+ 
transients are evident in line-scan plots as a rapid, step-like increase in Cal-520 
fluorescence intensity. In Ca2+ traces, EFS-induced Ca2+ transients had a faster rate of rise 
than a Ca2+ wave, and had a larger amplitude than a local Ca2+ transient (Figure 4.2C and 
D). EFS-induced Ca2+ transients were often whole cell responses, where the fluorescence 
increased simultaneously across all the regions of the cell. However, as discussed later, 
the ability of a PVC to respond to EFS depended on the occurrence of spontaneous Ca2+ 
signals.  
4.3.1.2 Identifying three types of Ca2+ signals in Ca2+ traces  
The Ca2+ traces presented in this study only display those Ca2+ signals that occurred within 
the cellular region that was both sampled during the experimental line-scanning and was 
analysed post-experiment. Since the majority of Ca2+ waves propagated within cells to a 
considerable extent, they were likely to be visible both within a line-scan and the Ca2+ 
trace that is subsequently derived. However, due to the limited spatial spreading of local 
Ca2+ transients, they tended to be undersampled. An example of this is shown in Figure 
4.2A, where more local Ca2+ transients are visible in the line scan than in the 
corresponding Ca2+ trace.  
As noted earlier, the three types of Ca2+ signals that were observed in PVCs have specific 
characteristics that allow them to be identified within line-scans. The three types of Ca2+ 
signals can also be distinguished in Ca2+ traces based on rate of rise of the Ca2+ signal and 
Ca2+ signal amplitude (Figure 4.2C and D). In this study, different Ca2+ signals were 
discriminated by using a combination of line-scan plots to establish their spatial 
properties, as well as Ca2+ traces to show their kinetic and amplitude characteristics. A 
187 
 
summary of the properties of local Ca2+ transients, Ca2+ waves and EFS-induced Ca2+ 
transients, and their discriminating characteristics, are presented in Table 4.1.  
 Properties of Ca2+ 
signal in a line-scan 
 
Properties of Ca2+ 
signal in a Ca2+ 
trace 
Amplitude 
(ΔF/F0) 
Rate of rise 
(ΔF/F0 per s) 
 
Local 
Ca2+ 
transient 
Spatially restricted 
increase in Cal-520 
fluorescence that was 
circular or comet-
shaped.  
 
 
 
 
 
The lowest 
amplitude Ca2+ 
signal recorded in 
the PVCs. Typically, 
<20% of the 
maximal amplitude 
change of a Ca2+ 
wave in the same 
cell. 
0.5 ± 0.1  
 
** vs.  
Ca2+ wave 
 
*** vs.  
EFS-induced 
Ca2+ 
transient 
0.005 ± 
0.0009 
 
n.s. vs.  
Ca2+ wave 
 
**** vs.  
EFS-induced 
Ca2+ 
transient 
Ca2+ 
wave 
Propagating increase 
in Cal-520 
fluorescence with /, \ 
or < shapes.  
 
 
 
 
 
 
Variable amplitude, 
slower in onset 
than an EFS-
induced Ca2+ 
transient. 
2.7 ± 0.2 
 
** vs.  
Local  
Ca2+ 
transient 
 
n.s. vs.  
EFS-induced 
Ca2+ 
transient 
0.02 ± 0.002 
 
n.s. vs.  
Local  
Ca2+ 
transient 
 
**** vs.  
EFS-induced 
Ca2+ 
transient 
Whole 
cell Ca2+ 
transient 
Rapid, step-like 
increase in Cal-520 
fluorescence. The 
increase in Cal-520 
could be whole-cell, or 
a portion of the cell 
depending on 
spontaneous Ca2+ 
signalling.  
 
Fastest rate of rise 
and highest 
amplitude of any 
Ca2+ signal 
recorded in the 
PVCs.  
3.3 ± 0.4 
 
** vs.  
Local  
Ca2+ 
transient 
 
n.s. vs.  
Ca2+ wave 
 
0.05 ± 0.007 
 
**** vs.  
Local  
Ca2+ 
transient 
 
**** vs.  
Ca2+ wave 
 
Table 4.1. Summary of the criteria used to distinguish different Ca2+ signals in line-scans 
plots and Ca2+ traces. *, **, *** and **** indicate P values of < 0.05, < 0.01, < 0.001 and < 
0.0001, respectively.  
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4.3.2. Complex spontaneous Ca²⁺ signals and EFS-induced Ca²⁺ transients in PVCs 
The local Ca2+ transients and Ca²⁺ waves described above are examples of spontaneous 
Ca2+ signalling in the PVCs. During the imaging experiments undertaken in this study, with 
recordings typically lasting for 10 - 35 seconds, the majority of PVCs from 3 month-old 
animals (70 ± 13.6%; n = 28 cells, 10 slices from 4 animals) showed local Ca2+ transients. 
Whereas, all PVCs from 3 month-old animals showed Ca²⁺ waves (n = 10 slices from 4 
animals). 
The frequency of spontaneous Ca2+ signals within the PVCs differed considerably. This 
was true on different levels: between animals, between slices prepared from one animal 
and also between adjacent PVCs within one lung slice. The average frequency for 
spontaneous activity (local Ca2+ transients and Ca²⁺ waves) was 0.4 ± 0.04 Hz (n = 62 slices 
from 11 animals), and ranged from ~0.1 Hz to ~1.7 Hz. 
The three types of Ca2+ signals introduced above could occur within the same cell (if EFS 
was applied) and interacted in the sense that the occurrence of one type of Ca2+ signal 
could affect the triggering of another. This is exemplified by the line-scans and Ca2+ traces 
in Figure 4.5. This figure shows the spontaneous activity within three PVCs prior to 
application of EFS, and then during stimulation with EFS at 1, 3 and 5 Hz. It is evident that 
the pattern of spontaneous Ca2+ signalling changed with application of EFS, and also that 
pacing of the cells with EFS was not always consistent. The three cells that were subjected 
to line-scanning all showed local Ca2+ transients and Ca2+ waves, but varied in their 
patterns of spontaneous Ca2+ signals (Figure 4.5B). The frequencies of spontaneous Ca2+ 
signals in these cells were 0.4, 0.7 and 0.3 Hz for cells 1 to 3, respectively.  
Application of EFS at 1 Hz triggered whole-cell EFS-induced Ca2+ transients in cell 1 and 
eradicated spontaneous Ca2+ signals. Whereas, cells 2 and 3 did not respond to 1 Hz EFS, 
and continued to show spontaneous Ca2+ signals (Figure 4.5C). Increasing the EFS 
189 
 
frequency to 3 Hz also caused evoked EFS-induced Ca2+ transients in cell 1, but with the 
appearance of alternans (Figure 4.5D). Cell 2 responded to 3 Hz EFS, albeit weakly, with 
relatively low-amplitude EFS-induced Ca2+ transients, and still some on-going 
spontaneous Ca2+ signals. Cell 3 continued to be non-paced and solely displayed 
spontaneous Ca2+ transients. Elevating the EFS frequency to 5 Hz led to a complex pattern 
of response in cell 1 with alternating EFS-induced Ca2+ transients, Ca2+ waves and missed 
responses to EFS (Figure 4.5E). Cell 2 showed a similar activity to cell 1, and cell 3 
remained unaffected the EFS pulses. The cells were imaged for a period after the EFS was 
turned off, and they typically re-set back to the pattern of spontaneous activity observed 
before EFS was applied, although there could be some lasting consequences, such as the 
increased entrainment of Ca2+ waves between cells (see the periods of spontaneous 
activity post EFS in Figure 4.5C – E).  
The complex patterns of response shown in Figure 4.5 demonstrate the heterogeneity 
and complexity of Ca2+ signalling within PVCs. Such complex patterns of Ca2+ signalling are 
not desirable in a cell type that is required to faithfully follow action potentials emanating 
from the sinoatrial node. Indeed, the spontaneous Ca2+ signals arising in PVCs have been 
shown to prevent PVCs from being regularly paced (Rietdorf et al., 2014, Rietdorf et al., 
2015). The observations presented above highlight one of the major aims of trying to 
understand Ca2+ signalling within PVCs; is it possible to abrogate spontaneous Ca2+ signals 
and ensure faithful electrical pacing?  
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Figure 4.5. Spontaneous Ca2+ signals and EFS-induced Ca2+ transients in PVCs. The 
cartoon of cells in Panel A illustrates the line that was repeatedly scanned placed across 
three adjacent cells (the scanned line is denoted by the dashed black line). Panel B shows 
a line-scan plot illustrating the spontaneous Ca2+ signals observed within the PVCs. The 
Ca2+ traces below the line-scans were derived from regions within the line-scans. The 
white dashed lines in the line-scans indicate the boundaries between the cells. Panels C – 
E show representative line-scans and corresponding Ca2+ traces obtained whilst applying 
EFS at 1 Hz (C), 3 Hz (D) and 5 Hz (E), followed by a period of with no EFS. The timing of 
EFS pulses is indicated by the series of black downward arrows above the line-scans. The 
scale bar represents 20 µm. 
191 
 
 
192 
 
4.4. Testing the role of different Ca²⁺ sources for spontaneous Ca²⁺ signalling in 
cardiac myocytes  
4.4.1. Testing the role of different Ca²⁺ sources for spontaneous Ca²⁺ signals and 
EFS-induced Ca2+ transients in NRVMs 
 
To understand the mechanisms underlying spontaneous Ca²⁺ signals within PVCs, and 
their impact on EFS-induced Ca2+ transients, experiments were designed in which 
pharmacological reagents would be used to inhibit putative components of the PVC Ca²⁺ 
signalsome. However, before these experiments were undertaken, as series of adjunct 
experiments were performed involving NRVMs, as described below. 
The reason for these adjunct experiments was to establish that the compounds were 
active prior to their use on lung slices. Whilst tissues slices, such as those used here, are 
advantageous in maintaining PVCs’ orientations and connections, it is more difficult to 
perfuse cells with external reagents. The lung slices used in this study are ~180 µm thick, 
and access to cells deep within a slice would be through a tortuous pathway of 
extracellular spaces. To avoid false negative observations, it was necessary to firmly 
establish that reagents were working within the laboratory.  
NRVMs were loaded with Cal-520 and imaged using a wide-field fluorescence microscope, 
since confocal imaging was not needed to record Ca2+ signals in monolayers of these cells. 
The experimental protocol used for these experiments is illustrated in Figure 4.6Ai and ii. 
To test the effect of the compounds, a field of NRVMs was imaged twice; once before 
addition of compound (Run 1) and once following addition of a compound (Run 2). Both 
imaging experiments lasted 35 seconds, and were comprised as follows: 
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Run 1: 
3. 10 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
4. 10 seconds with application of 2 Hz EFS. 
5. 30 seconds where no stimulus was applied to the cells. 
Following Run 1, a reagent (or HBSS as a control) was superfused over the cells whilst 
they were maintained on the microscope stage. Following a 5-minute incubation period, 
Run 2 was initiated.  
Run 2: 
1. 10 seconds where no stimulus was applied to the cells (in this period only 
spontaneous Ca2+ signals occurred). 
2. 10 seconds with application of 2 Hz EFS. 
3. 30 seconds where no stimulus was applied to the cells. 
Run 1 was used to assess the spontaneous activity of the NRVMs, and their 
responsiveness to EFS. Whilst Run 2 was used to assess the influence of the reagent on 
spontaneous Ca2+ signals and EFS-induced responses. The frequency and amplitude of 
spontaneous Ca2+ signals (largely Ca2+ waves in the NRVMs), and the ability of the cells to 
follow EFS pacing were analysed by comparing the respective responses before and after 
the reagent addition in a paired manner. Similar experiments were carried out using 
HBSS, JTV-519, carvedilol, dantrolene, SN-6 and BTP2 (Figure 4.6). The rationale for 
choosing these reagents was that they are reported to inhibit different Ca2+ transport 
pathways, as described in Chapter 1, section 5.3. PVCs were considered to be ‘successful 
paced’ if they responded to all the EFS pulses in continuous train of pulses, and with 
consistent Ca2+ signal amplitudes (+/- ≤ 10% of ΔF/F0 Ca
2+ signal amplitudes). 
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Representative Ca2+ traces obtained from individual cells recorded during these 
experiments are shown in Figure 4.6. Similar to PVCs, the NRVMs displayed spontaneous 
Ca2+ signals and whole-cell Ca2+ responses to EFS, although the frequency of spontaneous 
activity in the NRVMs was lower than typically seen in PVCs (NRVMs 0.18 ± 0.09 Hz vs. 
PVCs 0.38 ± 0.04 Hz (n = 40 cells from 3 litters for NRVMs and 24 slices from 11 animals 
for PVCs, respectively). The effects of the various reagents on the frequency and 
amplitude of displayed spontaneous Ca2+ signals are presented quantitatively in Figures 
4.7 and 4.8., whilst the effect of the reagents on the ability of the NRVMs to respond to 
EFS pulses is shown quantitatively in Figure 4.9. The control experiments, using HBSS 
superfusion, established that Run 1 and Run 2 evoked similar responses (Figures 4.6A, 
4.7A, 4.8A and 4.9A). Any changes in either spontaneous Ca2+ signals or ability to respond 
to EFS pulses between Run 1 and Run 2 would therefore be a consequence of 
superperfusion with the reagents. A summary of the effect of each of the reagents is 
given below. 
JTV-519 
JTV-519 is a RyR inhibitor that has been shown to reduce RyR2 activation by increasing 
the binding of FK506-binding proteins (FKBPs) to RyR2 (Shou et al., 1998; Vest et al., 
2005; Dobrev et al., 2012). JTV-519 is currently being tested in clinical trials and reduces 
RyR2 openings, thus reducing SR Ca2+ leak and prevents spontaneous firing rate and may 
prevent arrhythmias (Kumagai et al., 2003; Chen et al., 2008). Therefore, in this study, 
100 µM JTV-519 was used to inhibit the frequency of spontaneous Ca2+ signals in NRVMs 
here and PVCs later (section 4.6). Unfortunately, apart from inhibiting RyR2, JTV-519 has 
been demonstrated to affect other additional off targets (Kumagai et al., 2003, Chen et 
al., 2008, Elliot et al., 2011). JTV-519 has been shown to inhibit L-type Ca2+ currents and 
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inward and delayed rectifier K+ currents. In addition to this, JTV-519 has also been shown 
to prolong the AP duration in atrial myocytes (Kimura et al., 1999, Kumagai et al., 2003, 
Chen et al., 2008, Elliot et al., 2011). Therefore, although JTV-519 inhibits RyR2 by 
facilitating the closed state of the channel, one should consider the unspecific effects of 
the drug and it should be used with caution. 
In this study, a significant effect of JTV-519 was to reduce the occurrence spontaneous 
Ca2+ signals, both before and after EFS application (Figures 4.6B and 4.7B), but it did not 
alter the amplitude of spontaneous Ca2+ signals when they did arise (Figure 4.8B). JTV-519 
also reduced the ability of NRVMs to respond to EFS pulses (Figure 4.9B). Stimulation of 
NRVMs with EFS in the presence of JTV-519 caused the occurrence of Ca2+ signal 
alternans in 83.3 % of the cells (Figure 4.6B). 
Carvedilol 
Carvedilol is a β blocker that inhibits both α and β adrenoceptors and is used extensively 
in treating HF (Reiken et al., 2003, Zhou et al., 2011). For this study, 100 µM carvedilol 
was used to reduce the spontaneous Ca2+ in NRVMs and PVCs. Carvedilol was tested to 
investigate whether the changes observed after drug incubation were either from RyR2 
inhibition or from suppressing α/β adrenoceptors. It should be noted however, 
previously, carvedilol has also been shown to inhibit RyR2 openings (Reiken et al., 2003, 
Zhou et al., 2011).  
Carvedilol had a similar effect to JTV-519 on the NRVMs; it reduced the incidence of 
spontaneous Ca2+ signals, both before and after EFS application (Figures 4.6C and 4.7C), 
but it did not alter the amplitude of spontaneous Ca2+ signals when they occurred (Figure 
4.8C). Carvedilol also reduced the ability of NRVMs to respond to EFS pulses (Figure 4.9C). 
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In the presence of carvedilol, the responses to EFS were irregular in 66.7 % of the cells, 
and the amplitude of the Ca2+ transients gradually decreased with successive EFS pulses.  
Dantrolene 
Dantrolene is muscle relaxant that is highly used as a treatment for malignant 
hyperthermia (Fruen et al., 1997). It functions by inhibiting RyR1 opening, thereby 
reducing the SR Ca2+ leak. Although dantrolene is traditionally used to facilitate RyR1 
closure, it has also been reported to inhibit RyR2 (Jung et al., 2012). Hence, 100 µM 
dantrolene was tested in this thesis to investigate its effects on RyR2 in NRVMs and PVCs. 
Unlike JTV-519 and carvedilol, dantrolene had no effect on the occurrence of 
spontaneous Ca2+ signals, either before or after EFS application (Figures 4.6D and 4.7D), 
and it did not alter the amplitude of spontaneous Ca2+ signals when they occurred (Figure 
4.8D). Dantrolene had no effect on the ability of NRVMs to respond to EFS pulses (Figure 
4.9D). 
SN-6 
In this project, 10 µM SN-6 was tested to elucidate the role played by NCX in generating 
spontaneous Ca2+ signals. SN-6 inhibits the forward mode of NCX channel and therefore is 
used to inhibit NCX-mediated Ca2+ transport out of the cell. SN-6 has been demonstrated 
previously to be cardioprotective in ischaemia-reperfusion injury by inhibiting NCX (Inoue 
et al., 2004). Sadly, similar with other drugs, the effects of SN-6 are not fully specific to 
NCX. Previously, SN-6 has also been shown to inhibit L-type VOCCs (Gandhi et al., 2013). 
In contrast to the other reagents used, SN-6 reduced the amplitude of the spontaneous 
Ca2+ transients (Figure 4.8E). However, SN-6 had no effect on the occurrence of 
spontaneous Ca2+ signals, either before or after EFS application (Figures 4.6E and 4.7E). 
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There was a tendency for cells to be less responsive to EFS pulses in the presence of SN-6, 
but it was not statistically significant (Figure 4.9E). 
BTP2 
BTP2 is an antagonist of SOCE and has been shown to block an influx of Ca2+ without 
affecting K+ transport or VOCCs (Zitt et al., 2004, He et al., 2005). Previously, BTP2 has 
been shown to inhibit the firing rate in SA node cells (Liu et al., 2015).  Therefore, to 
explore if SOCE plays any role in cardiac myocytes, the effects of 100 µM BTP2 were 
analysed. 
BTP2 had the most dramatic effects of all the reagents used; it significantly reduced the 
occurrence and amplitude of spontaneous Ca2+ transients (Figures 4.7F and 4.8F), and it 
completely abrogated any cellular Ca2+ signals in 32% of the cells (Figure 4.6F). BTP2 
reduced the ability of NRVMs to respond to EFS pulses (Figure 4.9D).  
The test experiments using NRVMs indicated that the reagents could have complex 
effects and may affect different activities. Of the reagents used, JTV-519, carvedilol and 
BTP2 had significant effects on the occurrence of spontaneous Ca2+ transients (Figure 
4.7). Of these reagents, JTV-519 gave a strong suppressive effect on spontaneous Ca2+ 
transients. Not only was the frequency of the spontaneous Ca2+ transients reduced by 
JTV-519, but the percentage of NRVMs showing any spontaneous Ca2+ transients was 
reduced from 99 ± 0.2% to 26.7 ± 16% (P = 0.006, analysed using a paired t-test, n = 6 
coverslips from 2 litters). The fact that BTP2 could completely abrogate all Ca2+ signals 
within NRVMs suggests that it may have more targets than just SOCE, and should be used 
with caution. The reverse-mode NCX inhibitor SN-6 was seemingly only active in reducing 
the amplitude of spontaneous Ca2+ transients (Figure 4.8). Dantrolene did not affect the 
occurrence or amplitude of spontaneous Ca2+ transients in NRVMs (Figure 4.7), indicating 
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that under the conditions, or concentration, used in this study it did not block RyRs 
sufficiently to inhibit Ca2+ signalling. 
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Figure 4.6. Effects of various Ca2+ signalsome-affecting reagents on spontaneous Ca2+ 
signals and EFS responses in NRVMs. Panel Ai illustrates the stimulation protocol used in 
this experiment, and depicts a representative Ca2+ trace from a NRVM in the presence of 
HBSS. Between Run 1 and Run2 the NRVMs were superfused with fresh HBSS, incubated 
for 5 minutes on the stage of the microscope, and then Run 2 was initiated. Panel Aii 
shows cell’s responses post HBSS superfusion. Panels B – F depict similar paired 
experiments in which different NRVMs populations were superfused with the reagents 
shown. A fresh coverslip bearing naive NRVMs was used for each of the reagents shown. 
The concentrations of reagents applied were 100 µM for JTV-519, carvedilol, dantrolene 
and BTP2, and 10 µM for SN-6. 
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Figure 4.7. Effects of various Ca2+ signalsome-affecting reagents on the frequency of 
spontaneous Ca2+ signals in NRVMs. Panels A – F show the average frequency of 
spontaneous Ca2+ signals during Run 1 and Run 2 of the experiments depicted in Figure 
4.6. The data are presented as mean ± S.E.M., and were analysed using paired t-tests. * 
and ** denote P < 0.05 and P < 0.01, respectively. n = 6 coverslips from 2 litters per 
reagent. 
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Figure 4.8. Effects of various Ca2+ signalsome-affecting reagents on the amplitude of 
spontaneous Ca2+ signals in NRVMS. Panels A – F show the average amplitude of 
spontaneous Ca2+ signals during Run 1 and Run 2 of the experiments depicted in Figure 
4.6. The data are presented as mean ± S.E.M., and were analysed using paired t-tests. * 
denotes P < 0.05. n = 6 coverslips from 2 litters per reagent.  
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Figure 4.9. Effects of various Ca2+ signalsome-affecting reagents on ability of NRVMs to 
follow EFS pacing. Panels A – F show the percentage of NRVMs that followed EFS pulses 
during Run 1 and Run 2 of the experiments depicted in Figure 4.6. PVCs were considered 
to be ‘successful paced’ if they responded to all the EFS pulses in continuous train of 
pulses, and with consistent (+/- ≤ 10% of ΔF/F0 Ca
2+ signal amplitudes). The data are 
presented as mean ± S.E.M., and were analysed using paired t-tests. * denotes P < 0.05. n 
= 6 coverslips from 2 litters per reagent. 
 
 
  
203 
 
4.4.2. Testing the role of different Ca²⁺ sources for spontaneous Ca²⁺ signals and 
EFS-induced Ca2+ transients in PVCs 
 
Having assessed the effectiveness of the various reagents to alter Ca2+ signals in NRVMs, 
they were used advisedly on lung slices to examine whether they could reduce 
spontaneous Ca2+ signals and improve the fidelity of EFS pacing in PVCs. Verapamil was 
also used on lung slices, but was not tested on the NRVMs as it has already been 
established to be effective (Rietdorf et al., 2014). A similar experimental design to that 
used with NRVMs, using two experimental runs (i.e. before and after a drug incubation 
period), was employed for the lung slices (Figure 4.6), but with some changes: a 10-
minute incubation was used for the superfusion step to compensate for the likely slower 
dispersion of reagents within the tissue and line-scan imaging was performed using a 
confocal microscope to have a faster temporal resolution for the Ca2+ signals in PVCs.  
Run 1: 
1. 18-second line-scan recording of spontaneous activity.  
2. 18-second line-scan recording during application of 1Hz EFS. 
Following Run 1, a reagent (or HBSS as a control) was superfused over the lung slices 
whilst they were maintained on the microscope stage. Following a 10-minute incubation 
period, Run 2 was initiated.  
Run 2: 
1. 18-second line-scan recording of spontaneous activity.  
2. 18-second line-scan recording during application of 1Hz EFS. 
The experimental protocol was adopted to maximally preserve the Cal-520 
fluorescence, since laser illumination during confocal imaging can lead to 
photobleaching. Just as with NRVMs, the robustness of the experimental paradigm 
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was tested with control experiments in which HBSS was superfused over the lung 
slices for 10 minutes. An example of a control experiment is depicted in Figure 4.10. 
The line-scans and Ca2+ traces in Figure 4.10 show spontaneous Ca2+ signals and EFS-
induced responses in two adjacent cells. Importantly, the frequency of the 
spontaneous Ca2+ signals did not change between the two periods of recording 
without EFS (i.e. part 1 in Run 1 and Run 2, respectively, in the protocol shown above) 
(Figure 4.10Bi and Ci). Moreover, the response of both cells to application of 1 Hz EFS 
was not altered by the 10-minute incubation with HBSS (part 2 in Run 1 and Run 2, 
respectively, in the protocol shown above) (Figure 4.4Bii and Cii).  
In subsequent experiments, the reagents that were tested on NRVMs (and also 
verapamil) were applied to lung slices using the protocol described above and depicted in 
Figure 4.10. The concentrations of reagents used were 100 µM for verapamil, BTP2 and 
JTV-519, and 10 µM for SN-6. The effects of the reagents on the frequency, amplitude and 
duration of spontaneous Ca2+ signals within PVCs, and the ability of PVCs to follow EFS 
pulses are shown quantitatively in Figures 4.11 and 4.12.  
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Figure 4.10. Control experiments exemplifying the protocol used to test the effect of 
Ca2+ signalsome-affecting reagents on spontaneous Ca2+ signals and responses to EFS in 
PVCs. Panels A and B represent ‘Run 1’ of the protocol described in the text. Whereas, 
Panels C and D represent ‘Run 2’ of the protocol. Panel A shows a line-scan plot and a 
Ca2+ trace illustrating the spontaneous Ca2+ signals observed within the PVC. The Ca2+ 
trace below the line-scan was derived from a region within the line-scan. Panel B shows 
the response of the PVCs to application of 1 Hz EFS. After the line-scan in Panel B was 
obtained, the lung slice was superfused with HBSS for 10 minutes. The line-scan plot and 
Ca2+ trace in panel C show the spontaneous Ca2+ signals observed after the HBSS 
incubation. Panel D illustrates that the PVCs displayed regular responses to a second 
series of 1 Hz EFS pulses. Scale bar denotes 30 µm. 
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Figure 4.11. Quantitation of the effect of Ca2+ signalsome-affecting reagents on 
spontaneous Ca2+ signals in PVCs. The bars in columns A – E show averaged data 
obtained from spontaneous Ca2+ signals occurring in Run 1, before the 10-minute 
superfusion with HBSS/reagent (red bars; Run 1 in the protocol described above), and 
from spontaneous Ca2+ signals occurring in Run 2, after the 10-minute superfusion with 
HBSS/reagent (green bars; Run 2 in the protocol described above). Panels Ai - Ei quantify 
the frequency of Ca2+ waves, Panels Aii - Eii show the frequency of local Ca2+ transients, 
Panels Aiii - Eiii depict the amplitude of the Ca2+ waves, and Panels Aiv - Eiv indicate the 
duration of Ca2+ waves. The data are presented as mean ± S.E.M., and were analysed 
using paired t-tests. *, ** and *** denote P < 0.05, P < 0.01, and P < 0.001, respectively. n 
= 10 – 18 slices from 4 animals per HBSS/reagent. 
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Figure 4.12. Quantitation of the effect of Ca2+ signalsome-affecting reagents on the 
ability of PVCs to follow 1 Hz EFS pacing. Panels A - E show the percentage of PVCs 
following 1 Hz EFS during Run 1 (red bars; Run 1 in the protocol described above) and Run 
2 (green bars; Run 2 in the protocol described above), before and after a 10-minute 
addition of HBSS/reagent, respectively. The data are presented as mean ± S.E.M., and 
were analysed using paired t-tests. * and ** denote P < 0.05 and P < 0.01, respectively. n 
= 10 – 18 slices from 4 - 5 animals per HBSS/reagent. 
 
The quantitative analysis of the effect of the different reagents indicated that they had 
disparate effects. Each of the reagents had a significant effect on one or more of the 
parameters depicted in Figures 4.11 and 4.12. BTP2, SN-6 and JTV-519 all significantly 
suppressed some aspect of spontaneous Ca2+ signalling within the PVCs (Figure 4.11). 
Since spontaneous Ca2+ signals have been shown to prevent PVCs from being regularly 
paced (Rietdorf et al., 2014, Rietdorf et al., 2015), the actions of BTP2, SN-6 and JTV-519 
in reducing spontaneous Ca2+ signalling could be considered favourable and potentially 
anti-arrhythmic. However, both BTP2 and JTV-519 significantly decreased the proportion 
of PVCs that would follow regular EFS pulses (Figure 4.12). Only SN-6 was able to 
decrease spontaneous Ca2+ signalling (Figure 4.11) whilst PVCs were still able to respond 
to EFS pulses (Figure 4.12).  
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4.5. Characterisation of spontaneous Ca2+ signals and EFS-induced Ca²⁺ transients 
in PVCs from 3 month- and 24 month-old mice 
The data discussed above illustrate the nature of spontaneous Ca2+ signals that occur in 
PVCs within lung slices obtained from 3 month-old mice, and experimental attempts to 
alleviate spontaneous Ca2+ signals using pharmacological reagents. To examine whether 
Ca2+ signalling or homeostasis changes in PVCs during ageing, a comparison was made 
using lung slices prepared from 3 month- and 24 month-old mice. Putative changes in 
Ca2+ signalling were analysed by measuring the frequency, velocity, amplitude, duration 
and number of initiation points of spontaneous Ca2+ waves, and the frequency of local 
Ca²⁺ signals. Additionally, the ability to pace the slices with EFS pulses at 1, 3 and 5 Hz was 
explored.  
Representative line-scans recorded using PVCs obtained from 3 month-old (Figure 4.13A) 
and 24 month-old mice (Figure 4.13B and C) illustrate that spontaneous Ca2+ signals were 
evident at both ages. PVCs from the 3 month-old mice responded to 1, 3 and 5 Hz EFS, 
although the amplitude of the Ca2+ signals became progressively smaller as the 
stimulation frequency was increased (Figure 4.13Aii – Aiv). From the line-scans shown in 
Figure 4.13A, it is evident that the two adjacent cells differed in their responses to EFS. In 
particular, cell 1 displayed longer lasting EFS-induced Ca2+ transients at 1 and 3 Hz 
stimulation, compared to those seen in cell 2 (Figure 4.13Aii and Aiii). In addition, cell 1 
displayed Ca2+ waves when the EFS frequency was increased to 5 Hz, whereas cell 2 
maintained regular pacing (albeit with significantly reduced Ca2+ signal amplitude). With 
both cells, 3 Hz EFS pulses evoked alternans (Figure 4.13Aiii). In contrast to PVCs from 3 
month-old mice, where many cells responded to 1 Hz EFS pulses, PVCs from 24 month-old 
mice did not respond well to application of EFS pulses. The line-scans presented in Figure 
4.13B and C depict recordings from PVCs within two lung slices obtained from two 24 
month-old mice. The cell in Panel B displayed spontaneous Ca2+ signals, but it did not 
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respond to EFS pulses at 1, 3, or 5 Hz, whilst the cell in Panel C did follow the pacing with 
all three frequencies of EFS.  
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Quantitative analysis of spontaneous Ca2+ signals and EFS-evoked Ca2+ transients from 
experiments such as that shown in Figure 4.13 is presented in Figure 4.14. The 
characteristics of Ca2+ waves were significantly different between PVCs from 3 month- 
and 24 month-old animals in a number of ways; their frequency was increased (Figure 
4.14Ai), their amplitude was reduced (Figure 4.14Aii) and they lasted longer (Figure 
4.14iii). The frequency of local Ca2+ signals was not significantly different between PVCs 
from 3 month- and 24 month-old animals (Figure 4.14Aiv). Moreover, neither the 
proportions of cells with one, or more, Ca2+ wave initiation sites, nor their Ca2+ wave 
propagation velocities, were significantly different between PVCs from 3 month- and 24 
month-old animals (Figure 4.14B-C).   
 
 
 
212 
 
 
213 
 
 
Figure 4.13. Spontaneous Ca2+ signals and EFS-induced Ca2+ transients in PVCs from 3 
month- and 24 month-old mice. Panel A shows data recorded using PVCs obtained from 
a 3 month-old mouse. The line-scans and corresponding Ca2+ traces show spontaneous 
Ca2+ signals (Ai), and responses to 1, 3 and 5 Hz EFS pacing (Aii - Aiv). Panel B and C show 
data recorded using PVCs obtained from two 24 month-old mice. The line-scans and 
corresponding Ca2+ traces show spontaneous Ca2+  signals (Bi and Ci), and responses to 1, 
3 and 5 Hz EFS pacing (Bii – Biv, Cii-Civ). The PVC in Panel B could not be paced, whilst the 
PVC in Panel C followed the electrical pacing.  The scale bars in Panels Ai, Bi and Ci 
represent 30 µm. 
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Figure 4.14. Characteristics of spontaneous Ca2+ signals and EFS-induced Ca2+ transients 
in PVCs from 3 month- and 24 month-old mice. 
The data presented in this figure were obtained from experiments such as that shown in 
Figure 4.13. The plots in Panels Ai – Aiv, and B – C show quantitative analyses of 
spontaneous Ca2+ signals that occurred in PVCs from 3 month- and 24 month-old mice. 
The spontaneous Ca2+ signals were recorded prior to application of EFS, as illustrated in 
Figure 4.13Ai & Bi. Panels Ai – Aiii and B – C represent analyses of Ca2+ waves, whilst 
Panel Aiv shows the frequency of local Ca2+ transients. Panels D – E show the correlation 
between the spontaneous Ca2+ signals and the ability to follow 1 Hz electrical pacing in 
PVCs from 3 month- and 24 month-old mice. The plot in Panel G shows quantitative 
analyses of EFS-induced pacing in PVCs from 3 month- and 24 month-old mice, with data 
obtained from experiments such as those shown in Figure 4.13Aii – iv and Bii - iv. The 
data in Panels A - E are presented as mean ± S.E.M., and were analysed using unpaired t-
tests. The data shown in Panels F - G were compared using a Fisher’s Test. * and ** 
indicate P < 0.05 and P < 0.01, respectively. n = 10 – 82 slices from 4 – 11 animals for both 
3 month- and 24 month-old mice. 
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The ability of EFS to pace PVCs from 3 month- and 24 month-old mice was analysed by 
applying a train of EFS pulses for 12 seconds as shown in Figure 4.13, and then examining 
the characteristics of Ca2+ signals triggered by each EFS pulse. It was noted that EFS 
application evoked multiple, distinctive outcomes, as follows: 
1. Regular responses represent situations where PVCs responded to all the EFS 
pulses in continuous train of pulses, and with consistent Ca2+ signal amplitudes. 
 
2. Alternans denote situations where PVCs responded to EFS pulses with alternating 
large and small Ca2+ signal amplitudes. 
 
3. Irregular responses indicate situations where PVCs did not respond to each EFS 
pulse in continuous train of pulses, and/or showed Ca2+ signals with variable 
amplitudes, i.e. (+/- ≥ 50% ΔF/F0). 
 
4. No response designates situations were PVCs did not respond to any EFS pulse in 
continuous train of pulses. 
The quantitative analysis of EFS-induced Ca2+ signals is presented in Figure 4.14C, with the 
blue- and red-coloured bars indicating responses in PVCs from 3 month- and 24 month-
old animals, respectively. It is evident that a greater proportion of PVCs from 3 month-old 
mice reacted to EFS with any form of response, compared to PVCs from 24 month-old 
animals. The PVCs from 3 month-old animals responded best to 1 Hz EFS pulses, with 
~38% of cells showing regular responses. Increasing the EFS frequency from 1 Hz to 3 or 5 
Hz changed the nature of the outcomes in 3 month-old PVCs so that fewer cells 
responded, and alternans and irregular responses were more prominent. The proportion 
of PVCs from 24 month-old mice that reacted to EFS was the same at 1, 3 or 5 Hz, but 
there were more alternans and irregular responses with 3 or 5 Hz.  
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It should be noted that pacing PVCs within lung slices using EFS was not simple to achieve 
despite great care being taken in the handling of the slices, superfusion of the tissue and 
placement of electrodes. Indeed, in the best case, with PVCs from 3 month-old mice 
paced with 1 Hz EFS, only 56 % of cells responded in any way (Figure 4.14F). The reason 
why the remainder of the PVCs did not respond to EFS pulses at all is unclear, but may 
reflect a lack of penetration of the electrical signal within the 180 µm-thick lung slices. 
Interestingly, there was a significant difference between the ability to pace PVCs from 3 
month and 24 month-old mice (Figure 4.14F). The reasons why PVCs from 24 month-old 
animals were harder to pace using EFS pulses is unclear. It is important to point out that 
the cells were vital; they loaded to similar levels with Cal-520, had similar resting Cal-520 
intensities (i.e. similar basal Ca2+ levels), and showed spontaneous Ca2+ signals indicative 
of functional Ca2+ stores, channels and ATPases. Furthermore, the experiments presented 
within this chapter were performed using slices from 3 month- and 24 month-old mice 
that had identical genetic backgrounds. The 3 month- and 24 month-old animals were 
nurtured in the same facility (The Open University’s Biological Response Unit) over the 
same period of time. Furthermore, lung slices from both age groups were prepared for 
use on the same days to limit the variability within the experiments. It is therefore 
unlikely that differences in husbandry or treatment of the mice, lung slice preparation, 
stimulation conditions or experimental solutions were responsible for the discrepant EFS-
induced pacing of PVCs from young and old animals. Rather, it is plausible to suggest that 
ageing was somehow responsible for the differences in responses of 3 month- and 24 
month-old PVCs. 
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4.6. Characterisation of the role of RyR and adrenoceptors for Ca²⁺ transients in 
PVCs from 3 month- and 24 month-old mice 
4.6.1. Effect of RyR2 inhibition using JTV-519 on spontaneous Ca2+ signals in PVCs 
from 3 month- and 24 month-old mice 
JTV-519 was found to significantly reduce spontaneous Ca2+ signals in both NRVMs 
(Figures 4.6 and 4.7) and PVCs from 3 month-old mice (Figure 4.11). As discussed above, 
inhibition of spontaneous Ca2+ signals may plausibly help with the pacing of cardiac 
myocytes. Therefore, since PVCs from 24 month-old mice were found to have a higher 
frequency of spontaneous Ca2+ signals (Figure 4.14), the effect of JTV-519 was tested to 
examine whether it could similarly suppress spontaneous Ca2+ signals in PVCs from old 
animals.  
To examine the effect of JTV-519 on spontaneous Ca2+ signals in PVCs from 3 month- and 
24 month-old animals the following experimental protocol was used: 
Run 1: 
1. 35-second recording of spontaneous activity.  
Following Run 1, 100 µM JTV-519 (or HBSS as a control) was superfused over the lung 
slices whilst they were maintained on the microscope stage. Following a 10-minute 
incubation period, Run 2 was initiated.  
Run 2: 
1. 35-second recording of spontaneous activity.  
This protocol was repeated using PVCs from 3 month- and 24 month-old animals. For 
these experiments, spontaneous Ca2+ signals were recorded using 2D confocal imaging at 
10 Hz. The reason for using 2D confocal imaging rather than line-scanning was to ensure 
that spontaneous Ca2+ signals were not missed through sampling a limited area of the 
PVCs. Examples of spontaneous Ca2+ signals recorded using the experimental protocol 
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described above are shown in Figure 4.15. As discussed earlier, PVCs from both 3 month- 
and 24 month-old animals displayed spontaneous Ca2+ signals, with a mix of Ca2+ waves 
and local Ca2+ transients being evident. 
 
Figure 4.15. Protocol used to test the effects of drugs on the Ca2+ signalsome in PVCs 
from 3 month- and 24 month-old mice. Panels A and B show images of Cal-520-loaded 
PVCs and Ca2+ traces obtained by recording the Cal-520 fluorescence within the cells. 
Panel A depict recordings performed using PVCs from 3 month-old mice. Panel Ai show 
the activities of cells prior to a 10-minute incubation with HBSS (Run 1), panel Aii that 
after a 10-minute incubation with HBSS (Run 2). Panels Bi and Bii depict recordings 
performed using PVCs from 24 month-old mice. The yellow circles in the cell images show 
cellular regions used to obtain the Ca2+ traces. The scale bars represent 10 µm. 
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Quantitative analysis of experiments such as that depicted in Figure 4.15 is shown in 
Figure 4.16. The control experiments, with superfusion of HBSS, indicated that the 
frequency of spontaneous Ca2+ signals in both age groups was similar in Run 1 and Run 2 
(i.e. before and after a 10-minute HBSS superfusion interval; Figure 4.16).  
Variability in the nature and frequency of spontaneous Ca2+ signals is characteristic of 
PVCs (Rietdorf et al., 2014 and as described above in 4.3.1). As described in Chapter 2, all 
possible procedures were used to minimise the variability within and between 
experiments. Control and reagent-testing experiments were performed using lung slices 
prepared at the same time, and from the same batches of mice. However, it is obvious 
from the data presented in Figure 4.16Ai and 4.16Bi that there was a substantial variation 
in the frequency of spontaneous Ca2+ signals during the first 35-second recordings from 
the PVCs, and it was considered that this variability may have obscured significant effects 
that might be caused by the drugs used. Therefore, to analyse the action of drugs on 
spontaneous Ca2+ signals further the data presented in Figure 4.16Ai and 4.16Bi were re-
categorised. The re-categorisation defined PVCs based on their spontaneous Ca2+ signal 
frequency during Run 1 (i.e. prior to the 10-minute superfusion interval), as follows: 
1. PVCs with a frequency of spontaneous Ca2+ signals ≥ 0.5 Hz before HBSS 
superfusion were categorised as ‘high frequency’ cells.  
2.  PVCs with a frequency of spontaneous Ca2+ signals < 0.5 Hz before HBSS 
superfusion were categorised as ‘low frequency’ cells.  
This re-categorisation was applied to the data from both the 3 month- and 24 month-old 
PVCs, and is depicted in Figures 4.16Aii, Aiii, Bii and Biii. Sorting the PVCs into high and 
low frequency categories revealed no differences in the control experiments, but will 
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however applied throughout the following series of experiment investigating the effects 
of drugs on the Ca2+ signalsome in PVCs.  
 
 
 
 
Figure 4.16. Effect of HBSS (control) on spontaneous Ca2+ signals in PVCs from 3 month- 
and 24 month-old mice. The data were obtained from experiments such as those 
depicted in Figure 4.15. Panels A and B show the frequency of spontaneous Ca2+ signals in 
PVCs from 3 month- and 24 month-old mice, respectively. The data are presented as 
mean ± S.E.M., and were analysed using paired t-tests. * indicates P < 0.05. n = 15 – 17 
slices from 8 – 9 animals for both 3 month- and 24 month-old mice. 
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JTV-519 significantly reduced the frequency of spontaneous Ca2+ signals in PVCs from 24 
month-old mice (Figure 4.17Bi). As presented, the data in Figure 4.17Ai suggest that the 
PVCs from 3 month-old mice used in these experiments did not show a significant 
reduction in the frequency of spontaneous Ca2+ signals following incubation with JTV-519 
(Figure 4.17Ai), in contrast to the results presented in Figure 4.11. Categorising the data 
into low (Figures 4.17 Aii and Bii) and high (Figures 4.17 Aiii and Biii) frequency cells 
establishes a significant effect of JTV-519.  
JTV-519 did indeed reduce the frequency of spontaneous events in PVCs from both 3 
month- and 24 month-old mice. However, the action of JTV-519 was limited to PVCs that 
displayed a high frequency of spontaneous Ca2+ signals at the onset of the experiment (3 
month- vs. 24 month-old PVCs; 0.7 ± 0.05 vs. 1.3 ± 0.16 Hz respectively). JTV-519 did not 
appear to affect PVCs of either age that had a low frequency of spontaneous Ca2+ signals 
(3 month- vs. 24 month-old PVCs; 0.21 ± 0.04 vs. 0.23 ± 0.03 Hz respectively). 
The frequency of spontaneous Ca2+ signals during Run 2 (i.e. after the 10-minute JTV-519 
superfusion) was typically between 0.2 – 0.3 Hz for PVCs from PVCs from both 3 month- 
and 24 month-old mice (Figures 4.16 and 4.17). These observations indicate that JTV-519 
can reduce the occurrence of spontaneous Ca2+ signals by 50 – 84%, but it is only effective 
in situations where PVCs are highly spontaneously active (Figure 4.17Aiii – 4.17Biii).  
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Figure 4.17. Effect of JTV-519 on spontaneous Ca2+ signals in PVCs from 3 month- and 24 
month-old mice. The data were obtained from experiments such as those depicted in 
Figure 4.15, but with superfusion of 100 µM JTV-519. Panels Ai and Bi show the effect of 
JTV-519 on the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 
month-old mice, respectively. Panels Aii-Aiii and Bii-Biii show the effect of JTV-519 on the 
frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 month-old mice 
following categorisation of the cells into those that initially showed either low (< 0.5 Hz) 
or high (≥ 0.5 Hz) frequency of spontaneous Ca2+ signals. The data are presented as mean 
± S.E.M., and were analysed with paired Student’s t-tests. * and ** indicate P < 0.05 and P 
< 0.01, n = 10 slices from 4 animals.  
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4.6.2. Effect of RyR2 inhibition using dantrolene on spontaneous Ca2+ signals in 
PVCs from 3 month- and 24 month-old mice 
 
Although dantrolene was found to be ineffective in reducing spontaneous Ca2+ signals in 
NRVMs (Figures 4.6 and 4.7), it was tested on PVCs in case it was more efficacious on fully 
differentiated cells. The same experimental protocol described in Section 4.6.1 was used: 
Run 1: 
1. 35-second recording of spontaneous activity.  
Following Run 1, 100 µM dantrolene (or HBSS as a control) was superfused over the lung 
slices whilst they were maintained on the microscope stage. Following a 10-minute 
incubation period, Run 2 was initiated.  
Run 2: 
1. 35-second recording of spontaneous activity.  
This protocol was repeated using PVCs from 3 month- and 24 month-old animals. For 
these experiments, spontaneous Ca2+ signals were recorded using 2D confocal imaging at 
10 Hz. The quantitative analyses of the effects of dantrolene superfusion are presented in 
Figure 4.18.  
Collectively plotting all the data obtained from the experiments involving dantrolene 
indicated that there was no significant effect of the reagent on the frequency of 
spontaneous Ca2+ signals in PVCs obtained from either 3 month- or 24 month-old mice 
(Figure 4.18A and B). Moreover, categorising the PVCs into ‘low frequency’ or ‘high 
frequency’ cells based on their initial frequency of spontaneous Ca2+ signals (as was done 
for the results with JTV-519 above) did not reveal any significant effect of dantrolene 
superfusion (Figure 4.18Aiii and 4.18Biii). 
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Figure 4.18. Effect of dantrolene on spontaneous Ca2+ signals in PVCs from 3 month- and 
24 month-old mice. The data were obtained from experiments such as those depicted in 
Figure 4.15, but with superfusion of 100 µM dantrolene. Panels Ai and Bi show the effect 
of dantrolene on the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 
month-old mice, respectively. Panels Aii-Aiii and Bii-Biii show the effect of dantrolene on 
the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 month-old mice 
following categorisation of the cells into those that initially showed either low (< 0.5 Hz) 
or high (≥ 0.5 Hz) frequency of spontaneous Ca2+ signals. The data are presented as mean 
± S.E.M., and were analysed with paired Student’s t-tests. n = 13 – 15 from 5 animals per 
age group in Panels A and B. 
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4.6.3. Effect of RyR2 inhibition with carvedilol in PVCs from 3 and 24 month-old 
mice 
Since the two RyR inhibitors used in the experiments described above, JTV-519 and 
dantrolene, had differing effects on spontaneous Ca2+ signals in PVCs, a third RyR 
inhibitor, carvedilol, was also tested. Carvedilol has been used extensively in treating 
cardiovascular diseases (Zhou et al., 2011), but has not been tested in PVCs. However, 
unlike JTV-519 which mainly targets RyR2, the action of carvedilol is less specific. In 
addition to RyR2 inhibition, carvedilol antagonises α- and β-adrenoceptors. Indeed, one 
of the principle clinical applications of carvedilol is as a ‘beta blocker’ to reduce 
hypertension (Farha et al., 2017). 
The same experimental protocol described in Section 4.6.1 was used: 
Run 1: 
1. 35-second recording of spontaneous activity.  
Following Run 1, 100 µM carvedilol (or HBSS as a control) was superfused over the lung 
slices whilst they were maintained on the microscope stage. Following a 10-minute 
incubation period, Run 2 was initiated.  
Run 2: 
1. 35-second recording of spontaneous activity.  
This protocol was repeated using PVCs from 3 month- and 24 month-old animals. For 
these experiments, spontaneous Ca2+ signals were recorded using 2D confocal imaging at 
10 Hz. The quantitative analysis of the effects of carvedilol superfusion are presented in 
Figure 4.19.  
Collectively plotting all the data obtained from the experiments involving carvedilol 
indicated that there was a significant reduction of the frequency of spontaneous Ca2+ 
227 
 
signals in PVCs obtained from 3 month-old mice (Figure 4.19A), but not in PVCs obtained 
from 24 month-old mice (Figure 4.19B). PVCs were categorised into ‘low frequency’ (< 0.5 
Hz) or ‘high frequency’ (≥ 0.5 Hz) cells based on their initial frequency of spontaneous 
Ca2+ signals (as was done for the results with JTV-519 and dantrolene above). This 
categorisation revealed that carvedilol superfusion had a significant effect on PVCs 
obtained from both 3 month- and 24 month-old mice that had a high initial frequency of 
spontaneous Ca2+ signals (Figure 4.19Aiii and 4.19Biii). 
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Figure 4.19. Effect of carvedilol on spontaneous Ca2+ signals in PVCs from 3 month- and 
24 month-old mice. The data were obtained from experiments such as those depicted in 
Figure 4.15, but with superfusion of 100 µM carvedilol. Panels Ai and Bi show the effect 
of carvedilol on the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 
month-old mice, respectively. Panels Aii-Aiii and Bii-Biii show the effect of carvedilol on 
the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 24 month-old mice 
following categorisation of the cells into those that initially showed either low (< 0.5 Hz) 
or high (≥ 0.5 Hz) frequency of spontaneous Ca2+ signals. The data are presented as mean 
± S.E.M., and were analysed with paired Student’s t-tests. * and ** indicate P < 0.05 and P 
< 0.01, respectively. n = 17 - 18 from 6 animals per age group in Panels A and B. 
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4.6.3. Effect of propranolol on PVCs from 3 and 24 month-old mice  
As mentioned previously, carvedilol is not solely a RyR inhibitor, but also acts as an 
antagonist of α- and β-adrenoceptors (α/β-adrenoceptors). Moreover, it has been 
previously reported that the spontaneous electrical activity (firing rate) in PVCs could be 
increased by stimulating α/β-adrenoceptors using 10 nM and 1 µM isoproterenol (Chen et 
al., 2008, Chen et al., 2014). A potential contribution of α/β-adrenoceptors to the 
generation of spontaneous Ca2+ signals observed in PVCs was therefore examined using 
propranolol, which is a specific α/β-adrenoceptors antagonist and has been shown not to 
affect RyR2s in cardiac myocytes (Zhou et al., 2011).  
Run 1: 
1. 35-second recording of spontaneous activity.  
Following Run 1, 100 µM propranolol (or HBSS as a control) was superfused over the lung 
slices whilst they were maintained on the microscope stage. Following a 10-minute 
incubation period, Run 2 was initiated.  
 
Run 2: 
1. 35-second recording of spontaneous activity.  
This protocol was repeated using PVCs from 3 month- and 24 month-old animals. For 
these experiments, spontaneous Ca2+ signals were recorded using 2D confocal imaging at 
10 Hz. The quantitative analysis of the effects of propranolol superfusion are presented in 
Figure 4.20.  
Collectively plotting all the data obtained from the experiments involving propranolol 
indicated that there was no significant effect of the reagent on the frequency of 
spontaneous Ca2+ signals in PVCs obtained from either 3 month- or 24 month-old mice 
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(Figure 4.20A and B). Moreover, categorising the PVCs into ‘low frequency’ or ‘high 
frequency’ cells based on their initial frequency of spontaneous Ca2+ signals (as was done 
for the results with JTV-519 above). This categorisation revealed that propranolol 
superfusion had no significant effect on PVCs obtained from both 3 month- and 24 
month-old mice that had a high initial frequency of spontaneous Ca2+ signals (Figure 
4.20Aiii and 4.20Biii). 
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Figure 4.20. Effect of propranolol on spontaneous Ca2+ signals in PVCs from 3 month- 
and 24 month-old mice. The data were obtained from experiments such as those 
depicted in Figure 4.15, but with superfusion of 100 µM propranolol. Panels Ai and Bi 
show the effect of propranolol on the frequency of spontaneous Ca2+ signals in PVCs from 
3 month- and 24 month-old mice, respectively. Panels Aii-Aiii and Bii-Biii show the effect 
of propranolol on the frequency of spontaneous Ca2+ signals in PVCs from 3 month- and 
24 month-old mice following categorisation of the cells into those that initially showed 
either low (< 0.5 Hz) or high (≥ 0.5 Hz) frequency of spontaneous Ca2+ signals. The data 
are presented as mean ± S.E.M., and were analysed with paired Student’s t-tests. n = 10 – 
11 slices from 4 animals per age group in Panels A and B. 
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4.6.4. Activation of adrenoceptors in PVCs from 3 and 24 month-old mice  
To further investigate the putative role of α/β-adrenoceptors in causing spontaneous Ca2+ 
signals within PVCs, lung slices were superfused with a combination of norepinephrine 
(100 µM) and isoprenaline (100 µM). 
To examine the effects of norepinephrine (100 µM) and isoprenaline (100 µM), the 
following protocol was protocol was carried out: 
Run 1 
35-second recording of spontaneous activity 
Following Run 1, norepinephrine (100 µM) and isoprenaline (100 µM) (or HBSS as a 
control) were superfused over the lung slices whilst they were maintained on the 
microscope stage. Following a 10-minute incubation period, Run 2 was initiated.  
Run 2 
35-second recording of spontaneous activity 
This protocol was repeated using PVCs from 3 month- and 24 month-old animals. For 
these experiments, spontaneous Ca2+ signals were recorded using 2D confocal imaging at 
10 Hz. The quantitative analysis of the effects of 100 µM isoprenaline and 100 µM 
norepinephrine superfusion are presented in Figure 4.21. 
There was no change in the frequency of spontaneous Ca2+ signals in PVCs from 3 month- 
and 24 month-old mice following 10 minutes of norepinephrine and isoprenaline 
superfusion (Figure 4.21). Together with the observations made using propranolol (Figure 
4.20), these data suggest that the effects of carvedilol presented in Figure 4.19 were 
caused by inhibition of RyRs, rather than being due to antagonism of α/β-adrenoceptors. 
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Figure 4.21. Effect of norepinephrine and isoprenaline on spontaneous Ca2+ signals in 
PVCs from 3 month- and 24 month-old mice. The data were obtained from experiments 
such as those depicted in Figure 4.15, but with superfusion of norepinephrine and 
isoprenaline (100 µM of each). Panels Ai-Aiii and Bi-Biii show the effect of 
norepinephrine and isoprenaline on the frequency of spontaneous Ca2+ signals in PVCs 
from 3 month- and 24 month-old mice, respectively. The data are presented as mean ± 
S.E.M., and were analysed with paired Student’s t-tests. n = 10 slices from 4 animals per 
age group. 
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4.7. Assessing the production of reactive oxygen species production in PVCs from 
3 month- and 24 month-old mice 
The production of reactive oxygen species (ROS) has been reported to increase during 
ageing in ventricular myocytes (Cooper et al., 2013). In particular, a deterioration of 
mitochondria during ageing often leads to an increased ROS production (Turdi et al., 
2010). The data presented in Chapter 3 showed alterations in mitochondrial 
characteristics in PVCs from 24 month-old mice, consistent with a change in 
mitochondrial function. These observations provoke the question whether an increase in 
ROS was responsible for some of the differences in the frequency of spontaneous Ca2+ 
signals in PVCs from 3 month- and 24 month-old mice. To assess ROS production, slices 
from both 3 month- and 24 month-old mice were incubated with 50 µM ROS Brite (a 
fluorescence ROS indicator) for 30 minutes at 37°C before collecting images on the Zeiss 
510 META laser scanning microscope. When loaded into cells, ROS Brite increases its 
fluorescence intensity when modified by various ROS. Care was taken to ensure that the 
ROS Brite loading and imaging conditions were exactly the same in all experiments so that 
ROS production could be compared in PVCs obtained from 3 month- and 24 month-old 
mice.  
Images of ROS Brite-loaded PVCs are presented in Figure 4.22A-C. It was evident that 
PVCs from 3 month-old mice (Figure 4.22A) displayed a significantly lower ROS Brite 
fluorescence than cells from 24 month-old animals (Figure 4.22B and C). The bright 
structure with a wavy appearance in the ROS Brite images is collagen, which exhibits 
substantial autofluorescence. The ROS levels within the PVCs were quantified by placing a 
ROI over whole cells within lung slice from 3 month- and 24 month-old mice and sampling 
the ROS Brite fluorescence intensity (Figure 4.22C). ROS Brite fluorescence was 
significantly greater in PVCs obtained from 24 month-old mice compared to that recorded 
in cells from 3 month-old mice (Figure 4.22D). 
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Figure 4.22. Quantitative assessment of ROS production in PVCs from 3 month- and 24 
month-old mice. Panel A shows a representative image of PVCs from 3 month-old mice 
loaded with the fluorescent ROS indicator ROS Brite. Panel B shows a representative 
image of ROS Brite-loaded PVCs from 24 month-old mice. Panel C illustrates an example 
of a PVC outlined to measure ROS fluorescence. Panel D indicates the average ROS Brite 
fluorescence in PVCs from 3 month- and 24 month-old animals. The data presented as 
mean ± S.E.M., and were analysed using an unpaired Student’s t-test, * indicates P < 0.05. 
n = 34 – 35 cells, 9 slices from 4 animals per age group.  
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The data presented in this study, and in others (Honjo et al., 2003, Wang et al., 2005, 
Logantha et al., 2010), have clearly shown that stochastic RyR activity is responsible the 
spontaneous Ca2+ signals observed in PVCs. It is widely accepted that ROS induces 
activation of RyR2 in cardiac myocytes (Cooper et al. 2013), and it is therefore plausible 
that increased ROS production contributed to the greater frequency of spontaneous Ca2+ 
signals in PVCs from older animals. This hypothesis was examined by increasing the ROS-
buffering capacity of PVCs by loading them with the ROS scavenger Trolox (100 µM), and 
then subsequently characterising the frequency of spontaneous Ca2+ signals and fidelity 
of pacing in response to EFS pulses.  
To analyse the effects of 100 µM Trolox in PVCs, lung slices were incubated in either 
(HBSS with/without 100 µM Trolox) for 24 hours at 37°C prior imaging. The following day, 
the protocol below was carried-out. 
1. 18-second line-scan recording of spontaneous activity in either (HBSS +/- 100 µM 
Trolox). 
2. 18-second line-scan recording during application of 1 Hz in (HBSS +/- 100 µM Trolox). 
3. 18-second line-scan recording during application of 3 Hz in (HBSS +/- 100 µM Trolox). 
4. 18-second line-scan recording during application of 5 Hz in (HBSS +/- 100 µM Trolox). 
Cal-520-loaded PVCs were imaged using confocal line-scanning at 333 Hz. PVCs were 
incubated in (HBSS +/- 100 µM Trolox) throughout the recording period whilst they were 
maintained on the stage of the microscope. 
As described in section 4.5, spontaneous Ca2+ signals occurred with a high frequency in 
PVCs obtained from 24 month-old mice, compared to those from 3 month-old animals 
237 
 
(Figure 4.23A). Incubation of lung slices with Trolox significantly decreased the frequency 
of spontaneous Ca2+ signals in PVCs from both young and old animals (Figure 4.24A).  
Consistent with results presented in section 4.3.2, PVCs within lung slices obtained from 
24 month-old animals were more difficult to successfully pace with EFS than cells from 3 
month-old animals (Figure 4.23B - D). Moreover, similar to the results presented in 
section 4.3.2 the ability to successful pace the PVCs declined at both ages if the 
stimulation frequency was increased from 1 Hz to 3 or 5 Hz (Figure 4.23B - D). Incubation 
of slices with Trolox did not significantly increase the proportion of cells at either age that 
were successfully paced at a specific EFS frequency (i.e. 1, 3 or 5 Hz). However, for PVCs 
from 24 month-old mice, there was a trend for Trolox to improve the proportion of cells 
that were successfully paced at each of the frequencies tested. Due to a lack of 24 month-
old animals, these experiments could not be sufficiently repeated to have the same n 
number as in other protocols, and likely obtain statistical significance. It is intended that 
future studies will complete the data set.  
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Figure 4.23. Effects of the ROS scavenger Trolox on the spontaneous Ca2+ signals in PVCs 
from 3 month- and 24 month-old mice. Panel A shows the frequency of spontaneous 
Ca2+ signals in PVCs from 3 month- and 24 month-old mice, either without or following 
incubation with 100 µM Trolox for 24 hours. Panels B – D show the percentage of regions 
within lung slices from 3 month- and 24 month-old mice that were successfully paced 
with 1, 3 or 5 Hz EFS, either without or following incubation with 100 µM Trolox for 24 
hours. The data are presented as mean ± S.E.M., and were analyses using an unpaired 
Student’s t-test. * denotes P < 0.05. n = 8 slices from 4 animals per age group. 
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4.8. Analysis of mitochondrial function in PVCs from 3 month- and 24 month-old 
mice 
To assess the mitochondrial function in PVCs from 3 month- and 24 month-old mice, lung 
slices from both age groups were treated with 5 µM antimycin and 5 µM oligomycin 
(hereafter denoted ‘anti/oligo’). Together, these reagents lead to mitochondrial 
depolarisation, prevent mitochondrial respiration, and abrogate ATP production or 
consumption by the F1F0 ATP synthase (Hung et al., 2012, Zhao et al., 2013, Leonard et al., 
2014). As a control, 5 µM oligomycin was added by itself to solely inhibit the F1F0 ATP 
synthase without mitochondrial depolarisation. The effects of anti/oligo on spontaneous 
Ca2+ signals in PVCs, and the ability of PVCs to be paced by EFS, was analysed using a 
similar protocol to that presented in section 4.4.2, as follows:  
Run 1: 
1. 18-second line-scan recording of spontaneous activity.  
2. 18-second recording during application of 1 Hz EFS. 
Following Run 1, anti/oligo (or HBSS as a control) was superfused over the lung slices 
whilst they were maintained on the microscope stage. Following a 5-minute incubation 
period, Run 2 was initiated.  
Run 2: 
1. 18-second line-scan recording of spontaneous activity.  
2. 18-second recording during application of 1 Hz EFS. 
Cal-520-loaded PVCs were imaged using confocal line-scanning at 333 Hz. Anti/oligo and 
oligomycin solutions were superfused over the cells while they were maintained on the 
stage of the microscope.  
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Line-scans and Ca2+ traces of the spontaneous Ca2+ signals in PVCs from 3 month- and 24 
month-old mice, and responses to EFS pulses, are presented in Figure 4.24. In keeping 
with the data described earlier in this study, both Ca2+ waves and local Ca2+ transients 
were observed in the PVCs (Figure 4.24Ai and Bi). For the examples shown, the PVCs from 
both the 3 month- and 24 month-old animals both displayed regular responses to 1 HZ 
EFS application (Figure 4.24Aii and Bii).  
 
Quantitative analyses of the effect of anti/oligo on spontaneous Ca2+ signals in PVCs from 
3 month- and 24 month-old animals, and their ability of PVCs to be paced by EFS, are 
presented in Figure 4.25. Anti/oligo treatment had inconsistent effects on spontaneous 
Ca2+ signals in PVCs from 3 month- and 24 month-old animals, although there was a 
notable decrease in the frequency and/or amplitude of Ca2+ waves. There was a 
significant reduction in the ability of PVCs from 3 month-old mice slices to follow 1 Hz EFS 
after anti/oligo treatment (Figure 4.25Aiv, whereas PVCs from 24 month-old animals 
were not affected (Figure 4.25Biv).  
The fact that the treatment with oligomycin alone, thus inhibiting the ATP production 
without affecting the mitochondrial membrane potential, generally did not affect the Ca2+ 
signalling parameters measured (apart from the frequency of Ca2+ waves, Figure 4.25Ai) 
indicates that the observed effects are caused by the changes in the mitochondrial 
membrane potential. The duration of spontaneous Ca2+ signals was not affected by 
anti/oligo superfusion (Figure 4.26).   
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Figure 4.24. Effects of oligomycin + antimycin treatment on spontaneous Ca2+ signals 
and EFS pacing in PVCs from 3 month- and 24 month-old mice. Panels Ai and Aii show 
spontaneous Ca2+ signals and EFS-induced Ca2+ transients prior to superfusion with a 
solution containing 5 µM oligomycin and 5 µM antimycin for 5 minutes in PVCs from both 
age groups. Panels Bi and Bii show spontaneous Ca2+ signals and EFS-induced Ca2+ 
transients following the superfusion with a solution containing 5 µM oligomycin and 5 µM 
antimycin for 5 minutes. All scale bars represent 20 µm. 
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Figure 4.25. Effect of antimycin and oligomycin, or oligomycin alone, on Ca2+ signals in 
PVCs from 3 month- and 24 month-old mice. Panels Ai and Bi show the frequency of Ca²⁺ 
waves. Panels Bi and Bii illustrate the frequency of local Ca2+ transients. Panels Aiii and 
Biii show the amplitude of Ca2+ waves. Panels Aiv and Biv represent the percentage of 
slices following 1 Hz EFS from 3 month- and 24 month-old mice before or after 
superfusion with a combination of antimycin and oligomycin, or oligomycin only. The data 
are presented as mean ± S.E.M., and were analysed using paired t-tests, * indicates P < 
0.05. n = 7 – 11 slices from 3 animals per age group. 
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Figure 4.26. Effects of antimycin and oligomycin, or oligomycin alone, on the duration of 
Ca2+ transients in PVCs from 3month- and 24 month-old animals. Panels Ai and Bi show 
representative examples of Ca²⁺ waves in PVCs from 3 month- and 24 month-old mice 
before and after superfusion with 5 µM anti/oligo. Panels Aii and Bii show representative 
examples of Ca²⁺ waves in PVCs from 3 month- and 24 month-old mice before and after 
superfusion with 5 µM oligomycin. Panels C and D quantify the durations of Ca²⁺ 
transients in PVCs from 3 month- and 24 month-old mice before and after superfusion 
with 5 µM anti/oligo, or oligomycin alone. The data are presented as mean ± S.E.M., and 
were analysed using paired t-tests. n = 8 – 10 slices from 3 animals per age group. 
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4.9. Summary 
1. Lung slices are a viable way to study PVC function; the PVCs maintain cell-cell 
contacts, organisation and orientation, they have low basal Ca2+ levels, display 
frequent spontaneous Ca2+ signals and demonstrate excitation-contraction 
coupling.  
2. Ca2+ signals occurring in PVCs within lung slices from 3 month- and 24 month-old 
mice could be readily visualised using confocal imaging. The single wavelength 
Ca2+ indicator Cal-520 was ideal for visualising both spontaneous Ca2+ signals and 
EFS-induced Ca2+ transients. For reasons that are not fully known, PVCs 
preferentially loaded with Cal-520 (compared to their neighbouring endothelial 
and smooth muscle cells), which aided their identification and visualisation in 
imaging experiments. 
3. PVCs displayed heterogeneous, complex patterns of spontaneous Ca2+ signals 
ranging from localised events occurring over a few micrometers and lasting for a 
hundreds of milliseconds, as well as Ca2+ waves that initiate as local signals but can 
propagate throughout the entirety of a PVC. Although most PVCs behaved as 
isolated Ca2+ signalling entities, a Ca2+ wave in one cell could occasionally trigger a 
response in an adjacent cell. 
4. The spontaneous Ca2+ signals (local Ca2+ signals and Ca2+ waves) and EFS-induced 
Ca2+ transients could be distinguished on the basis of amplitude and kinetics, as 
well as their appearance in line-scans and 2D images. 
5. In addition to their heterogeneity in spontaneous Ca2+ signals, PVCs show differing 
responses to EFS. Adjacent cells, which are likely to receive the same degree of 
electrical stimulation, do not show the same patterns of pacing in response to a 
train of EFS pulses. 
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6. NRVMs were used to test the efficacy of reagents that affect cardiac myocyte Ca2+ 
signals. JTV-519, carvedilol and BTP2 had significant effects on the occurrence of 
spontaneous Ca2+ transients in NRVMs, but also negatively affected the proportion 
of cells that could be paced by EFS. 
7. After testing on NRVMs, the Ca2+ signalsome-affecting reagents were applied to 
PVCs in order to establish whether spontaneous Ca2+ signals could be inhibited 
with a concomitant improvement in the fidelity of EFS pacing. The results 
obtained using PVCs were broadly similar to those observed with NRVMs; some of 
the reagents (e.g. JTV-519 and BTP2) reduced various aspects of spontaneous Ca2+ 
signals, but they also caused significant decrease in the ability of PVCs to follow 
EFS pacing.  
8. PVCs from 24 month-old mice displayed a significantly high frequency of 
spontaneous Ca2+ signals compared to PVCs from 3 month-old mice, and were 
more difficult to pace using EFS. 
9. PVCs from 24 month-old mice tended to show more Ca2+ signal alternans and 
irregular responses than PVCs from 3 month-old mice.  
10. Ca2+ signalsome-affecting reagents were used to investigate whether they could 
reduce the spontaneous Ca2+ signals in PVCs from 24 month-old mice. JTV-519 and 
carvedilol both significantly reduced the occurrence of spontaneous Ca2+ signals. 
However, they were only effective on cells that had a high frequency of 
spontaneous Ca2+ signals prior to reagent superfusion. 
11. PVCs from 24 month-old mice displayed a higher rate of ROS production than 
PVCs from 3 month-old mice.  
12. Application of the Trolox to PVCs to buffer ROS production significantly reduced 
the frequency of spontaneous Ca2+ signals in cells from both 3 month- and 24 
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month-old animals. However, while there was a trend for improved EFS-induced 
pacing of the PVCs from 24 month-old mice, it was not statistically significant with 
the data set available in this study. 
13. Using a combination of antimycin + oligomycin to cause inhibition of 
mitochondrial electron transport, concomitant with mitochondrial depolarisation, 
altered some aspects of spontaneous Ca2+ signals in PVCs from 3 month-old mice, 
but also significantly reduced the ability of the cells to follow EFS pacing. PVCs 
from 24 month-old mice we much less affected by application of antimycin + 
oligomycin.  
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4.10. Discussion 
It is established that electrical activity arising from PVCs in the pulmonary veins causes AF 
(Haissaguerre et al., 1998, Chen et al., 1999, Sueda et al., 2005). However, the 
mechanism(s) underlying the generation of ectopic action potentials within PVCs are not 
clear. A number of studies have proposed that spontaneous Ca²⁺ signals contribute to the 
pro-arrhythmic activity of cardiac myocytes (Vest et al., 2005, Neef et al., 2010, Tsuneoka 
et al., 2012, Voigt et al., 2012). Indeed, altered Ca²⁺ homeostasis in atrial cardiac 
myocytes is one of the factors thought to contribute to the development and 
maintenance of AF during ageing (Lai et al., 1999; Vest et al., 2005; Zhu et al., 2005; 
Wongcharoen et al., 2007; Voigt et al., 2012). Consequently, the work described in this 
Chapter characterised aspects of Ca²⁺ signalling in PVCs to help elucidate the pro-
arrhythmic nature of these cells. Since the incidence of AF increases with age (Hayashi et 
al., 2002, Nattel et al., 2008), differences in Ca²⁺ signalling between PVCs from 3 month- 
and 24 month-old mice were examined to gain an insight into the changes that may occur 
during ageing.     
PVCs utilise the same excitation-contraction coupling machinery as atrial and ventricular 
myocytes (Tsuneoka et al., 2012, Rietdorf et al., 2014). However, they appear to have a 
greater propensity to show spontaneous Ca2+ signals (Logantha et al., 2010, Rietdorf et 
al., 2014, Rietdorf et al., 2015). The first observation of spontaneous activity involving 
PVCs was reported in 1876, when Brunton and Fayrer observed an independent pulsation 
of a rabbit pulmonary vein after all motion had ceased in the heart (Brunton and Fayrer, 
1876). Since then, a number of studies have characterised the structure of PVCs, as well 
as their electrophysiological and Ca²⁺-handling properties (Ho et al., 2001, Chen et al., 
2002, Ehrlich et al., 2003, Okamoto et al., 2008, Schotten et al., 2011), but as yet a 
definitive mechanism for the spontaneous Ca²⁺ signalling in PVCs is unclear. While the 
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mechanism causing spontaneous Ca²⁺ signals may be unclear, previous work has 
demonstrated that such spontaneous events can prevent PVCs from being electrically 
paced (Rietdorf et al., 2014, Rietdorf et al., 2015). Principle aims of this study were to 
probe the cellular Ca2+  sources of that are responsible for spontaneous Ca2+ signals in 
PVCs, and to examine whether it is possible to prevent these events in order to promote 
fidelity in EC-coupling. In addition to corrupting pacing, spontaneous Ca²⁺ signals can lead 
to arrhythmias via a variety of mechanisms, such as the triggering of electrical events, as 
described in Chapter 1. It is therefore beneficial to gain a clear understanding of how 
spontaneous Ca²⁺ signals may occur in PVCs in order to develop therapies to prevent the 
induction of AF.  
The data presented in this Chapter shows that blocking the supply of Ca2+ from different 
sources within PVCs can reduce various aspects of spontaneous Ca²⁺ signalling. Of the 
reagents used, verapamil, BTP2 and JTV-519 were the most efficacious in reducing the 
frequency of spontaneous Ca²⁺ signals in PVCs from 3 month-old mice (see section 4.4 
above). However, whilst these compounds reduced spontaneous Ca²⁺ signalling, they had 
a negative impact on EC-coupling because fewer cells responded to EFS pulses (Figure 
4.9). These data indicate that it may be difficult to dissociate the Ca²⁺ sources that 
promote spontaneous Ca²⁺ signals from those Ca²⁺ sources required for EC-coupling. 
Further experiments could use lower concentrations of the reagents employed in this 
study, in order to preserve EC-coupling. However, even at the relatively high reagent 
concentrations used in this study, there was sometimes a modest inhibition of 
spontaneous Ca²⁺ signalling (see sections 4.4 and 4.6.1). It is therefore unlikely that lower 
concentrations of the reagents would have a significant effect on spontaneous Ca²⁺ 
signals and deter them from interfering with pacing of PVCs. 
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The contribution of VOCCs to spontaneous Ca²⁺ signalling in PVCs was investigated using 
verapamil (100 µM), which caused a significant reduction in the frequency and amplitude 
of Ca2+ waves (Figure 4.7). These findings agree with previous results where the VOCCs 
antagonist nifedipine (100 µM) also reduced spontaneous Ca²⁺ signalling (Rietdorf et al., 
2014). In that earlier study, it was observed that spontaneous Ca²⁺ signalling continued in 
the presence of nifedipine, but the Ca²⁺ signals progressively declined in amplitude and 
frequency over tens of minutes. These observations indicate that spontaneous Ca²⁺ 
signalling in PVCs is not directly triggered by Ca2+ influx via VOCCs, but that VOCCs are 
needed to sustain the spontaneous Ca²⁺ signals, plausibly by supplying Ca2+ to replenish 
the SR. This notion is further supported by the previous findings that removal of Ca2+ from 
extracellular medium caused a progressive reduction in the frequency and amplitude of 
Ca2+ waves (Logantha et al., 2010, Rietdorf et al., 2014). The results presented in this 
study did not differentiate between different sub-types of VOCCs that may be involved in 
the generation of spontaneous Ca²⁺ signals. Verapamil has been shown to inhibit both L-
type and T-type Ca2+ channels (Bergson et al., 2011), and PVCs have been shown to 
express both L-type and T-type Ca2+ channels (Chen et al., 2004, Logantha et al., 2010). It 
is plausible that either, or both, types of VOCCs could be involved in the maintenance of 
spontaneous Ca²⁺ signals. It would be of interest, in future studies, to examine if 
spontaneous Ca²⁺ signals are more susceptible to inhibition of a particular VOCCs sub-
type. 
The pyrazole derivative BTP2 was used in this study to explore the possible contribution 
of SOCE to PVC Ca²⁺ signalling. BTP2 has been used in other studies as a SOCE antagonist 
and has been shown to block Ca2+ influx without affecting K+ transport or VOCCs (Zitt et 
al., 2004, He et al., 2005). BTP2 has also been used to inhibit SOCE and was able to reduce 
SR Ca2+ content and firing rate in SA node cells  (Liu et al., 2015). In non-electrically 
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excitable cells, SOCE is activated by depletion of Ca2+ from intracellular stores, which 
causes the formation of a signalling complex involving members of the STIM1 and Orai 
protein families (Hogan et al., 2015). STIM1 and STIM2 function as sensors of Ca2+ within 
intracellular stores, and following depletion of Ca2+ stores they interact with Orai1, Orai2 
and Orai3 proteins on the plasma membrane to form channels (often denoted ‘CRAC’ for 
Ca²⁺ release-activated channel) that allow Ca2+ into the cytosol (Vig et al., Feske et al., 
2005; Feske et al., 2006). In non-electrically excitable cells, SOCE has been established as 
a key source of Ca²⁺ and its role is to replenish endoplasmic reticulum Ca2+ after activation 
of channels such as inositol 1,4,5-trisphosphate receptors (Mathews et al., 1989). 
However, although the molecular components responsible for SOCE (STIM1, STIM2 and 
Orai channels) are expressed in cardiac myocytes, the role of SOCE in the heart is unclear 
(Bootman and Rietdorf, 2017). Nevertheless, recent studies have shown that SOCE plays a 
role in Ca2+ homeostasis in some excitable cell types (Touchberry et al., 2011; Liu et al., 
2015). For example, SOCE plays an important role in vascular contraction; Ca2+ influx 
induced by store depletion activated pulmonary artery and arterial smooth muscle 
contraction (Snetkov et al., 2003; Bergdahl et al., 2005). Additionally, SOCE is involved in 
maintaining pacemaker currents in SA node cells (Liu et al., 2015).  
At present, it is unclear what role SOCE may play, if any, in PVCs. Moreover, it remains to 
be established whether PVCs express STIM and Orai proteins (although their expression is 
near ubiquitous in mammalian tissues). The results presented here show that BTP2 
significantly reduced the frequency of spontaneous Ca2+ signals, increased the duration of 
spontaneous Ca2+ waves and inhibited electrical pacing (Figures 4.5, 4.7, 4.8). However, 
whilst it is possible that there may be a role for SOCE as a source of Ca2+ for PVCs, it is not 
realistic to develop firm conclusions based on the use of one reagent. Moreover, the fact 
that BTP2 could completely inhibit both spontaneous Ca2+ signals and EFS-induced Ca2+ 
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transients (Figure 4.6) suggests that the reagent is not fully specific for SOCE, and should 
be used with caution (at least for studies involving cardiac myocytes).  
NCX is the dominant mechanisms for extrusion of Ca2+ out of electrically excitable cells 
(Bassani et al., 1994, Pieske et al., 1999, Bers 2002, 2008). In its forward electrogenic 
mode, the NCX extrudes 1 Ca2+ in exchange for 3 Na+, thus generating a net inward 
electrical current that depolarises the membrane potential. Conversely, immediately after 
a myocyte depolarises, the exchanger generates an outward current due to its reverse 
mode i.e. an increased in the efflux of Na+ and an influx of Ca2+. This outward current 
contributes to the initial repolarisation phase (Bers, 2000). NCX expression has been 
shown to be upregulated in AF, contributing to the generation of EADs and DADs, and 
thereby promoting arrhythmias (Patterson et al., 2006; Venetucci et al., 2007; Okamoto 
et al., 2012). Previous studies have established that NCX plays a role in extruding Ca2+ in 
PVCs, and may be involved in the generation of spontaneous electrical activity (Patterson 
et al., 2006; Namekata et al., 2009; Okamoto et al., 2012). For example, it was shown that 
the forward mode of NCX is activated in PVCs by increasing the SR Ca2+ load using the 
Na+/K+ ATPase inhibitor Ouabain, leading to spontaneous electrical events (Namekata et 
al., 2009). Moreover, inhibiting Ca2+ release from the SR within PVCs using 10 µM 
Ryanodine prevented both NCX current activation and EADs (Patterson et al., 2006).  
In this study, SN-6 (10 µM) was used to inhibit NCX-mediated Ca2+ transport. SN-6 did not 
affect the frequency of Ca2+ waves, but it did reduce that of the local Ca2+ transients 
(Figure 4.7). In addition, SN-6 significantly reduced the amplitude of Ca2+ in waves, but did 
not significantly alter the ability of PVCs to follow 1 Hz EFS (Figure 4.8). Similar to our 
findings, Ghandi et al., (2013) showed that 10 µM SN-6 reduced spontaneous peak 
amplitude of Ca2+ transients (Gandhi et al., 2013). However, they also showed that SN-6 
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also inhibited L-type VOCCs. In this study, the VOCCs inhibitor verapamil and the NCX 
inhibitor SN-6 were the only two reagents that reduced the amplitude of Ca2+ waves, 
raising the possibility that Ca2+ influx via VOCCs somehow specifically enhances the 
amplitude of these signals. Further studies are required to elucidate the roles of VOCCs 
and NCX for Ca2+ signalling in PVCs. 
It has been established that the spontaneous Ca²⁺ signals in PVCs occur due the activation 
of RyRs (Honjo et al., 2003, Wang et al., 2005, Logantha et al., 2010). Therefore, the 
effects JTV-519, a RyR inhibitor that is currently used in clinical trials, were examined. JTV-
519 has been shown to inhibit RyR2 activation by increasing the binding of FK506-binding 
proteins (FKBPs) to RyR2 (Shou et al., 1998; Vest et al., 2005; Dobrev et al., 2012). A 
number of studies have demonstrated that both FKBP12 and FKBP12.6 can regulate RyR2 
activity by stabilising the channel in a closed state, and thereby decreasing both the open 
probability and Ca²⁺ flux (Timerman et al., 1993, Galfré et al., 2012). FKBPs have been 
shown to be tightly associated with RyRs, with up to 4 FKBPs per channel (Jayaraman et 
al., 1992). Further insights into the role of FKBP12s in regulating RyRs came with the 
development of FKBP12 and FKBP12.6 knockout mice. In particular, FKBP12.6 knockout 
mice showed significantly increased RyR2 open probability and channel conductance 
(Shou et al., 1999, Vest et al. 2005). Although most studies suggest that FKBP12.6 binds to 
RyR2 and stabilises the channel in a closed state, thereby reducing the open probability of 
the channel, this topic still remains controversial and others have found different results 
(Galfré et al., 2012). Nonetheless, expression of FKBP12.6 has been shown to decrease in 
left atrial and PVCs, thereby resulting in an increased SR Ca2+ leak. JTV-519, a RyR2 
stabiliser which facilitates the binding of RyR2 and FKBP12.6 was demonstrated to 
attenuate induction of AF in a canine model and PVCs (Kumagai et al., 2003; Chen et al., 
2008). JTV-519 inhibits RyR2 openings and thereby reduces SR Ca2+ leak that may induce 
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DADs, spontaneous firing rates and results in arrhythmias (Kumagai et al., 2003; Chen et 
al., 2008). Our results shows that JTV-519 significantly reduces the frequency of both local 
and Ca2+ waves in PVCs (Figure 4.7), but also significantly affected the ability of slices to 
follow EFS (Figure 4.8). The utility of JTV-519 for controlling spontaneous Ca²⁺ signals 
within PVCs requires further studies to establish if there are conditions in which 
spontaneous events could be preferentially abrogated. 
A summary of the Ca²⁺ signalsome-affecting reagents used in this study and their putative 
targets are illustrated in Figure 4.27.  
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Figure 4.27. Summary of the pharmacological tools used to inhibit excitation-
contraction coupling in PVCs. Inhibiting Ca2+ influx from extracellular medium by 
inhibiting VOCCs with verapamil or CRAC channel with BTP2 reduced the frequency of 
global Ca2+ transients and the pacing success rate. Interestingly, inhibiting Ca2+ influx by 
blocking NCX reduced the frequency of local Ca2+ transients, but not that of Ca2+ waves 
and did not affect pacing. Additionally, both verapamil and SN-6 reduced the amplitude of  
Ca2+ waves whereas BTP2 did not. Unlike the others, BTP2 is the only drug that increased 
the transient duration of Ca2+ waves. Inhibiting SR Ca2+ release with JTV-519 had the most 
profound effects on excitation-contraction coupling and reduced the frequency of both 
Ca²+ waves and local Ca2+ transients, the amplitude and the pacing success rate. 
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The comparison of Ca²⁺ signalling in PVCs from 3 month- and 24 month-old mice 
indicated that spontaneous Ca²⁺ signals were more prevalent in the older animals (Figures 
4.13 and 4.14). Such spontaneous Ca²⁺ signalling was observed in the atrial cardiac 
myocytes of AF patients, and was attributed to enhanced RyR2 opening probability (Neef 
et al., 2010). In addition to their increased frequency in PVCs from 24 month-old mice, 
the spontaneous Ca²⁺ waves had significantly lower amplitudes and longer durations 
(Figures 4.9 and 4.10). Further studies are required to establish why spontaneous Ca²⁺ 
signals occur more frequently, and with altered properties, in PVCs from 24 month-old 
mice. In particular, it would be important to establish whether the RyRs have altered 
covalent modifications and gating characteristics, and if the PVCs from older animals have 
changes in NCX or Ca²⁺ ATPase activity causing them to be less efficient in transporting 
Ca2+. The reduction in SERCA2a activity and an increase in NCX forward current have also 
been found in other studies of ageing in cardiac myocytes (Hatch et al., 2011; Herraiz-
Martinez et al., 2015). Similarly, Wongcharoen et al., 2007 found a decreased expression 
of SERCA2a and increase in NCX and RyR expressions in PV tissues from aged rabbits. 
Based on these results and others, Wongcharoen et al., 2007 suggested that SR Ca2+ leak 
is increased via stimulated RyR2 activity that stimulated the occurrence of DADs and may 
promote arrhythmias in PV from aged tissues. The results presented here show that JTV-
519 and carvedilol reduced the frequency of spontaneous Ca2+ waves in PVCs that had a 
higher level of activity (≥ 0.5 Hz) regardless of the age group (Figures 4.17 and 4.19). Since 
a greater proportion of PVCs from 24 month-old mice had a spontaneous Ca²⁺ signals 
with a frequency ≥ 0.5 Hz, the effects of JTV-519 and carvedilol were more prominent 
with cells from older mice. Surprisingly, opposite to the results described here, ryanodine, 
another blocker of the RyR, induced spontaneous firing rates and incidence of DADs in 
PVs from young and aged rabbits rather than reducing DADs (Wongcharoen et al., 2007). 
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The ability of these compounds to have a more selective action on PVCs with a higher 
level of spontaneous activity could be potentially useful in terms of therapeutic 
intervention to assist cells maintaining rhythmic pacing. However, further studies are 
needed as previous studies have reported different results in PVCs. 
An intriguing observation was that PVCs from 24 month-old animals were significantly 
more difficult to pace using EFS than their 3 month-old counterparts (Figure 4.14). As 
described above, this difference was not due to the animals being treated any differently, 
or variation in the preparation of the cells. It would be informative to establish whether 
there are changes in the expression of proteins involved in responding to APs and 
triggering Ca²⁺ signals during EC-coupling. The major differences in spontaneous and EFS-
induced Ca2+ signals, and the effects of inhibiting RyR2 are summarised below in Table 4.2 
below. 
3 months vs. 24 months 24 months vs. 3 months 
1. Frequency of spontaneous Ca2+ waves 
(lower). 
2. Amplitude of spontaneous Ca2+ waves 
(higher). 
3. Transient duration of spontaneous Ca2+ 
waves (faster). 
4. EFS (efficient). 
1. Frequency of spontaneous Ca2+ waves 
(Higher). 
2. Amplitudes of spontaneous Ca2+ waves 
(lower). 
3. Transient duration of spontaneous Ca2+ 
waves (slower). 
4. EFS (less efficient). 
5. Carvedilol (only in PVCs with frequency ≥ 
0.5 Hz spontaneous Ca2+ waves). 
 
5. Carvedilol (only in PVCs with frequency ≥ 
0.5 Hz spontaneous Ca2+ waves). 
 
6. JTV-519 (only in PVCs with frequency ≥ 
0.5 Hz spontaneous Ca2+ waves). 
 
JTV-519 effects (only in PVCs with 
frequency ≥ 0.5 Hz spontaneous Ca2+ 
waves). 
 
7. Dantrolene (no effects). 7. Dantrolene (no effects). 
Table 4.2. Summary of the changes in Ca2+ homeostasis and the effects of RyR2 inhibition 
in 3 and 24 month-old mice. 
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One limitation of this study is that all experiments were conducted at room temperature 
(RT). Other studies have reported better potency of various compounds when 
experiments are undertaken at 37°C (de Tombe and ter Keurs, 1990, Chung and 
Campbell, 2003, Kanaya et al., 2005). The major disadvantages of performing the 
experiments at 37°C are a greater loss of the fluorescent Ca2+ indicator (Malgaroli et al., 
1987; Bootman et al., 2013), and difficulties in maintaining a steady temperature without 
gradients. The imaging performed in this study utilised inverted microscopes, and the 
objective lens that comes close to the lung slice is a substantial heat sink. Importantly, a 
previous study has shown that the frequency of the spontaneous activity in PVCs is not 
different at RT and 37 °C (Rietdorf et al., 2014). 
3 months 24 months 
1. ROS levels (lower). 1. ROS levels (Higher). 
2. Trolox (ROS scavenger)   
2 (a) spontaneous Ca2+ waves (decreased). 
2 (b) Pacing (No significant effects). 
2. Trolox (ROS scavenger)   
2 (a) spontaneous Ca2+ waves (decreased). 
2 (b) Pacing (No significant effects). 
 
3. Oligomycin + antimycin 
(a) Spontaneous local Ca2+ signals 
(reduced). 
(b) Amplitude (Reduced). 
(c) Pacing (Inhibited). 
3. Oligomycin + antimycin 
(a) Spontaneous local Ca2+ signals (No 
effects). 
(b) Amplitude (Reduced). 
(c) Pacing (Not affected). 
Table 4.3. The effects of Trolox and mitochondrial inhibition of Ca2+ homeostasis in PVCs 
from 3 and 24 month-old mice. 
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Measurements using ROS Brite indicated that PVCs from 24 month-old mice had 
significantly higher basal ROS production than PVCs from young mice (Figure 4.22, Table 
4.3). These findings concur with previous studies that showed increased ROS production 
during ageing (Cooper et al., 2013; Dorighello et al., 2017). It is also interesting to note 
that increased ROS production has been reported during AF (Huang et al., 2017) and in 
stressful conditions such as heart failure and obesity (Niemann et al., 2011; Guo et al., 
2013). The potential source(s) of ROS in PVCs were not investigated in this study, and 
require further work. However, increased ROS production has been linked to 
mitochondrial dysfunction (Xi et al., 2005, Yang et al., 2006, Cooper et al., 2003, Ni et al., 
2016). Mitochondria in cardiac myocytes have been shown to deteriorate during ageing 
and stressful conditions such as diabetes; they can be enlarged with disrupted cristae, 
and become more heterogeneous in shape (Feldman et al., 1981; Gupta et al., 2010). 
An increase in ROS production has been shown to affect Ca2+ homeostasis by modulating 
the opening of channels that are cysteine rich through redox modification (Cooper et al., 
2013). For example, RyR2 has been shown to be activated by ROS (Cooper et al., 2013). 
Moreover, post-translational thiol oxidation of RyRs caused by mitochondrial ROS 
production during ageing caused a significantly increased SR Ca2+ leak (Cooper et al., 
2013). To examine the consequences of ROS production on Ca2+ homeostasis, PVCs were 
incubated with the ROS scavenger Trolox, which significantly reduced the frequency of 
Ca2+ waves in PVCs from both 3 month- and 24 month-old mice (Figure 4.23, Table 4.3).  
Taken together with the data presented in Chapter 3, the results of this study support a 
hypothesis in which PVCs have deteriorating function as they age. The myofibres and 
mitochondria are less organised in PVCs from old animals, and they display significantly 
more spontaneous Ca2+ signals and are harder to stimulate using EFS. Moreover, PVCs 
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produce more ROS as they age, potentially as a consequence of mitochondrial 
dysfunction. The increased ROS production promotes spontaneous Ca2+ signals that can 
negatively affect the ability of PVCs to follow electrical pacing. Whilst it is difficult to 
control spontaneous Ca2+ signals in PVCs by using Ca2+ signalsome-affecting reagents 
without also affecting EC-coupling, ameliorating mitochondrial changes or ROS 
production may be helpful preventing pro-arrhythmic events. 
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Chapter 5: Development of a cellular model of cardiac ageing 
using chemical induction  
 
5.1. Introduction 
As outlined in Chapter 1, ageing studies in animals are typically conducted via protracted 
longitudinal experiments that compare cells, tissues or samples from young and old 
animals, or by using progeroid (usually mouse) models. Although these studies are 
effective, they are expensive and time-consuming. Moreover, it may be difficult to ensure 
that the growth environments of the young and old animals are exactly alike over 
prolonged periods. Previous studies have shown that acute treatment with hydroxyurea 
(HU) can induce cellular senescence and ageing phenotypes in both isolated cells (Park et 
al., 2000; Yeo et al., 2000; Narath et al., 2007) and animals (Banh et al., 2013). For 
example, HU was used to establish a model of neuronal ageing, using neural stem cells 
(Dong et al., 2014). For the reasons given above, an acute ageing model would be 
valuable research tool. To date, no attempt has been made to acutely age cardiac 
myocytes, for example by using HU. The studies described in this Chapter therefore 
sought to explore whether an acute, chemically-induced, cellular model of cardiac ageing 
could be established using cultured neonatal rat ventricular myocytes (NRVMs).  
5.1.1. Using NRVMs to develop a cellular model of cardiac ageing 
A putative cellular model of cardiac ageing was created by treating NRVMs with HU for up 
to 7 days. NRVMs were used for this study, since they are a more tractable system than 
PVCs. Moreover, there are some experimental parameters that are difficult to assess 
when using PVCs. For example, measuring SR Ca2+ is difficult with PVCs because they do 
not show the typical fast release of Ca2+ from the SR following the application of a high 
caffeine concentration (Rietdorf et al., 2014). As a result, SR Ca2+ content was not 
measured using the PVCs from 3 month- and 24 month-old mice that were described in 
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Chapter 4. In contrast, NRVMs responded to caffeine application with a rapid release of 
Ca2+ from the SR. Autophagy was also difficult to measure in PVCs within lung slices. The 
commercial kits that are currently available to stain autophagosomes were tested using 
PVCs, but did give a poor outcome due to significant background labelling. However, 
autophagy levels were readily characterised in NRVMs. Generally, autophagy is 
upregulated in stress (Russell et al., 2014), but downregulated in cardiac myocytes from 
aged animals (Shirakabe et al., 2016), so reduced autophagic flux was expected in HU-
treated NRVMs if this treatment induces an ageing phenotype. 
Based on the previous work discussed in Chapter 1, the results from the structural study 
in PVCs, atrial and ventricular myocytes (Chapter 3) and the functional study in PVCs 
(Chapter 4), it was anticipated that many cellular changes would be apparent in an ageing 
phenotype. In particular, it was considered plausible that the following aspects of NRVMs 
would be altered. 
(1) Ca2+ homeostasis: 
• The frequency of spontaneous Ca2+ signals would increase. 
• The percentage of cells that successfully follow pacing with EFS would 
decrease. 
• The SR Ca2+ content and the rate of SR Ca2+ re-uptake would be affected.  
(2) Mitochondria will show functional changes.  
(3) ROS production (basal and inducible) would be increased. 
(4) Autophagy would be decreased. 
(5) Structural changes:  
• Appearance of cellular ageing markers (e.g. lipofuscin) would be increased. 
• The number and size of mitochondria would be changed (although unclear 
whether increased or decreased). 
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5.2. Aims of the Chapter 
The work presented in this Chapter compared Ca2+ signalling, mitochondrial function, ROS 
production, autophagy and structural changes in control and HU-treated NRVMs. The 
principal aims were to characterise the physiological effects of HU-treatment, and 
compare them to features seen in naturally aged animals. The specific aims were:  
(1) Characterise Ca2+ homeostasis in control and HU-treated cells. In particular, the 
following aspects were investigated: 
• Frequency of spontaneous Ca2+ signals 
• Percentage of cells that successfully followed pacing with 2 Hz EFS  
• SR Ca2+ content and the rate of SR Ca2+ re-uptake 
(2) Compare the mitochondrial membrane potential in control and HU-treated cells.   
(3) Examine the basal and inducible ROS production in control and HU-treated cells.   
(4) Characterise autophagy and autophagic flux in control and HU-treated cells.   
(5) Investigate structural changes in control and HU-treated cells, with special attention to 
the:  
• Appearance of cellular ageing markers (e.g. lipofuscin) 
• Number and size of mitochondria 
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5.3. Changes in spontaneous Ca²⁺ signals and EFS-induced Ca²⁺ signals in HU-
treated cells compared to control cells 
The effects of HU treatment on Ca²⁺ homeostasis were analysed by studying the 
frequency of spontaneous Ca2+ signals, and the ability of NRVMs to follow pacing with 2 
Hz EFS, in control and HU-treated cells. NRVMs were imaged on a widefield fluorescence 
microscope, as described in Chapter 4, Figures 4.6 – 4.9. Whereas line-scanning was 
largely used for studies of PVCs, as described in the previous Chapter, widefield imaging 
was sufficient to record Ca2+ signals in monolayers of NRVMs. To visualise Ca2+ signals, 
NRVMs were loaded with Cal-520 and imaged at 12 Hz, similar to the experiments shown 
in Chapter 4, Section 4.4.1, Time-lapse widefield videos of all cells in a field of view were 
collected. ROIs were placed within the individual NRVMs, and Ca2+ traces were obtained 
for each of the individual ROIs using ImageJ, as described in Chapter 2 (Figure 2.3). For 
this Chapter, spontaneous Ca2+ signals were not categorised into local Ca2+ transients and 
Ca2+ waves. Successful responses to EFS pacing were classified according to the timing of 
the responses relative to an EFS pulse, and the rate of rise of the Ca2+ signal. As shown in 
Chapter 4, Figure 4.2D, EFS-induced Ca2+ transients had a faster rate of rise than Ca2+ 
waves.  
 
The experimental protocol used for these experiments is illustrated in Figure 5.1A. The 
imaging experiments lasted 30 seconds and were performed as follows:  
 
1. 10 seconds recording of spontaneous activity (pre EFS).  
2. 10 seconds with 2 Hz EFS (EFS). 
3. 10 seconds recording of spontaneous activity (post EFS).  
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This protocol was repeated on days 1, 4 and 7 days following addition of either 50 or 500 
µM HU to the NRVM growth medium. The first part of the recording, pre EFS, established 
the spontaneous Ca2+ signals activity in the cells prior to the application of EFS pacing. The 
second phase of the recording, during EFS, showed whether the HU-treatment of the cells 
affected their ability to follow electrical pacing, and the third and final part of the 
recording, post EFS, was used to assess whether the pacing affected the spontaneous Ca2+ 
signal activity in the cells. The frequency and amplitude of spontaneous Ca2+ signals 
(largely Ca2+ waves in the NRVMs), and the ability of the cells to follow EFS pacing were 
analysed by comparing these values between the different treatments, and on the 
different days post HU addition.  
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Figure 5.1. Spontaneous Ca2+ signals and EFS-induced Ca2+ signals in HU-treated NRVMs. 
Panel A illustrates the imaging and EFS stimulation protocol used, and shows 
representative Ca²⁺ traces obtained from control NRVMs, and cells incubated with 50 or 
500 µM HU for 4 days. Panel B quantifies the average frequency of spontaneous Ca2+ 
signals pre EFS for cells incubated with 0, 50 or 500 µM HU for 1, 4 or 7 days. Panel C 
quantifies the average frequency of spontaneous Ca2+ signals post EFS for cells incubated 
with 0, 50 or 500 µM HU for 1, 4 or 7 days. The data are presented as mean ± S.E.M., and 
were analysed using one-way ANOVA. n = 9 coverslips from 3 litters per treatment.  
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The Ca2+ traces shown in Figure 5.1A were derived from representative NRVMs on day 4 
of HU incubation, and illustrate the imaging protocol used. In all three conditions (0, 50 
and 500 µM HU), NRVMs displayed a low frequency of spontaneous Ca2+ signals (typically 
<1 Hz). Similar to the results observed when applying EFS pulses to PVCs (Chapter 4, 
Section 4.5, Figures 4.13 – 4.14), NRVMs showed regular responses and alternans during 
EFS pacing. Contrary to the observations made using PVCs, irregular responses were 
never observed in NRVMs. The Reponses of NRVMs were therefore classified into two 
types: 
 
1. Regular responses. Ca2+ transients during regular responses were elicited by every 
EFS pulse, and had similar pulse-to-pulse amplitudes. 
2. Alternans. During alternans, cells also responded to every EFS pulse, but the 
amplitude of the Ca2+ transients alternated between large and small. 
  
The control cells (orange trace on the left-hand side of Figure 5.1A) responded to 2 Hz EFS 
with regular Ca2+ transients. In contrast, the representative NRVM treated with 50 µM HU 
showed alternans (purple trace in the middle of Figure 5.1A). The representative NRVM 
treated with 500 µM HU only responded to every other EFS pulse (green trace on the 
right- hand side of Figure 5.1A). The frequency of spontaneous Ca2+ signals appeared to 
be lowest in control cells, greatest in NRVMs treated with 500 µM HU, and the frequency 
generally increased with duration of HU incubation (Figure 5.1B and C), but these 
differences are not statistically significant.  
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Figure 5.2. Frequency of spontaneous Ca2+ signals before and after application of 2 Hz 
EFS in HU-treated NRVMs. Panel A shows the frequency of spontaneous Ca2+ signals pre 
and post 2 Hz EFS on day 1 in control and HU-treated NRVMs. Panels B and C show the 
frequencies of spontaneous Ca2+ signals pre and post 2 Hz EFS on days 4 and 7. The data 
are presented as mean ± S.E.M., and were analysed using paired t-tests. * and ** denote 
P < 0.05 and P < 0.01, respectively. n = 9 coverslips from 3 litters. 
 
 
A direct comparison of the spontaneous activity in the three treatments pre- and post EFS 
showed that the frequency of spontaneous Ca2+ signals increased following application of 
2 Hz EFS (Figure 5.2). This effect was independent of the duration of NRVM incubation 
with HU. The responses of control and HU-treated cells to 2 Hz EFS were classified into 
regular pacing or alternans, as shown in Figure 5.3. 
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Figure 5.3. EFS elicited either regular responses or alternans in HU-treated NRVMs. 
Panel A illustrates regular responses during EFS application (Ai) and alternans (Aii). Panel 
B shows the percentage of NRVMs that displayed regular responses to EFS on different 
days of incubation with HU. Panel C illustrates the percentage of NRVMs that responded 
to EFs with alternans. The data are presented as mean ± S.E.M., and were analysed using 
one-way ANOVA. * denotes P < 0.05. n = 9 coverslips from 3 litters. 
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Almost all NRVMS, whether HU-treated or control, showed regular pacing when applying 
2 Hz EFS on day 1 (Figure 5.3B). The majority of control cells continued to show regular 
responses to EFS pacing on days 4 and 7 (Figure 5.3B). In contrast, the number of HU-
treated NRVMs that showed regular responses to EFS pulses was reduced on days 4 and 7 
of HU incubation (Figure 5.3B).  
On day 1, neither control nor HU-treated cells showed an abundant occurrence of 
alternans (<5 % of cells, Figure 5.3C). Moreover, under control conditions, few cells 
showed alternans on days 4 or 7. In contrast, the occurrence of alternans increased by 
day 4 in NRVMs treated with 50 µM HU, and on day 7 cells significantly more cells treated 
with 50 or 500 µM HU responded to EFS with alternans (Figure 5.3C).  The observation 
that changes in the responses of NRVMs to EFS were not evident following 1 day of 
incubation with HU suggested that these effects were not due to an acute action of the 
reagent, but rather that they appeared as a consequence of cellular remodelling over 
time. 
5.4. Comparison of SR Ca2+ uptake and Ca2+ content in control and HU-treated 
NRVMs 
The decreased ability of NRVMs to follow EFS in HU-treated NRVMs pointed to a change 
in either Ca2+ homeostasis or the expression of proteins involved in EC-coupling. One 
possible reason for dysregulated Ca2+ homeostasis in cardiac myocytes would be a change 
in the SR Ca2+ concentration (Trafford et al., 2000), for example caused by alterations in 
activity of the SERCA2a Ca2+ ATPase. To test whether this occurred in HU-treated NRVMs, 
the rate of SR Ca2+ uptake in control and HU-treated cells was measured.  
For these experiments, the SR Ca2+ store was emptied with caffeine, and the 
characteristics of the caffeine-induced Ca2+ transient were assessed. The imaging 
experiment lasted 120 seconds and was performed by continuously recording the 
following three parts as follows:  
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1. 20 seconds recording of the spontaneous activity.   
2. 30 seconds superfusion with Ca2+ free imaging buffer containing the Ca2+ chelator 
EGTA (500 µM).  
3. 30 seconds superfusion with 1 mM caffeine.  
 
During the first part of the recording, the basal Ca2+ concentration and spontaneous Ca2+ 
signalling within the cells were measured, thereby establishing that the cells were viable 
and showed typical Ca2+ signalling. During the second part of the recording, lasting 30 
seconds, extracellular Ca2+ was removed, thereby ensuring that only Ca2+ release from the 
SR was measured in the last part of the recording, and also causing the spontaneous Ca2+ 
signals in the NRVMs to cease. During the third and final part of the recording, caffeine 
was added to the cells for 30 seconds. At the concentration used (1 mM), caffeine added 
in phase 3 of the recording caused a rapid increase of cytosolic Ca2+ concentration due to 
activation of RyRs on the SR (Figure 5.4A). As expected, the caffeine-induced increase in 
cytosolic Ca2+ concentration was transient. The Ca2+ removal was due to the action of 
various Ca2+ transport processes, including export of Ca2+ across the sarcolemma by NCX 
and plasma membrane Ca2+ ATPases, and Ca2+ uptake into mitochondria. The parameters 
analysed for the caffeine-induced Ca2+ transient were illustrated in Figure 5.4B. The rate 
of Ca2+ clearance was characterised by fitting a one-phase exponential decay curve, and 
by measuring the transient duration at half-maximal amplitude (Figure 5.3B). In addition, 
the integrated caffeine-induced Ca2+ signal (hereafter denoted ‘area under the curve’; 
AUC) was used as an estimate for the total SR Ca2+ content (Díaz et al., 1997; Greensmith 
et al., 2014), and the maximal change in the peak amplitude for the Ca2+ release was 
calculated.  
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Figure 5.4. Comparison of recovery of caffeine-induced Ca2+ transients and SR Ca2+ 
content in control and HU-treated NRVMs.  Panel A shows representative caffeine-
induced Ca2+ transients in control and HU-treated cells. Panel B illustrates the parameters 
quantified in order to characterise the caffeine-induced Ca2+ signals. TD denotes transient 
duration. Panel C shows quantification of the time constant, tau, derived from fitting 
mono-exponential decay curves to the caffeine-induced Ca2+ signals. Panel D shows 
quantification of the transient duration, measured as full-width at half-maximal 
amplitude. Panel E shows quantification of the AUC. Panel F indicates the maximum 
amplitude (ΔF/F0) of caffeine-induced Ca
2+ transients in control and 500 µM HU-treated 
cells. The data present were all obtained on day 4 of HU incubation. The data are 
presented as mean ± S.E.M., and were analysed using unpaired t-tests. * and *** denote 
P < 0.05 and P < 0.001, respectively. n = 7 coverslips from 7 litters per group. 
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The transient duration (measured at 50 % of the maximum amplitude) and the time 
constant tau (Figure 5.4C and D) were both significantly increased in HU-treated NRVMs. 
These data indicate that the HU treatment slowed the rate of decay of the Ca2+ transient. 
In contrast, neither the AUC nor the maximum amplitude of the Ca2+ transient were 
different between control and HU-treated NRVMs (Figure 5.4E and F). The results 
observed here suggest that HU did not alter the SR Ca2+ content. Although this study 
found no change in the SR Ca2+ content, there might be still be alterations in either 
SERCA2a and/or NCX activity or in the Ca2+ leak from the SR. The fact that there were 
significant increases in the rate constant (5.4C) and transient duration (5.4D) in HU 
treated cells supported this further, but more studies are needed to establish whether 
SERCA2a and NCX activity are altered with HU treatment.  
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5.5. Assessing mitochondrial membrane potential in control and HU-treated 
NRVMs 
To understand the mechanisms underlying the changes in Ca2+ signalling found in HU-
treated NRVMs, experiments were performed to measure the mitochondrial membrane 
potential in control and HU-treated cells. The mitochondrial membrane potential was 
quantified using the ratiometric fluorescent indicator JC-10 (Kustiawan et al., 2017, Wang 
et al., 2016). This indicator emits green or red fluorescence during excitation with 488 
nm. The colour of the emission depends on presence of monomeric or aggregated forms 
of JC-10 within the mitochondrial matrix. In normally respiring cells, JC-10 accumulates 
within mitochondria and forms aggregates that have a red fluorescence emission. An 
example of the accumulation of red-emitting JC-10 aggregates is shown in Figure 5.5Ai. 
The JC-10 aggregates are in equilibrium with JC-10 monomers, which have a green 
fluorescence emission. An example of the green emission from JC-10 monomers within 
the same cells is shown in Figure 5.5Bi.  
Depolarisation of the mitochondrial membrane potential, for example using antimycin, 
causes the red-emitting JC-10 aggregates to dissipate into green-emitting JC-10 
monomers. An example of the effects of 10 µM antimycin on the red and green emission 
profiles of JC-10 is depicted in Figure 5.5A and B. It is evident that addition of antimycin 
caused a rapid decrease in the red emission, whilst simultaneously increasing the 
intensity of the green emission. JC-10 can be used to monitor mitochondrial membrane 
potential by assessing either the red or green fluorescence emission (Figure 5.5Ci), or by 
calculating the ratio of red to green fluorescence (Figure 5.5 Cii). Note that whilst the 
green emission from JC-10 initially increases after dissociation of the red-emitting 
aggregates, prolonged depolarisation of the mitochondrial membrane potential leads to 
the eventual loss of green-emitting monomers too.  
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Figure 5.5. Using ratiometric fluorescent indicator JC-10 to determine mitochondrial 
membrane potential in NRVMs. Panels A shows the red fluorescence of JC-10 aggregates 
before (Ai) and after (Aii and Aiii) addition of 10 µM antimycin. Panel B shows the green 
fluorescence of JC-10 monomers before (Bi) and after (Bii and iii) addition of antimycin. 
Panel Ci illustrates the fluorescence (a.u.) of JC-10 monomers (green bars) and aggregates 
(red bars) before (pre) and after (post) addition of antimycin. The ratio of the red/green 
JC-10 fluorescence is presented in Panel Cii. The data presented as mean ± S.E.M., and 
were analysed using one-way ANOVA. **** denotes P < 0.0001. n = 16 cells from one 
litter. The scale bar represents 20 µm. 
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JC-10 was used to compare the mitochondrial membrane potential in control cells with 
that of NRVMs on days 1, 4 and 7 of incubation with 50 µM or 500 µM HU (Figure 5.6). 
For these experiments, cells were co-loaded with MitoTracker Red (> 650 nm emission to 
avoid overlap with JC-10) to control the correct mitochondrial localisation of JC-10. The 
MitoTracker fluorescence was used to focus on the cells to allow the regions to be chosen 
unbiased, and to avoid photo bleaching of the JC-10 fluorescence prior to the image 
acquisition. After focussing on the cells, images for the green and the red JC-10 
fluorescence emission, and the MitoTracker fluorescence emission, were obtained.   
The representative images in Figure 5.6A show NRVMs on day 7. Control cells displayed 
substantial green and red JC-10 fluorescence emission profiles (Figure 5.6A, top row). The 
correct mitochondrial localisation of JC-10 was confirmed by co-loading the cells with 
MitoTracker Red. In contrast, NRVMs incubated with HU showed almost no red JC-10 
fluorescence emission, and a lesser green fluorescence (Figure 5.6A, middle and bottom 
rows). The MitoTracker Red labelling was also reduced.  
 In order to quantitate JC-10 fluorescence, 5 regions per coverslip were chosen by their 
MitoTracker Red staining, and the intensity of JC-10 green and red emission in those 
regions was recorded. Quantification of the JC-10 fluorescence indicated that incubation 
with either 50 µM or 500 µM HU caused a significant reduction in the JC-10 fluorescence. 
Surprisingly, the JC-10 fluorescence was increased on day 1 for cells treated with HU 
(Figure 5.6Bi). On day 4 NRVMs treated with 500 showed a reduced JC-10 fluorescence, 
indicating the presence of more depolarised mitochondria (Figure 5.6Bii). This is even 
more evident on day 7 when both groups of HU-treated NRVMs showed a reduction in 
the JC-10 fluorescence (Figure 5.6Biii). Unexpectedly, the JC-10 fluorescence in control 
cells on day 7 was higher than that on day 4 and 1.  
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Figure 5.6. Assessment of the mitochondrial membrane potential in control and HU-
treated NRVMs using JC-10. Panel A shows representative JC-10 and Mitotracker Red 
fluorescence images of NRVMs on day 7. MitoTracker Red was used to confirm that the 
JC-10 staining was localised in mitochondria. The scale bar represents 10 µm. Panels Bi - 
Biii summarise the data collected on days 1, 4 and 7. The red/green ratio changes in 
proportion with the mitochondrial membrane potential. The data are presented as mean 
± S.E.M., and were analysed using one-way ANOVA. * denotes P < 0.05. n = 9 coverslips 
from 3 litters. 
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5.6. Measurement of basal and inducible ROS levels in control and HU-treated 
NRVMs  
Basal ROS production was found to be significantly higher in PVCs from 24 month-old 
mice compared to cells from 3 month-old mice (Chapter 4, Section 4.7, Figure 4.22). 
Depolarised mitochondria have been shown to have an increased ROS production (Zhao 
et al., 2013). To test whether the decrease in the mitochondrial membrane potential 
found in HU-treated cells was associated with a change in the cellular ROS production, 
control and HU-treated NRVMs were loaded with the fluorescent ROS indicator ROS Brite. 
Images of ROS Brite-loaded NRVMs were captured on a widefield fluorescence 
microscope. The experimental protocol for these experiments was:  
 
1. 10-second recording of ROS Brite fluorescence within control or HU-treated 
NRVMs. 
2. Addtion of 10 µM antimycin, followed by imaging of ROS Brite fluorescence for 
120 seconds at 25 Hz. 
 
The basal ROS levels were analysed by comparing the mean fluorescence in the first 5 
images that were acquired. The inducible ROS production was analysed by calculating the 
mean ROS Brite fluorescence within control or HU-treated NRVMs at 10-second intervals. 
Control and 500 µM HU-treated NRVMs on day 4 after the treatment were chosen for this 
experiment, since  500 µM HU incubation for 4 days significantly altered mitochondrial 
membrane (Section 5.5, Figure 5.6Bii). NRVMs were co-loaded with MitoTracker Red to 
identify the cells (Figure 5.7Ai) since ROS Brite only showed a minimal fluorescence at the 
initiation of experiments (Figure 5.7Aii). The inducible ROS production was measured as 
illustrated in Figure 5.7B. After 10 seconds of collecting the baseline values, 10 µM 
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antimycin was added and the inducible ROS production was measured over a 120 seconds 
period (Figure 5.7B). The ROS Brite fluorescence increased strongly after addition of 10 
µM antimycin (Figure 5.7Aiii). The change in ROS Brite fluorescence was normalised to 
the starting level within each cell. Collapsing the mitochondrial membrane potential 
caused a greater increase in ROS Brite fluorescence in HU-treated NRVMs compared to 
the control cells. This difference was evident from 20 seconds after the antimycin 
addition until the end of the experiment when the ROS levels were still increasing (Figure 
5.7B). Despite the increased capacity of HU-treated cells to produce ROS after antimycin 
application, the basal ROS levels at the start of the experiment were not different in 
control and HU-treated cells (Figure 5.7C). 
These results suggested that HU treatment of NRVMs decreased their mitochondrial 
membrane potential, and increased the production of ROS when the mitochondria were 
further depolarised, but without altering the basal ROS levels within the cells. Both, the 
changes in mitochondrial membrane potential and the increased ROS levels can affect the 
cellular Ca2+ homeostasis (Cooper et al., 2003, Niemann et al., 2011; Guo et al., 2013, 
Huang et al., 2017). 
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Figure 5.7. Basal and inducible ROS production in control and HU-treated NRVMs. 
Panel Ai shows an image of NRVMs stained with MitoTracker Red. Panels Aii and Aiii 
show ROS Brite fluorescence in the same cells pre and 120 seconds post antimycin 
treatment, respectively. The scale bar represents 20 µm. Panel B shows changes in the 
ROS Brite fluorescence pre and post antimycin addition in control and 500 µM HU-treated 
cells on day 4 post HU treatment. The data presented as mean ± SEM., and were analysed 
using unpaired t-tests for the individual time points. Panel C compares the basal ROS 
levels in control and 500 µM HU-treated cells. The data are presented as mean ± S.E.M., 
and were analysed using an unpaired t-test. * denotes P < 0.05. n = 5 coverslips from 2 
litters per group. 
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5.7. Effects of HU treatment on autophagy 
Autophagy is a housekeeping process by which a cell recycles damaged and dysfunctional 
organelles and other molecules. In cardiac myocytes, increased autophagy was found in 
stressful conditions, but generally, the levels of autophagy were found to be reduced 
during ageing (De Meyer et al., 2010). A widely accepted method for quantifying basal 
autophagy is to count the number of autophagic vesicles in a cell after staining them with 
a fluorescent probe (e.g. CytoID kit, Enzo) (Klionsky et al., 2007; Mauvezin et al., 2014). 
Therefore, if HU treatment recapitulated an ageing phenotype a lesser number of 
autophagosomes would be expected in HU-treated cells compared to control cells 
(Shirakabe et al., 2016). To assess autophagy in the NRVMs, cells were loaded with the 
CytoID reagent for 30 minutes at 37°C degrees, and images were subsequently acquired 
using a widefield fluorescence microscope. For each coverslip, 5 - 10 regions were imaged 
and the mean number of autophagosomes per region was calculated.  
After staining with the CytoID reagent, the autophagosomes within NRVMs were evident 
as green fluorescent vesicles (Figure 5.9A). The number of autophagosomes was similar in 
control and HU-treated cells on day 1 (Figure 5.8Bi). Independent of the treatment, the 
number of autophagosomes increased over time. However, the increase was more 
pronounced in the HU-treated cells (Figure 5.8Bii and Biii).  
These results suggest that the HU treatment caused an induction of autophagy was not 
acute, but rather developed over time. The fact that the number of autophagosomes 
increased over time in control NRVMs was a sign that the conditions in which the cells 
were kept caused some stress to the cells, which was increased by HU.  
A better measure for autophagy is to characterise autophagic flux by observing the 
effects of inhibiting autophagosome production using the PI3-kinase inhibitor 3-MA, and 
inhibiting autophagosome degradation using bafilomycin-A1 or chloroquine. However, 
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these experiments were not achievable within this study. The preliminary results are 
presented in the context of future work in Chapter 6.  
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Figure 5.8. Effects of HU treatment on the level of autophagy in NRVMs. Panel A shows 
representative images of autophagosomes stained with the CytoID kit in control and HU-
treated cells. The scale bar represents 10 µm. Panels Bi - Biii show quantitation of 
autophagosome numbers in control cells and HU-treated NRVMs on days 1, 4 and 7. The 
data are presented as mean ± S.E.M., and were analysed using one-way ANOVA. **** 
denotes P < 0.0001, respectively. n = 20 - 60 regions from 3 litters. 
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5.8. Structural changes in HU-treated compared to control NRVMs 
Cardiac myocytes from old mice showed changes in their structure in TEM images 
(Chapter 3), with the organisation of their myofilaments and/or the number and size of 
mitochondria being different from those in young mice (Section 3.7.1, Figures 3.25 and 
3.26, Tables 3.1-3.3). As this study was intended to establish a cellular model of cardiac 
ageing, it was of interest whether markers of cellular stress or ageing appeared in HU-
treated cells. To investigate this, the structure of control cells and NRVMs treated with 
500 µM HU for 7 days was compared using TEM. The day 7 time point was chosen as it 
was expected to show the biggest difference between the treatments.  
TEM images of control NRVMs (Figure 5.9A-C) showed typical structures seen in cardiac 
myocytes: myofilaments with Z-lines (Figure 5.9A), abundant mitochondria in between 
the myofilaments (Figure 5.9A) and intercalated disks between the myocytes (Figure 
5.9B). The myofilaments in NRVMs appeared less densely packed than in ventricular 
myocytes (Chapter 3.6.3, Figures 3.20 and 3.21), and were more comparable to those 
found in atrial myocytes (see Chapter 3.6.2, Figures 3.14 and 3.15) or PVCs (Chapter 3.6.1, 
Figures 3.10 and 3.11). 
NRVMs treated with 500 µM HU for 7 days showed the same characteristic cardiac 
myocyte structure with myofilaments and intercalated discs (Figure 5.9D). However, they 
also contained structures that were less frequently seen in the untreated control cells 
(Figure 5.9E). In particular, there was an increase in the abundance of reticular 
membranes (plausibly ER or SR) decorated with ribosomes that were less evident in 
controls cells (Figure 5.9E and Figure 5.10D). These ribosome-associated reticular 
structures appeared around the sarcolemma and perinuclear area of the HU-treated 
NRVMs. In addition, HU-treated cells displayed autophagosomes and ‘membranous 
cytoplasmic bodies’, which are circular lipid aggregates linked to ganglioside 
accumulation in various lysosomal storage diseases (Ferreira and Gahl 2017 (Figure 5.9E).  
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Figure 5.9. TEM images of control and HU-treated cells. Panels A - C show representative 
TEM images of control cells on day 7, illustrating the presence of myofilaments (mf), 
intercalated discs and mitochondria (mi) with preserved cristae (outlined in orange). 
Panels D and E are representative images from 500 µM HU-treated cells on day 7, 
showing the presence of mitochondria with disrupted cristae, outlined in green (Panel D), 
ribosome-associated reticular membranes (r-a RM), membranous cytoplasmic bodies 
(MCB) and autophagosomes (au) (Panel E). 
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The increased appearance of autophagosomes in TEM images from HU-treated cells 
accord with the data presented in section 5.7 (Figure 5.9) that reported an increased 
number of autophagosomes found with live cell staining. In contrast to PVCs, atrial and 
ventricular myocytes from 24 month-old mice, no lipofuscin was seen in the HU-treated 
NRVMs.  
The size of individual mitochondrial was not different following the HU treatment (Figure 
5.9C and D, Figure 5.10A). The size of mitochondria was similar to that found in 
ventricular myocytes from 3 month- and 24 month-old animals, and to that in PVCs from 
24 month-old animals (Chapter 3, Section 3.7.2 and Figure 3.26). HU treatment reduced 
the number of mitochondria found in NRVMs (Figure 5.10B).  
NRVMs contained the smallest number of mitochondria: control NRVMs contained 8 ± 1 
mitochondria per 50 µm2, whilst the other cardiac myocytes from 3 month-old animals 
showed between 28.4 ± 1.8 (PVCs) and 43.8 ± 1.8 (atrial myocytes) per 50 µm2 (see 
Chapter 3, Tables 3.1 – 3.3, in which the number is given per 25 µm2).  
One structural sign for damaged/dysfunctional mitochondria is a disruption of the cristae 
(Terman et al., 2004a). An increase in the space in-between individual cristae in 
mitochondria was used to classify the mitochondria in ‘intact cristae’ or ‘disrupted 
cristae’, with a space of 100 nm cristae width as a threshold value. This analysis showed 
that HU treatment almost doubled the number of mitochondria that contained disrupted 
cristae (Figure 5.10C).  
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Figure 5.10. Quantification of the size and total number of mitochondria, and 
appearance of mitochondria with disrupted cristae, and the percentage of NRVMs 
containing ribosome-associated membranes in HU-treated NRVMs compared to control 
cells. Panel A shows mitochondrial size. Panel B shows mitochondrial number per 50 µm². 
Panel C shows the number of mitochondria with disrupted cristae per 50 µm². Panel D 
shows the percentage of NRVMs containing ribosome-associated membranes in control 
and HU-treated cells. The data are presented as mean ± S.E.M., and were analysed using 
unpaired t-tests. * and ** denote P < 0.05 and P < 0.01, respectively. n = 22 images from 
2 litters. 
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5.10. Summary of the chapter 
 
1. The frequency of spontaneous Ca2+ signals in NRVMs before or after application of EFS 
was not affected by HU treatment. Independent of the treatment, NRVMs showed a 
higher frequency of Ca2+ signals after a period of EFS application (section 5.3).  
 
2. HU treatment decreased the percentage of NRVMs that show regular responses to EFS 
pulses, and increased the percentage of cells showing alternans over time (section 5.3). 
 
3. The rate of decline of the cytosolic Ca2+ signal after addition of caffeine was decreased 
after HU treatment. The amount of Ca2+ in the SR, measured via the area under the curve 
for the caffeine release, and the maximum amplitude of the caffeine-induced Ca2+ 
transient, was not affected by HU treatment (section 5.4).  
 
 4. The mitochondrial membrane potential was measured using the fluorescent indicator 
JC-10. HU treatment of NRVMs caused mitochondrial depolarisation over time (section 
5.5). 
 
5. ROS levels were measured using the fluorescent indicator ROS Brite. ROS production 
was induced by depolarising mitochondria with 10 µM antimycin. Antimycin-inducible 
ROS production was increased in HU-treated cells (section 5.6).  
 
6. Autophagy was not affected by HU treatment on day 1. Accumulation of autophagic 
vesicles increased over time of NRVMs being in culture, and was greater in HU-treated 
cells than in control cells (section 5.7).  
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7. An analysis of TEM images from control cells and NRVMs incubated with 500 µM HU 
for 7 days revealed an increased number of ribosome-associated reticular membranes 
after HU treatment. Membranous cytoplasmic bodies, presumably an accumulation of 
gangliosides, and autophagosomes were present in the HU-treated cells. Lipofuscin was 
not present in either control or HU-treated NRVMs (section 5.8)  
 
8. The size of mitochondria, measured in TEM images, was not changed by HU treatment, 
and was similar to that in ventricular myocytes from 3 month- and 24 month-old mice 
(section 5.8).  
 
9. HU treatment reduced the number of mitochondria in NRVMs. In comparison to the 
other types of cardiac myocytes, NRVMs contained less than half the number of 
mitochondria per 50 µm2 (section 5.8).  
 
10. An increased proportion of mitochondria with disrupted cristae was found in HU-
treated NRVMs (section 5.8).  
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5.11. Discussion 
5.11.1. Cellular Model of Cardiac Ageing 
5.11.1.1. Why would a cellular model of cardiac ageing be useful?  
 
Investigating ageing using longitudinal studies of ‘naturally’ aged animals or genetically 
modified progeroid mouse models requires a long lead-time, administrative work and is 
expensive. Working with isolated primary cardiac myocytes is quicker and more flexible. 
However, adult myocytes do not survive for long in culture and so cannot be used for 
longitudinal ageing studies. NRVMs will survive in culture for much longer than adult 
myocytes, but cells isolated from neonates are the opposite of an ‘aged’ cell.  
Acute models of ageing have been used before to circumvent the issues with longitudinal 
studies. For example, mice models that show accelerated ageing induced by D-Galactose 
have been used to study neurological and behavioural effects of ageing (Wang et al., 
2009; Nam et al., 2014) and the loss of muscle strength (Chang et al., 2014), but their 
success depends on the exact conditions and age of the mice used for the treatment 
(Parameshwaran et al., 2010). A so-called cellular model of ageing in which an ageing 
phenotype is induced by addition of HU was been established for neural stem cells (Dong 
et al., 2014), but not for cardiac myocytes. Such a cellular model would allow the study of 
certain cellular aspects of ageing in cardiac in a more flexible manner. 
5.11.1.2. How does chemical induction of ageing work?  
 
HU is widely used in the treatment of sickle cell anaemia and as a tumour therapeutic 
agent. It exerts its effects by inhibiting DNA synthesis, increasing cellular ROS and causing 
growth arrest and senescence by inducing cell cycle inhibitors. These cellular effects of 
HU are believed to lead to a cellular phenotype similar to that observed in physiological 
ageing in animals or cells treated with HU  (Krakoff et al., 1968, Park, Jeong et al., 2000). 
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5.11.1.3. How can a cellular model of cardiac ageing be validated?  
 
To validate a cellular model of cardiac ageing it is important to show that the effects of 
the HU addition are mimicking those of natural ageing, and are not merely caused by 
cellular stress. The intention of this chapter was to compare the phenotype of HU-treated 
NRVMs with the structural (Chapter 3) and functional (Chapter 4) changes found in 
cardiac myocytes from old mice.  
Based on the results from Chapters 3 and 4, the following changes were expected in 
NRVMs if the HU addition mimicked ageing as it was seen in 24 month-old mice:  
 Increased frequency of spontaneous Ca2+ signals and occurrence of alternans 
 Elevated basal ROS levels 
 Diminished mitochondrial membrane potential 
 Dysregulated autophagy 
 Disrupted structure of myofilaments and mitochondrial changes 
 
Additional measures would be necessary for a comprehensive validation of an ageing 
model, but characterising these parameters would suggest whether it is worth pursuing 
this goal in future studies. Figure 5.11 summarises the results from Chapter 5, and 
compares them with findings presents in Chapters 3 and 4.  
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Figure 5.11. Summary of the changes in naturally aged PVCs and in chemically induced 
NRVMs. Changes in the ultrastructure, Ca2+ handling and ROS during ageing resemble 
those found in HU-treated cells which may be caused by either cellular ageing or cellular 
stress. All of changes may actually be facilitating the occurrence of AF. 
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5.11.2. HU effects on Ca2+ homeostasis 
5.11.2.1. Measurement of Ca2+ signals and EFS responses 
 
ROIs were placed inside the cells and the changes in fluorescence over time in were 
analysed in ImageJ and plotted as Ca2+ traces.  
The experimental paradigm was to measure the spontaneous activity for 10 seconds, 
then applies 2 Hz EFS for 10 seconds, followed by recording the spontaneous activity for 
another 10 second period.  
Successful responses to EFS pulses were identified by the fast rate of rise of the Ca2+ 
transient, as it was explained in Section 4.3.1.1 (Figure 4.2). For each day and treatment, 
the responses to EFS were classified into two groups: percentage of cells showing regular 
responses and percentage of cells showing alternans. Irregular responses, as described 
for PVCs, were not seen in NRVMs.  
 
5.11.2.2. Changes in the frequency of Ca2+ signals 
 
NRVMs displayed a lower frequency of Ca2+ signals before EFS application than after the 
pacing period (Figure 5.2), independent of the HU treatment or number of days in 
culture. Before EFS application, NRVMs showed generally a lower frequency of Ca2+ 
signals than PVCs: ~ 0.1 Hz in NRVMs (Figures 5.1 and 5.2), and ~ 0.4 Hz in PVCs from 3 
month-old animals (Chapter 4, Figures 4.7 and 4.14). However, following the EFS 
application, the frequency of Ca2+ signals in NRVMs increased and matched that seen in 
PVCs or was potentially higher (range between 0.3-0.6 Hz, Figure 5.2).  
A possible explanation for the increased frequency of Ca2+ signals following the EFS 
application is that during the period of EFS responses, whilst the cells showed 
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synchronous Ca2+ transients with a large amplitude, the content of the SR Ca2+ store was 
refilled, allowing for more frequent Ca2+ signals (Diaz et al., 2004).  
 
5.11.2.3. Changes in the EFS responses in HU-treated NRVMs 
 
Control cells responded to 2 HZ EFS with regular responses on days 1, 4 and 7. HU 
treatment reduced the percentage of cells that showed regular responses to pacing on 
day 4 and 7 after the HU addition (Figure 5.3). The cells not showing regular responses to 
the EFS responded with alternans; no irregular responses were observed. The fact that 
the occurrence of alternans was only significantly increased from day 4 onward indicated 
that the HU effects were not acute. A similar increase in alternans was seen in naturally 
aged PVCs, as discussed in Chapter 4 (Figures 4.9 and 4.10). Alternans were shown to be 
important for the development of arrhythmia (Kanaporis and Blatter, 2017). The 
occurrence of irregular pacing and alternans has been described in both, stressful 
conditions and during ageing (Narayan et al., 2011; Cutler et al., 2009; Narayan et al., 
2002), and thus do not allow the distinction of whether HU addition caused an ageing 
phenotype or merely cellular stress. 
 
5.11.2.4. Changes in SR Ca2+ uptake and SR Ca2+ content in HU-treated NRVMs 
 
The SR Ca2+ content was estimated by opening the RyRs on the SR with caffeine in the 
absence of extracellular Ca2+. The maximum amplitude of the caffeine-induced Ca2+ 
transient and the AUC were not different between the control and 500 µM HU-treated 
cells (Figure 5.4E and F). At any given time, the SR Ca2+ content is affected by several 
parameters, e.g. the size of the SR, the rate of Ca2+ loss via leaky RyRs and the rate of Ca2+ 
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uptake via the SERCA2a activity. Therefore, the maximum amplitude and the AUC are 
only rough estimates of the SR Ca2+ content, but they indicate that HU-treatment did not 
strongly affect the SR Ca2+ content. More detailed experiments, outlined in Chapter 6 
Section 6.2  ‘Future directions’, would be needed to test for changes in the leakiness of 
RyRs or SERCA2a activity, as it has been described to occur in AF (Neef et al., 2010, Hatch 
et al., 2011, Herraiz-Martinez et al., 2015). However, the rate of Ca2+ clearance was 
significantly longer in HU-treated cells (Figure 5.4C and D). The most important channel 
causing Ca2+ clearance in cardiac myocytes is the SERCA2a, estimated to remove 70 % -  
90 % (Lipskaia et al., 2010). The remaining Ca2+ is either removed over the sarcolemma via 
the NCX, PMCA, or taken up into mitochondria (Bassani et al., 1994, Pieske et al., 1999, 
Bers 2008, Lipskaia et al., 2010). Further experiments are necessary to test which of these 
processes was affected by the HU-treatment, and to establish whether the SERCA2a 
activity might be affected by HU. Taking into account that HU-treated cells had a larger 
proportion of depolarised mitochondria (Figure 5.6), that had a disturbed structure 
(Figure 5.9D – cristae), it is likely that Ca2+ uptake into the mitochondria is reduced in the 
HU-treated cells. If this is the case, application of antimycin and oligomycin to depolarise 
the mitochondria as it is the case in HU-treated cells should mimic the HU-effects in 
control NRVMs.  
 
However, changes in the level or activity of the NCX could also explain the quicker rate of 
Ca2+ clearance from the cytoplasm seen in control cells (Herraiz-Martinez et al., 2015; 
Hatch et al., 2011), and control experiments need to be performed to establish whether 
HU treatment affects the expression and/or activity of SERCA2a or the NCX.  
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5.11.3. HU induced changes in the mitochondrial membrane potential 
 
Changes in the mitochondrial membrane potential were investigated using the 
fluorescent indicator JC-10. A significant decrease of the mitochondrial membrane 
potential was found on days 4 and 7 in HU-treated cells (Figure 5.6).  
It had previously been shown that the mitochondrial membrane potential collapsed 
during ageing, calorific restrictions and p53-induced senescence (Pieri et al., 1994; Sugrue 
et al., 1999; Terman et al., 2004a; Niemann et al., 2011), which agrees with the results in 
HU-treated NRVMs. As a consequence, mitochondria cannot provide energy, in form of 
ATP, to the cell. Depolarised mitochondria also produce more ROS (Lin et al., 2017).   
 
5.11.4. Changes in basal and inducible ROS levels in NRVMs 
 
The basal ROS levels in HU-treated NRVMs were not different to those in control cells 
when measured using the fluorescent ROS indicator ROS Brite (Figure 5.7C). After 
collapsing the mitochondrial membrane with antimycin, HU-treated NRVMs showed a 
higher (inducible) ROS production than the control cells (Figure 5.7B).  
Both, ageing and stressful conditions have been shown to increase ROS levels as 
discussed before in Chapter 4 (Niemann et al., 2011, Cooper et al., 2013, Sag et al., 2014, 
Tribulova et al., 2015). In NRVMs, an age-dependent increase in lipofuscin granules and 
ROS levels coupled with a decrease in the mitochondrial membrane potential was found 
after keeping the cells in culture for up to 3 months (Terman et al., 2004a; Terman et al., 
2005).  
Cellular ROS can have many origins. Without further controls it is not possible to 
determine the cellular origin of the ROS measured here, but because the increase was 
measured acutely after the antimycin addition on the microscope stage, it likely 
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originates from the mitochondria, but this will need to be proven in future experiments. 
HU itself was shown to lead to the production of hydroxyl radicals and hydrogen peroxide 
inside cells (Banh & Hales, 2013). It was therefore surprising that HU treatment did not 
affect the basal ROS levels, rather, it only induced a temporary increase in the ROS 
production by inducing NRVMs to produce ROS after antimycin addition. Again, these 
results indicate that over time, HU treatment induced either cellular stress or senescence 
in the NRVMs, but it was impossible to distinguish between the two.  
 
5.11.5. Autophagy in HU-treated NRVMs 
 
This study highlighted that autophagy, measured by counting autophagic vesicles, was 
increased whilst NRVMs were kept in culture, and that the level of autophagy was 
significantly higher in HU-treated cells compared to control cells on day 4 and 7 (Figure 
5.9). Generally, studies have found that the level of autophagy in cardiac myocytes 
decreased with age. Increasing the rate of autophagy was found to alleviate the effects of 
ageing (Del Rosso et al., 2003, De Meyer et al., 2010, LaRocca et al., 2012, Shirakabe et 
al., 2016). In addition to ageing, long lasting external stress can also reduce autophagy 
and its cardioprotective effects (Nishida et al., 2015), whilst cells tend to respond to short 
term stress with an upregulation of autophagy (Russell et al., 2014).  
Therefore, the increased basal autophagy found here is more likely a sign for stress than 
an ageing phenotype. However, the experiments presented in this thesis only measure 
the total number of autophagosomes at one point in time, whilst autophagy has to be 
assessed as a balance of the production and degradation of autophagosomes (i.e. 
‘autophagic flux’). All steps of the autophagic flux are impaired by ageing (De Meyer et al., 
2010). An increased number of autophagic vesicles could be explained if the rate of 
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autophagosome degradation is slower than the rate of production, even if the overall 
level of autophagy in the cells is low. Attempts were made to characterise the autophagic 
flux (as illustrated in Chapter 1, Figure 1.8). The preliminary results are presented in 
Chapter 6 ‘Future Experiments’. However, the experiments have not yet been conclusive 
and need further optimisation. Therefore it is at this time impossible to comment on 
which part of the autophagic flux was affected by the HU treatment.  
 
5.11.6. Structural changes in HU-treated NRVMs 
 
To validate whether the HU treatment mimics processes occurring during physiological 
ageing, the structure of NRVMs was studied in TEM images. Particular attention was paid 
to changes of the mitochondria, after their number and size was changed when 
comparing TEM images of cardiac myocytes from young and old mice in Chapter 3. Only 
differences between control and 500 µM HU-treated NRVMs on day 7 on were studied in 
this part of the thesis.  
 
5.11.6.1. Appearance of structures that indicate cellular stress and/or ageing in 
HU-treated NRVMs  
 
The appearance of rough ER/SR indicates that HU-treated NRVMs might have a higher 
level of protein synthesis compared to the control cells. Protein synthesis and the number 
of ribosomes are usually reduced with increasing age in cardiac myocytes (Terman et al., 
2007), so the increased amount of rough SR could be a response to cellular stress (Han et 
al., 2013, Antonucci et al., 2015).  
An upregulation of the level of autophagy was shown in HU-treated NRVMs using live-cell 
staining (Figure 5.8). This was confirmed by the more frequent appearance of 
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autophagosomes in TEM images from the HU-treated cells compared to the control 
NRVMs. Autophagosomes were also more frequently seen in TEM images of the 24 
month-old mice, but not frequent enough to be reliably quantified. The apparent 
contradiction that autophagy is declining with age (Del Rosso et al., 2003, De Meyer et al., 
2010, LaRocca et al., 2012, Shirakabe et al., 2016), but autophagosomes are observed 
more frequently in TEM images could be due to the fact that these are actually 
dysfunctional autophagosomes accumulate during ageing, whilst smaller 
autophagosomes that are processed normally have not been seen in the images as we did 
not intend to quantify them. These dysfunctional autophagosomes are larger and more 
obvious in a TEM image, and contain material that can no longer be properly degraded, 
including lipofuscin (Terman et al., 2007).  
Another structure that was obvious in many images of the HU-treated NRVMs were 
membranous cytoplasmic bodies. These structures are most likely formed by ganglioside 
accumulations, and are a product of a defective lipid metabolism and a type of lipid 
storage product that is found in old cells and is a prominent marker in some lysosomal 
storage diseases (Ferreira and Gahl 2017). Like autophagosomes, membranous 
cytoplasmic bodies have also been observed in some TEM images of PVCs from 24 month-
old mice. However, neither of them appeared frequently enough to be quantified in the 
study of physiologically aged mice (Chapter 3), or in this chapter.  
None of the TEM images of control or HU-treated NRVMs showed the common ageing 
marker lipofuscin. Lipofuscin is an aggregation of non-degradable products that 
accumulate in the cell over time (Jung et al., 2007). Even if HU treatment accelerated an 
ageing process, the experiments presented here might not be sufficiently long to allow 
the accumulation of lipofuscin. This highlights that not all phenotypes of ageing could be 
recapitulated in an accelerated model of ageing.    
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5.11.6.2. Changes in size and number of mitochondria in HU-treated NRVMs  
 
HU-treated NRVMs showed a significant reduction in the number of mitochondria, but 
not change in their size. The different types of cardiac myocytes from adult mice showed 
different changes in the number and size of mitochondria: In PVCs, both, number and size 
of mitochondria were increased in, whilst atrial myocytes showed an increase in the size 
of mitochondria (Chapter 3, Table 3.1 and 3.2). The reduction in the number of 
mitochondria found in HU-treated NRVMs was therefore opposite to the changes 
observed in physiologically aged mice. The total number of mitochondria in control 
NRVMs appeared to be lower than that found in all three types of cardiac myocytes from 
adult mice. Control NRVMs contained ~ 8 mitochondria per 50 µm2, whilst the myocytes 
from adult mice contained between 28 – 44 mitochondria in the same area (PVCs and 
atrial myocytes from 3 month-old animals, respectively).  
As discussed in Chapter 3, previous studies reported variable alterations in the number 
and size of mitochondria, and within one disease opposing results can be found in 
different models, e.g. an increased mitochondrial size in atrial myocytes of a dog model of 
AF (Morillo et al., 1995) but a decreased mitochondrial size and increased mitochondrial 
number and in a goat model of AF (Ausma et al., 1997). Variable changes were also 
reported from other cardiac diseases, during ageing and in stressful conditions (Furuoka 
et al., 2001, Gupta et al., 2010).   
This indicates that the number and size of mitochondria were not a reliable indicators 
whether the observed in NRVMs reflect ageing or merely a stress response.  
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5.11.6.3. Disruption of the mitochondrial cristae 
 
The space between individual cristae, measured in the TEM images, was used as an 
indicator for intact or disrupted cristae. HU treatment increased the number of 
mitochondria that showed disrupted cristae. HU treatment also reduced the absolute 
number of mitochondria in the NRVMs. As a consequence, not only were fewer 
mitochondria present to deliver the ATP for the cell homeostasis in HU-treated NRVMs, 
but these also showed structural changes that are likely to lead to a dysfunction of the 
mitochondria. Previous studies have also reported disruption of cristae in aged animals 
compared to control ones. In some cases, mitochondrial cristae were found to be 
concentrated in some areas within the mitochondrion and absent from other areas 
(Feldman et al., 1981; Terman et al., 2004b, Gupta et al., 2010).  
 
5.11.7. Does HU treatment induce cellular stress or ageing? 
 
As mentioned before, the main purpose of this chapter was to gain further understanding 
of the changes that are happening in cardiac myocytes after treatment with HU to scope 
whether this treatment can be used to establish a cellular model of cardiac ageing. If it 
were successful, a cellular model of ageing should be able to reduce animal use, reduce 
costs and administrative work, and it can be available in a matter of weeks rather than 
years.  
Based on the comparison of cellular signalling in cardiac myocytes from 3 month- and 24 
month-old mice, the following parameters were chosen to judge whether HU treatment 
caused changes similar to those seen in ageing:  
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Parameter Change observed with 
age in mice / described 
in the literature 
Observed 
change in 
chemically 
induced ageing 
Criterion 
for 
ageing 
met 
Frequency of Ca2+ signals Increased  Unchanged No 
Successful pacing Decreased  Decreased  Yes 
Occurrence of alternans Increased Increased Yes 
Mitochondria with collapsed 
membrane potential 
Increased Increased Yes 
Basal ROS levels Increased unchanged No 
Level of autophagy Decreased (literature) Increased No 
Appearance of structural 
markers of ageing (TEM)  
Increased gangliosides 
and autophagosomes  
Increased  Yes 
Appearance of structural 
markers of ageing (TEM)  
Increased lipofuscin Absent No 
Mitochondrial size Changed / more 
variable 
Unchanged No 
Mitochondrial number  Changed / more 
variable 
Reduced Yes 
Disrupted cristae in 
mitochondria 
Increased (literature) Increased  Yes 
Table 5.1. Summary of the parameters studied in aged mice (Chapter 3 and 4), or if not 
investigated in mice, taken from the literature, and whether the changes in HU-treated 
NRVMs are similar or different to the expected changes. 
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Some of the observed changes, summarised in Table 5.1, are similar to those seen in aged 
mice, whilst others are different.  One explanation for the results would be that HU 
induced cellular stress and NRVMs became weaker over time, as has been suggested for 
the ageing models (Park et al., 2000; Yeo et al., 2000; Narath et al., 2007). To decipher 
whether HU treatment really caused an ageing phenotype, a characterisation beyond the 
cellular signalling parameters measured here is required. It would be of particular 
importance to focus on markers that are affected by ageing but not stress (or vice versa).  
 
In conclusion, the data collected at this point do not distinguish between HU inducing 
cellular stress or an ageing phenotype. However, it could be argued that ageing causes 
cellular stress and vice versa, and therefore an ageing model will always show signs of 
increased cellular stress. Further work is required to determine whether or not it is worth 
pursuing chemically-induced ageing models such as that described here. 
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Chapter 6. General discussion 
 
The heart is a muscular organ that beats continuously to pump blood and supply oxygen 
to the lungs and the rest of the body in mammals. To achieve this enormous task, the 
heart contains various cardiac myocytes that are structured in a highly ordered manner. 
In the heart, Ca2+ acts as a mediator between the electrical depolarisation of the cell and 
excitation-contraction coupling that results in contractions of the heart to pump the 
blood and ultimately blood flow. Therefore, maintenance of the heart’s structure and 
Ca2+ homeostasis are crucial to allow its function. Sadly, during ageing or in disease states 
like in AF, structural and Ca2+ handling remodelling in cardiac myocytes appear that 
results in a deficient cardiac output (Lai et al., 1999, Ausma et al., 2002, Klein et al., 2003, 
Van der Velden et al., 2003, Boldt et al., 2006, Sun et al., 2008). It is now widely accepted 
that structural and functional remodelling in atrial myocytes and PVCs are some factors 
that facilitate AF (Ausma et al., 1997, Thijssen et al., 2000, Ausma et al., 2001, Schotten et 
al., 2003, Gaborit et al., 2005). As ageing is a major risk factor for the development of AF, 
this thesis focused on the changes in the structural and Ca2+ homeostasis changes in PVCs 
during ageing, and how these changes can facilitate arrhythmias like AF.  
6.1. Overview of chapters 3, 4 and 5 
 
The work presented in Chapter 3 compared the changes in structure in PVCs, atrial and 
ventricular myocytes during ageing. The localisation of RyR2, Cx40 and Cx43 was 
compared in PVCs from 3 and 24 month-old mice and found a reduction of the Cx40 
expression in old mice. Electrical coupling of cardiac myocytes is critical for a smooth 
signal propagation and alteration of the Cx40 expression levels and localisations have 
been reported to occur in AF (Chaldoupi et al., 2009, Tribulova et al., 2015). The most 
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obvious structural changes in PVCs, atrial and ventricular myocytes from 3 and 24 month-
old mice regarded the number and size of mitochondria, the organisation of the 
myofibres and the appearance of lipofuscin. Mitochondria are of importance for cardiac 
myocytes to deliver the energy for the constant contractions, and a reduced number or 
impaired function would seriously affect the ability of a cardiac myocytes to contract. 
Changes in number and/or size of mitochondria of PVCs and atrial myocytes from 24 
month-old mice were found. Whether these result in an impaired mitochondrial function 
could only be tested for PVCs (Chapter 4). This thesis established a method to quantify 
the organisation of myofibres within a cardiac myocyte, and reported a better 
organisation in ventricular myocytes compared to atrial myocytes and PVCs. This could 
reflect that the main force to pump blood through the body and lungs is delivered by the 
ventricular myocytes. However, this organisation deteriorated and ventricular myocytes 
from 24 month-old mice had an organisation comparable to that in atrial myocytes and 
PVCs from 3 and 24 month-old mice, potentially explaining the reduced ability to pump 
blood found in hearts from aged animals (Mongensen et al., 2017; Nanayakkara et al., 
2017). For all three cell types, there was a significant increase in the ‘ageing pigment’ 
lipofuscin during ageing. 
To link the structural changes with alterations in Ca2+ homeostasis in PVCs during ageing, 
chapter 4 investigated changes in Ca2+ handling, contribution of mitochondria to the Ca2+ 
homeostasis and ROS production PVCs during ageing. Perhaps the most intriguing feature 
of murine PVCs is the occurrence of spontaneous Ca2+ transients both locally and globally, 
without an electrical input from the SA node cells. Therefore chapter 4 started by 
describing the features and channels involved in the development of spontaneous local 
Ca2+ transients and Ca2+ waves, and in the responses to EFS. Ageing of PVCs did not affect 
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the speed, Ca2+ wave directions and the characteristics of initiation points. Activity of 
RyR2 is critical for all Ca2+ waves and EFS responses in PVCs from both age groups.  
The Ca2+ waves from 3- and 24 month-old mice showed several differences: They 
occurred at a higher frequency in PVCs from 24 month-old mice, had reduced amplitude 
and a longer transient duration. Especially the combination of a higher frequency with a 
prolonged transient duration is likely to disrupt the ability of cardiac myocytes to respond 
to the next incoming AP (Hatch et al., 2011, Rietdorf et al., 2014, Herraiz-Martinez et al., 
2015, Rietdorf et al., 2015) as the cells would still be in a refractory period. In general, 
PVCs from 24 month-old mice were less able to follow pacing with 1, 3 and 5 Hz EFS when 
compared to PVCs from 3 month-old mice. In an animal, this may facilitate the occurrence 
of irregular heartbeats and impair the cardiac output. 
To investigate which components of the Ca2+ signalsome are causing the observed 
changes in the Ca2+ waves, a pharmacological study was performed, investigating the 
function of RyRs, NCX and SOCE. However, these did not show conclusive differences 
which channels cause the increased activity in PVCs from 24 month-old animals.  In 
contrast, it highlighted the importance of the frequency of the spontaneous activity for 
the effectiveness of the drugs. Chapter 4 revealed that JTV-519 and carvedilol reduced 
the spontaneous activity in PVCs with ≥ 0.5 Hz basal activity regardless of the age group. 
As PVCs from 24 month-old mice had a higher proportion of PVCs with frequency of 
spontaneous activity ≥ 0.5 Hz, JTV and carvedilol were more potent on PVCs from 24 
month-old mice. The increase in spontaneous Ca2+ signals in PVCs with age facilitates the 
occurrence of DADs and hinders their ability to follow electrical pacing (Hatch et al., 2011, 
Rietdorf et al., 2014, Herraiz-Martinez et al., 2015, Rietdorf et al., 2015). The average 
spontaneous activity reported herein is lower than the average spontaneous activity 
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reported by Rietdorf et al., 2014 which could be attributed to the differences in mouse 
strains used in the two studies.  
Chapter 4 also demonstrated that basal ROS levels were significantly higher in PVCs from 
24 month-old mice compared to 3 month-old ones. Reducing cellular ROS levels, e.g. by 
antioxidant treatment, is frequently discussed as a way to prevent typical ageing-induced 
changes (Yasuo et al., 2006; Sun et al., 2010), and indeed treating PVCs of both age 
groups with the ROS-scavenger Trolox significantly reduced the frequency of Ca2+ waves, 
which suggested that ROS may activate RyRs opening as previously suggested (Cooper et 
al., 2013). It is unclear what the ROS source was, but one possibility would be 
dysfunctional mitochondria (Cooper et al., 2003, Xi et al., 2005, Yang et al., 2006, Ni et al., 
2016).  
After seeing an increased in number and size of mitochondria in PVCs in TEM images from 
24 month-old mice (Chapter 3), the work in Chapter 4 examined whether this affected 
their function. An accumulation of defective mitochondria, often with an increased size 
and collapsed membrane potential, is typical for ageing (Feldman et al., 1981; Gupta et 
al., 2010) and ways of maintaining mitochondrial function are considered to prevent the 
development of cardiac dysfunctions (Graham et al., 2009, Javadov et al., 2009, Sun and 
Yang, 2017). For methodological reasons, was not possible to investigate whether there 
were differences in the mitochondrial membrane potential in PVCs from 3 and 24 month-
old mice inside lung slices. However, it was possible to inhibit the mitochondrial function 
in both age groups by addition of a combination of anti- and oligomycin and study the 
effects on the Ca2+ signalling. This treatment significantly reduced the frequency of local 
Ca2+ transients, affected successful pacing and inhibited the amplitude of Ca2+ waves. 
These effects were more pronounced in PVCs from 3 month-old mice. This might indicate 
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that the function of a proportion of mitochondria in PVCs from 24 month-old mice was 
already impaired so that a further inhibition had less of an impact. However, this theory 
would need further experimental proof before it could be accepted.  
The work presented in Chapters 3 & 4 demonstrated changes in the structure and Ca2+ 
signalling during ageing that are similar to those reported as facilitating arrhythmias like 
in AF, and highlighting the importance of PVCs as a pro-arrhythmic cell type. However, as 
will be outlined in Section 6.2 ‘Future Directions’, a more detailed study will be needed to 
deepen the understanding of the function of PVCs and help to identify potential new drug 
targets.  
Performing the experiments that were presented in Chapter 3 and 4 highlighted some 
problems of working with naturally aged animals, namely the long delays between the 
availability of animals, and the problems if further experiments needed to be performed 
at the end of an experimental period. Because ageing is a very popular research topic, e.g. 
a PubMed search of ‘cardiac ageing’ limited to 2017 found 2164 publications, ways of 
accelerating ageing to study it in an easier manner have been developed. These are e.g. 
progeroid mouse models or models using chemical induction of ageing (see Chapter 1, 
Section 1.8). The work presented in Chapter 5 was aimed to provide evidence whether or 
not the addition of HU could cause an ageing phenotype in NRVMs, or whether possible 
phenotypic changes were only caused by cellular stress. For this, Ca2+ signalling, 
mitochondrial function, ROS production and structure of control and HU-treated NRVMs 
were characterised and compared to those found in Chapters 3 and 4 or the literature. 
Similar to the findings in naturally aged cardiac myocytes, the HU-treated cells showed a 
reduced ability to follow electrical pacing, an increased occurrence of alternans and more 
mitochondria with a collapsed membrane potential. All of these are pro-arrhythmic 
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occurrences. Parameters that were not investigated in the PVC study, but were changed 
in HU-treated NRVMs included a higher proportion of dysfunctional mitochondria 
(indicated by a wider cristae width), increased inducible ROS production and an increase 
in the number of autophagosomes. Most of the parameters measured are affected in 
both, ageing and stress, making it difficult to distinguish between the two processes and 
validate the HU-treatment as a model of cellular ageing. Factors other than the cellular 
signalling processes investigated will have to be studied further to distinguish between 
the two. This could include markers for genetic instability, telomere attrition, epigenetic 
alterations like histone modifications or DNA methylation, loss of proteostasis (Lopez-Otin 
et al., 2013). It was intended to study the protein expression levels of proteins that 
change more profoundly in senescence than with stress (p53, PARP and advanced 
glycation end products), but the analysis was not successful (see Section 6.2 ‘Future 
directions’). However, seeing that ageing is putting the cell in a stressful situation, a 
certain amount of overlap of both processes is to be expected. 
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In summary, the most significant results when comparing the natural and chemically-
induced ageing were: 
 Altered structure in both, naturally aged PVCs and chemically induced NRVMs. 
Both of these changes manifest during ageing as well as in cellular stress 
conditions that hinder the cardiac output. 
 
 Pro-arrhythmic changes in the Ca2+ homeostasis were found in naturally aged PVCs 
and HU-treated NRVMs.  
 
 Basal and inducible ROS production was increased in PVCs from 24 month-old 
mice and HU-treated NRVMs, respectively. These may affect Ca2+ homeostasis. 
 
 Accumulation of structural ageing markers: lipofuscin in naturally aged PVCs; rSR, 
in HU-treated NRVMs; autophagosomes and gangliosides in both cell types.  
 
 Changes in the number (PVCs), size (PVCs and HU-treated NRVMs) and cristae 
width (HU-treated NRVMs), which might disrupted the normal Ca2+ homeostasis. 
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6.2. Future directions 
 
The data presented in this thesis demonstrate that changes in structure as well as Ca2+ 
signalling occur in PVCs during ageing. EM analysis carried out in Chapter 3 demonstrated 
poor mitochondrial integrity, an increased presence of lipofuscin granules and dis-
organised myofilaments in PVCs from aged mice compared to young ones (Figures 3.9 – 
3.12). To further confirm these changes especially in mitochondrial size and number, a 3D 
analysis on mitochondrial number and size in PVCs during ageing should be of great 
interest. Furthermore, more detailed study of connexins, including the localisation (end 
or lateral in the cells) that has been found to change in PVCs and including Cx45 that is 
found in other cells of the cardiac conductive system. Presence of Cx45 in PVCs is unclear, 
found to be present in PVCs (Kugler et al., 2017) or absent (Yamamoto et al., 2006). 
Potentially also test the functional importance of gap junction connectivity by 
blocking/opening gap junctions in functional studies.  
Whilst Chapter 4 revealed that verapamil; BTP2 and JTV-519 were successful in reducing 
the frequency of spontaneous Ca2+ signalling, they also reduced the ability of PVCs to 
follow electrical pacing (Figure 4.9). These data suggest reagents used affected the 
spontaneous activity and had negative effects on excitation-contraction coupling. This 
makes it difficult to pick out the Ca2+ sources involves in generating the spontaneous Ca2+ 
transients. Further studies are needed to be able to establish this particularly with BTP2 
reagent. BTP2 has been used in other studies to inhibit SOCE in SA node cells (Liu et al., 
2015). In this study, BTP2 significantly reduced the frequency of spontaneous Ca2+ waves, 
increased the duration of spontaneous Ca2+ waves and inhibited electrical pacing (Figures 
4.5, 4.7, 4.8). These data may indicate the possibility of SOCE role in generating 
spontaneous Ca2+ signals but the fact that it affected both spontaneous and EFS-induced 
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Ca2+ transients, this suggests that BTP2 may not be fully specific. Additionally, it still 
remains to be established whether PVCs express STIM and Orai proteins. Therefore, 
future studies investigating the role of SOCE in PVCs either during ageing or in AF should 
be desirable. Similarly, more detailed study of the role of the NCX in PVCs is needed, 
especially seeing that it reduced the frequency of local Ca2+ transients without affecting 
the ability of the cells to follow EFS, making it potentially interesting for the treatment of 
arrhythmia. 
Another interesting finding in Chapter 4 was the increased frequency of spontaneous Ca2+ 
transients in PVCs from aged mice compared to young mice (Figures 4.9 and 4.10). This 
data could indicate SR Ca2+ leakage but such conclusions cannot be made at the moment 
and further studies are needed to be carried-out looking at altered gating properties of 
RyR2s, protein and mRNA. This would mean that PVCs have to be isolated, which proved 
difficult in this study after considerable amount of time and efforts was spent in trying to 
isolate PVCs.  
The HU-treatment caused a prolonged rate of recovery after a caffeine-induced Ca2+ 
release from the SR, but didn’t show gross differences in the SR Ca2+ content. The 
experiments performed in this thesis do not distinguish between the different molecules 
that could cause the slowing down of the recovery: a reduced expression or activity of the 
NCX, the PMCA or the Ca2+ uptake into mitochondria. Taking into account the effects the 
HU treatment had onto mitochondria, it is likely that an impaired mitochondrial function 
contributed to the slower rate of Ca2+ clearance. However, this needs to be addressed in 
experiments specifically targeting the mitochondria (antimycin and oligomycin treatment 
before caffeine addition) or the NCX (NCX inhibition before the caffeine addition). 
Analysing the SERCA2a activity by measuring the rate of rise of the Ca2+ transient after 
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blocking SERCA2a with CPA would also contribute to a better understanding of the 
changes in SR Ca2+ handling seen after the HU treatment. Apart from structural and 
signalling changes, Chapter 5 also investigated the effects of HU treatment on autophagy. 
One of the widely accepted methods to investigate autophagy is to count the number of 
autophagosomes using fluorescence kits Klionsky et al., 2007; Mauvezin et al., 2014). By 
counting the number of fluorescently tagged autophagosomes, Chapter 5 demonstrated 
that basal autophagy was up-regulated in both control and HU-treated cells on day 4 and 
7 post HU treatment (Figure 5.8). However, this increase is significantly higher in HU-
treated cells compared to control cells on day 4 and 7 after HU incubation (Figure 5.8). To 
fully comment on the effect of HU treatment on autophagy, it is necessary to conduct 
further studies looking at the autophagic flux by monitoring the degradation and 
production of autophagosomes. It was intended to characterise the autophagic flux by 
using the mTORC1 / mTORC2 inhibitor PP242 to induce autophagy, 3-MA to prevent the 
production of autophagosomes and bafilomycin A1 or chloroquine to prevent the 
degradation of autophagosomes. However, the optimisation of the experiments was not 
achievable within the timeframe of this thesis. In this study, pp242 was used to induce 
the production of autophagosomes. Preliminary results in this thesis suggest an increase 
in autophagosomes with 5 µM pp242 in both control and HU-treated cells (Figure 6.1). 
However, as measures to prevent autophagosome formation using 3-MA were not done, 
and the inhibition of their degradation with bafilomycin or chloroquine were not 
consistent, it was difficult to draw any possible conclusion thus far and further studies 
investigating autophagic flux in control and HU-treated NRVMs are needed. The 
preliminary results collected so far are presented in Figure 6.1.  
 
317 
 
 
Figure 6.1. mTOR inhibition with pp242 increases the level of autophagy in control and 
HU-treated cells. Panel A shows representative images of autophagosomes in control and 
HU-treated cells with and without 5 µM pp242. Scale bar 10 µm. Panel B illustrates that 
pp242 can induce autophagy on day 4 in control, 50 µM HU, but not in 500 µM HU-
treated cells. A one way ANOVA, *P < 0.05. n = 3 coverslips from 3 litters. Data presented 
as means ± S.E.M. 
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Furthermore, Chapter 5 also revealed that HU treatment in NRVMs did not change AUC 
or maximum peak amplitude, but it slowed the clearance of Ca2+ (Figure 5.4). Although no 
attempts were made to directly measure the SERCA2a activity, considerable efforts were 
put in this thesis to quantify SERCA2a protein levels of control and HU-treated cells on 
day 1, 4 and 7. Unfortunately, data in this are not fully conclusive due to technical 
problems whilst harvesting cells, extracting sufficient quantities of protein and most 
importantly getting consistent loading. Troponin T was used as a loading control and did 
not give consistent loading for the various samples (Figures 6.2A and 6.3 A). It is therefore 
difficult to say whether the expression of SERCA2a changed over time, or whether there 
were problems with the sample loading (Figure 6.2). Therefore, quantifying SERCA2a 
protein levels in control and HU-treated cells should be of great interest.  
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Figure 6.2. Down-regulation of SERCA2a in both control and HU-Treated cells with no 
significant changes between the groups. Panel Ai shows representative blots of control 
and HU-treated cells showing representative bands of SERCA2a and Troponin T on day 1 
(Ai), day 4 (Aii) and day 7 (Aiii). Panel B summarises the relative protein levels of SERCA2a 
normalised to Troponin T of control and HU-treated cells on day 1, 4 and 7. Data 
presented as means ± S.E.M., a one way ANOVA, * P < 0.05, n = 3 litters per group. 
 
Finally, Chapter 5 demonstrated changes in the structure and Ca2+ signalling which are 
similar to those found in naturally aged PVCs. However, to fully establish whether HU 
treatment affected NRVMs down to the molecular level, a Western Blotting study was 
performed to analyse the effects of HU on protein levels of some ageing markers which 
include, p53, PARP-1 and advanced glycation end products. These suffered from the same 
methodological difficulties as described for studying the SERCA2a expression levels, and 
are therefore also inconclusive. The preliminary results and Western Blots are shown in 
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Figure 6.3. Hence further studies are needed on analysing either mRNA or protein levels 
of ageing markers.  
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Figure 6.3. No change in the levels of proteins linked to ageing in control and HU-
treated cells. Panel A shows representative immunoblots of advanced glycation end 
products, PARP-1, p53 and Troponin T of control and HU-treated cells on day 1, panel Aii 
(day 4) and Aiii (day 7). Panel Bi summarises the relative protein levels of advanced 
glycation end products normalised to Troponin T in control and HU-treated cells on day 1, 
4 and 7. Panel Bii represents relative protein level of PARP-1 and Panel Biii shows p53 
protein levels. A one way ANOVA, n = 3 litters per group, data presented as means ± 
S.E.M. 
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6.3. Limitations 
 
Perhaps the biggest obstacle of this study was not being able to isolate PVCs from mice. A 
modified Langendorff preparation to isolate PVCs was attempted several times but did 
not yield viable PVCs. Studying cells whilst they are in their normal tissue environment, 
like in the lung slice preparation, has several advantages (Sanderson, 2011), but also 
limitations. For example, it did not allow to load certain indicators (e.g. JC-10, CytoID to 
measure autophagy) to study the function of PVCs from aged mice and compare them to 
HU-treated cells.  
Studying murine PVCs only allows access to very limited amounts of material. For 
example, it would be difficult to obtain enough material for a PCR analysis or even a 
Western Blot.  
Mice and rats have a very high resting heart rate and do not naturally develop AF. The 
spontaneous activity so typical for murine PVCs is not commonly observed in larger 
animals. The easy access to murine PVCs in lung slices makes these a good model to study 
their basic signalling, but it would be desirable to move these studies to a larger animal 
model.  
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6.4. Wider implications of the results 
 
Ageing is a complex process which leads to an increased damage of molecules, cells, 
tissues and organelles that is characterised by a progressive decline in the function and 
rise in susceptibility in diseases. Advancing age is associated with the onset of 
cardiovascular and neurological diseases. As the proportion of the ageing population 
increases, the prevalence of ageing associated diseases will also increase. Results 
presented in this thesis demonstrated that ageing is associated with structural 
remodelling and disturbed Ca2+ handling in cardiac myocytes. Changes in the structure 
and function of mitochondria, an increased appearance of lipofuscin granules, higher ROS 
levels and an altered Ca2+ homeostasis were described to occur in PVCs during ageing.  
These changes are not confined just in cardiac myocytes, but similar changes have also 
been reported in the brain (Pearce et al., 1997; Smith et al., 2010). 
This thesis has shown that altered Ca2+ homeostasis is a complex matter that involves a 
range of organelles, channels and pathways. This provides us the means to develop 
pharmacological interventions to target a range of channels and organelles to tackle the 
changes that manifest during ageing. Finding a PVC-specific target would allow AF 
treatment without off-target effects on atrial and ventricular myocytes. So far, most 
drugs that are used to treat AF are Na+ channels inhibitors, beta-blockers, Ca2+ channel 
blockers, K+ channel blockers and sodium-potassium ATPase blockers (see Chapter 1.1 for 
AF pharmacological treatments). Although these drugs are effective in relieving AF 
symptoms, they are associated with severe side-effects and in some cases in-effective 
(Camm et al., 2010). This reinforces the need for better and more specific treatments. 
Our study has demonstrated connexin remodelling in PVCs, the appearance of 
dysfunctional mitochondria and elevated ROS levels during ageing which in turn may 
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interfere with the Ca2+ homeostasis. Hence, targeting ROS production and mitochondrial 
dysfunction provides other means of tackling altered Ca2+ homeostasis during ageing.  
New drugs are now being developed and tested that target gap-junctions. One such drug 
is 9f (GAP-134) that is currently in phase I clinical trials for the treatment of AF. This drug 
has been shown to significantly prolong the time to AV block in the mouse CaCl2 
arrhythmia model after oral administration (Butera et al., 2009). Another antiarrhythmic 
peptide rotigaptide (ZP-123) increased gap junction intercellular communication in 
cardiac myocytes expressing Cx43 (Clarke et al., 2006). Additionally, other sets of anti-
ageing drugs that are emerging are natural phenolic compounds that targets ROS. 
Amongst these is resveratrol which is found largely in the skins of red grapes, nuts and 
pomegranates, is a ROS scavenger and has been shown to improve cell survival (Yasuo et 
al.; Baur et al., 2006; Sun et al., 2010). Additionally, other natural compounds including 
omega-3 that is in fish oil have also been shown to have protective effects in patients 
with arrhythmias (Leaf et al., 2005; Brouwer et al., 2009). However, results from clinical 
trials in patients with arrhythmias have produced conflicting results, and hence need 
further investigations (Leaf et al., 2005; Brouwer et al., 2009). With regards to 
mitochondrial dysfunction, preventive measures are surfacing that seek to inhibit this 
reduction by re-strengthening the already weakened antioxidant mechanisms. 
Glutathione which is an intracellular thiol compound, which is produced in the cytosol of 
mammalian cells, is the main antioxidant mechanism form of defence against ROS and 
electrophiles. Previous studies have reported reduced levels of glutathione in the brains 
of patients with Parkinson’s disease (Pearce et al., 1997) and in the ageing brains of mice 
(Mo et al., 1995). Dietary supplements that include vitamins have been found to protect 
against the development of AF (Carnes et al., 2001; Lin et al., 2010). (Carnes et al., 2001) 
showed that Vitamin C attenuated pacing-induced atrial remodelling atrial peroxynitrite 
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production. However, (Shiroshita-Takeshita et al., 2004) did not find the protective 
effects of vitamins C and E against AF. Therefore, maintaining these antioxidants could be 
another protective measure to protect against AF, but further studies are still needed. 
In conclusion, this thesis has shown that PVCs undergo structural remodelling and 
develop abnormal Ca2+ handling during ageing, which facilitate the maintenance of AF. 
Whilst most of the available pharmacological treatments in AF rely on classical channel 
inhibitors, there is a still a lack of drugs that target ROS, mitochondrial dysfunction and 
gap junctional changes, all of which are shown to be dysregulated during ageing and in 
AF. 
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